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Summary 
 
The translation of a messenger RNA (mRNA) into a polypeptide chain is a complex and tightly 
regulated process that requires the concerted action of a plethora of factors at the ribosome. 
Failure of this process, e.g. due to translation of damaged transcripts or insufficient translational 
fidelity, can result in inhibition of translation elongation or termination, an aberrant condition 
known as ribosomal stalling. This situation is further aggravated by the fact that erroneous 
translation leads to the production of faulty nascent polypeptides, which pose a serious threat to 
cellular protein homeostasis (proteostasis) as they typically lack function and tend to form 
potentially toxic aggregates. Thus, organisms from all kingdoms of life have evolved mechanisms 
to maximize translational fidelity, to recognize and rescue stalled ribosomes, and to rapidly 
degrade faulty mRNAs and their translation products. 
 In eukaryotes, the ribosomal quality control (RQC) complex recognizes 60S-peptidyl-
tRNA complexes, an aberrant species generated by noncanonical splitting of stalled ribosomes. 
Following recognition of an exposed tRNA moiety in the ribosomal P-site by Rqc2p, recruitment 
of the RING E3 ubiquitin ligase Ltn1p to the 60S subunit allows for ubiquitination of the aberrant 
polypeptide. After extraction of the nascent chain by Cdc48p in an ATP-dependent manner, the 
polypeptide is targeted for proteasomal degradation. Failure of this process has been linked to 
neurodegeneration in mice. However, the cellular mechanisms underlying this phenotype remain 
unclear. 
 In this study, we systematically investigated the effects of RQC impairment on the 
proteostasis network in the baker’s yeast Saccharomyces cerevisiae using a wide array of 
biochemical methods and recombinant reporter constructs. We found that deletion of LTN1 leads 
to the formation of detergent-insoluble aggregates that sequester various key proteostasis factors, 
thus impairing general protein quality control mechanisms and exerting proteotoxic stress. We 
were also able to show that protein aggregation depends on an unexpected, Rqc2p-mediated 
modification of the nascent chain. Moreover, we could provide evidence that the ribosome 
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provides a central hub at which RNA and protein quality control pathways tightly cooperate in 
order to maintain proteostasis. Finally, we were able to propose a mechanism for aggregate 
formation and to identify several potential endogenous faulty polypeptide chains. 
 Our study not only provides novel insights into the molecular mechanisms of protein 
aggregation in vivo, but also suggests an explanation for pathological conditions such as 
neurodegeneration observed upon failure of the proteostasis network. These findings could help 
in understanding various incurable diseases that have been linked to protein aggregation and 
proteostasis imbalance. Moreover, due to the continuous increase in life expectancy during the 
last century, the importance of ageing as a risk factor for proteostasis imbalance has greatly 
increased, underlining the need to find ways to stop or at least delay the progressive decline of 
proteostasis network capacity. Our results might aid in finding novel therapeutic approaches that 
counteract the deleterious effects of disease-related proteostasis imbalance and help to preserve 
proteome integrity even at an advanced age. 
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I. Introduction 
 
I.1 Protein folding and molecular chaperones  
 
Proteins (from Greek “proteios”, meaning “primary” or “of the first order”) form the most 
versatile group of biomacromolecules and play an essential role in almost every cellular process. 
They are synthesized as linear chains of amino acids that are connected to each other via a peptide 
bond. The formation of this peptide bond is catalyzed by ribosomes, large assemblies of protein 
and RNA that read the nucleotide sequence of an input messenger RNA (mRNA) and translate 
this information into an amino acid sequence. As it emerges from the ribosome, the resulting 
nascent polypeptide chain needs to fold into a unique, three-dimensional structure in order to 
yield a functional protein (Dobson, Šali et al. 1998). The state under which a protein is functional 
is defined as its native fold and generally represents a thermodynamically stable condition, i.e. a 
state where it has a minimum of free energy (Anfinsen 1972). Anfinsen’s experiments with 
ribonuclease A (RNase A), a small protein that can fold spontaneously in vitro, showed that all 
information that is necessary for a protein to fold into its native state is encoded in its primary 
structure, i.e. its amino acid sequence (Anfinsen 1972, Anfinsen 1973). Based on these results, it 
was suggested that the folding process is mainly driven by the sum of interactions between amino 
acid side chains and the polypeptide backbone. Hydrophobic side chains tend to collapse into a 
core region inside the folding protein, with hydrophilic residues exposed to the aqueous 
environment of the cell, a phenomenon called the hydrophobic effect (Dill, Bromberg et al. 1995, 
Daggett and Fersht 2003). This mechanism works well for polypeptides consisting of up to 100 
amino acids, which can fold into their native state spontaneously within milliseconds and to full 
yield (Brockwell and Radford 2007); for larger proteins, however, the folding process is 
intrinsically error-prone. Since more than 90 % of the eukaryotic proteome consists of proteins 
longer than 100 amino acids, cells invest considerable resources in order to ensure productive 
protein folding (Balchin, Hayer-Hartl et al. 2016).  
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 How do proteins ultimately find their native state? If we assume that a newly synthesized 
polypeptide chain randomly samples all possible conformations until it finds its native fold, then 
a small protein consisting of 100 amino acids would need more than 1070 years to fold, even if 
sampling would occur at picosecond rates; most proteins of that size, however, fold within 
milliseconds, a contradiction referred to as “Levinthal’s Paradox”. To resolve this paradox, it has 
been suggested that protein folding does not occur in a random manner, but by following defined 
pathways consisting of folding intermediates, thereby reducing the folding time to physiological 
timescales (Dill and Chan 1997). This model was later refined by the introduction of a rugged 
“folding funnel” concept (Fig. I.1), which accounts for the fact that progressive folding and burial 
of hydrophobic residues in folding intermediates further restrict the number of possible 
conformations (Dinner, Sali et al. 2000). In addition, this model is able to explain the slow or 
unproductive spontaneous folding of some large proteins: while navigating the free energy 
landscape, the folding polypeptide chain might encounter kinetic barriers and transiently 
populate partially folded or even misfolded states that correspond to local minima of free energy 
(Fig. I.1, green area). A hallmark of these kinetically trapped species is the exposure of “sticky”, 
hydrophobic patches that would otherwise be buried inside the native protein structure due to 
the hydrophobic effect. Since a polypeptide chain can spend a considerable amount of time in 
such a partially folded state, kinetically trapped folding intermediates are especially vulnerable 
to unwanted intermolecular interactions that might result in the formation of potentially toxic 
oligomers, amorphous aggregates or amyloid fibrils (Jahn and Radford 2005, Hartl and Hayer-
Hartl 2009) (Fig. I.1, red area). 
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Fig. I.1: The rugged protein folding funnel concept. On their way down the free energy landscape, 
unfolded proteins sample various conformations such as folding intermediates or partially folded states 
until they finally reach their thermodynamically favored native state, a process that is driven by 
intramolecular interactions (green area). Partially folded states might correspond to local minima of free 
energy, leading to protein molecules being kinetically trapped and prone to aberrant intermolecular 
interactions, resulting in the formation of potentially toxic oligomers, aggregates or highly stable amyloid 
fibrils (red area). Molecular chaperones help in guiding protein molecules along a productive folding 
pathway by both reducing kinetic energy barriers and preventing unwanted intermolecular interactions. 
Figure adapted from (Balchin, Hayer-Hartl et al. 2016). 
 
To overcome the energy barriers of kinetically trapped folding intermediates, cells have 
evolved a broad arsenal of molecular chaperones: highly conserved proteins that interact with 
the non-native states of other proteins, stabilize them, and help them to acquire their native state 
without being present in their final structure (Hartl 1996). Chaperones assist in protein folding 
by binding to newly synthesized polypeptide chains as well as to partially folded or misfolded 
states, thereby preventing aggregation and promoting both de novo protein folding and refolding 
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events. In addition, chaperones participate in the dissociation of protein aggregates and clearance 
of terminally misfolded proteins by cooperating with the proteasomal and autophagosomal 
degradation machinery (Fig. I.2) (Gamerdinger, Hajieva et al. 2009, Ciechanover and Kwon 2015, 
Mogk, Kummer et al. 2015).  
 
 
Fig. I.2: The roles of molecular chaperones in protein folding. Chaperones assist in protein folding by 
binding to newly synthesized polypeptide chains, to partially folded or misfolded states and to protein 
aggregates, thereby preventing their participation in unwanted off-pathway interactions and promoting 
both de novo folding and refolding events. Chaperones also cooperate with the cellular degradation 
machinery in order to target aberrant protein species for proteasomal or autophagosomal degradation. 
Figure adapted from (Balchin, Hayer-Hartl et al. 2016). 
 
A subset of chaperones is usually referred to as “Heat Shock Proteins” (Hsps), because 
they were found to be strongly upregulated during conditions of conformational stress, e.g. heat 
stress. They are usually classified into six evolutionary conserved groups according to their 
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molecular weight: Hsp40s, Hsp60s, Hsp70s, Hsp90s, Hsp100s and the small Hsps. Small Hsps are 
almost exclusively stress-induced, and work as ATP-independent “holdases” that prevent 
aggregation by transiently binding to non-native protein species. In contrast, the members of the 
other chaperone families can be either constitutively expressed or stress-inducible, are ATP-
dependent and participate more actively in the folding process as so-called “foldases” (Vabulas, 
Raychaudhuri et al. 2010, Kim, Hipp et al. 2013, Treweek, Meehan et al. 2015). 
 
I.2 Protein aggregation in vivo 
 
Folding of proteins in vivo differs substantially from the isolated and dilute in vitro conditions in 
which protein folding is studied. Due to the extremely high concentration of macromolecules 
such as proteins, carbohydrates and nucleic acids in the cell (up to 300-400 mg/mL total protein 
in the cytosol), the effective space in which a newly synthesized polypeptide chain can move and 
fold is greatly reduced, a phenomenon called macromolecular crowding, or the excluded volume 
effect (Ellis 2001, Ellis and Minton 2006). This crowding effect leads to extremely high effective 
concentrations of unfolded polypeptide chains, a condition which in turn promotes aberrant 
intermolecular interactions and therefore aggregation (Ellis and Minton 2006). This situation is 
further aggravated by the fact that translation, with an incorporation rate of only 4-20 amino acids 
per second, is a rather slow process. Folding cannot occur until the complete polypeptide chain 
(or at least a domain) has been synthesized, leaving the unfolded nascent chain exposed to the 
crowded cellular environment for up to several minutes in the case of a medium-sized protein 
(Etchells and Hartl 2004, Lu and Deutsch 2005). This leaves enough time for exposed hydrophobic 
patches to participate in unproductive intermolecular interactions, thereby further promoting 
aggregation of nascent polypeptides. In addition, protein aggregation in vivo can also be the result 
of stress-induced unfolding, or mutations that affect protein stability. 
Introduction 
 
8 
 
 Protein aggregation has been linked to numerous progressive and late-onset 
neurodegenerative disorders including Huntington’s disease (aggregated huntingtin protein), 
Alzheimer’s disease (Aβ and tau protein), Parkinson’s disease (α-synuclein), amyotrophic lateral 
sclerosis (TDP-43, FUS and SOD1) and Creutzfeldt-Jakob disease (prion protein). A hallmark of 
these diseases is the age-dependent accumulation of the respective protein in a non-native state 
and, subsequently, the formation of amyloid-like fibrils that form visible intra- or extracellular 
inclusions especially in the brain (Dobson 1999, Bucciantini, Calloni et al. 2004). Strikingly, despite 
having completely different chemical properties and functions in the cell, these proteins form 
highly stable amyloid fibrils consisting of β-sheet structures running perpendicular to the fibril 
axis, probably due to the fact that this state represents a thermodynamically favored condition 
for proteins that cannot fold into their native structure (Fandrich and Dobson 2002). Thus, the 
ability to form amyloid fibrils has been recognized as a generic feature of proteins, and extensive 
studies on the mechanism of fibril formation have been carried out using model proteins such as 
lysozyme or polyQ proteins (Booth, Sunde et al. 1997, Scherzinger, Lurz et al. 1997). A generic 
feature of fibril formation seems to be the thermodynamically unfavored, nonspecific 
oligomerization of partially unfolded or misfolded proteins. These soluble oligomers can serve 
as “aggregation nuclei” for the formation of protofilaments, which then rapidly assemble into 
fibrillary structures and form visible aggregate deposits (Buell, Dobson et al. 2014, Knowles, 
Vendruscolo et al. 2014). Since the occurrence of visible deposits in patients has been historically 
associated with disease, it was reasoned that amyloid fibrils have a cytotoxic effect on the cell. 
More recent studies, however, indicate that soluble oligomers might be the cytotoxic species due 
to their exposure of hydrophobic patches: in fact, the formation of amyloid fibrils and their 
storage in extracellular deposits might have a cytoprotective role (Arrasate, Mitra et al. 2004). 
 The toxicity of protein aggregation in vivo can be explained by two theories: the loss-of-
function theory, which assumes that aggregation leads to depletion of functional protein and 
failure of essential cellular processes, and the gain-of-toxicity theory, which reasons that exposure 
of hydrophobic patches on the surface of protein aggregates leads to unwanted interactions with 
functional or newly synthesized polypeptides, or with cellular membranes. Oligomeric 
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aggregates provide a “sticky” surface due to the exposure of hydrophobic patches and unpaired 
β-strands, and can therefore participate in aberrant intermolecular interactions with newly 
synthesized polypeptides or metastable proteins. In fact, several studies have shown that 
common patterns of aggregation-mediated cytotoxicity are the sequestration of essential 
chaperones from the cytosol and interference with RNA homeostasis (Olzscha, Schermann et al. 
2011, Park, Kukushkin et al. 2013, Choe, Park et al. 2016, Woerner, Frottin et al. 2016). 
 Cells have evolved numerous mechanisms to protect themselves from the deleterious 
effects of protein aggregation. First, chemical parameters such as pH, temperature and 
macromolecule concentration are tightly regulated in order to ensure an optimal environment for 
proteins to rapidly reach and maintain their native state. Second, evolution has optimized the 
primary structure of proteins to favor folding over aggregation, for example by avoiding the 
repetition of motifs that promote formation of β-strands (Dobson 2004, DePristo, Weinreich et al. 
2005). Third, cells have developed an extensive network of chaperones and other factors that 
monitor protein synthesis, target aberrant polypeptides for degradation, and actively promote 
both de novo folding of newly synthesized proteins and refolding of misfolded polypeptides. 
Furthermore, chaperones interfere at different steps of the aggregation process and actively 
promote disaggregation, thereby preventing or at least slowing down the formation of amyloid 
fibrils (Schaffar, Breuer et al. 2004, Knowles, Waudby et al. 2009, Cohen, Arosio et al. 2015). 
 
I.3 The protein homeostasis network 
 
A healthy and intact proteome is an absolute prerequisite for the survival of any living structure 
from a single cell to a complex multicellular organism. Protein homeostasis (“proteostasis”) is 
defined as a state in which there is a tightly regulated equilibrium between protein synthesis and 
degradation. The corresponding concept of the “proteostasis network” describes an integrated 
network of quality control factors that ensures proteome integrity by maintaining this 
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equilibrium (Balch, Morimoto et al. 2008). This complex network includes the cellular chaperone 
machinery as well as the ubiquitin-proteasome system (UPS) and components of the autophagy 
pathway. Its main tasks are to preserve the balance between protein synthesis and degradation, 
to recognize and remove misfolded or aggregated proteins, and to respond to external or 
endogenous stressors (Powers, Morimoto et al. 2009, Brehme, Voisine et al. 2014, Hipp, Park et al. 
2014). A decline in proteostasis network capacity has been linked to a variety of protein folding 
and aggregation-related diseases as well as to the process of aging, with increasing proteostasis 
imbalance being both the result and cause of this decline (Taylor and Dillin 2011, Labbadia and 
Morimoto 2015) (Fig. I.3). 
 
 
Fig. I.3: The cellular responses to protein misfolding under balanced versus imbalanced PN conditions. 
A healthy cell copes with aberrant protein species by the induction of PN factors that ultimately lead to 
their degradation or refolding (green arrows). Conversely, a collapsed PN leads to the accumulation of 
even more misfolded proteins participating in unwanted intermolecular interactions, thereby inducing a 
vicious cycle that ultimately results in cell death (red arrows). Figure adapted from (Balchin, Hayer-Hartl 
et al. 2016). 
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I.3.1 Protein synthesis and folding in the cytosol 
The productive folding of newly synthesized proteins is crucial for a healthy proteome. Hence, 
quality control mechanisms have evolved that monitor proteome integrity already at the level of 
translation. Protein translation is slow compared to folding, suggesting that folding can occur 
cotranslationally. Except for α-helices and some small domains that can fold inside the exit 
tunnel, the C-terminal 30-40 amino acids of the nascent chain are largely excluded from 
intramolecular interactions due to the architecture of the ribosomal exit channel (approximately 
100 Å long and 10-20 Å wide) (Wilson and Beckmann 2011, Balchin, Hayer-Hartl et al. 2016). This 
makes de novo folding of the nascent polypeptide especially challenging, as the sequence 
information that can be used for proper folding is continuously changing and incomplete until 
the end of translation. Recent studies, however, have shown that the expanded vestibule at the 
very end of the ribosomal exit tunnel might provide enough space for very small proteins or 
domains of up to 70 amino acids to reach their native structure or to fold almost to completion 
before release of the nascent chain from the ribosome (O'Brien, Christodoulou et al. 2011, Nilsson, 
Hedman et al. 2015). In addition, the ribosome itself might actively modulate protein folding by 
surface effects and by translational pausing, allowing the nascent chain to explore local 
conformations and to fold into initial subdomain structures that can assemble into larger domains 
upon nascent chain release (Kaiser, Goldman et al. 2011, O'Brien, Christodoulou et al. 2011). 
Finally, it has also been shown that the distance between nascent polypeptide chains emerging 
from ribosomes is maximized by the arrangement of translating polyribosomes, thereby 
minimizing the chance of unwanted intermolecular contacts (Brandt, Carlson et al. 2010). 
Besides the active and passive roles of the translating ribosome in protein folding, cells 
have also evolved a subset of ribosome-associated chaperones that shield nascent chains from 
unwanted intra- or intermolecular interactions and to prevent protein misfolding and 
aggregation. In bacteria, the chaperone trigger factor (TF) binds in close proximity to the 
ribosomal exit channel and interacts with hydrophobic residues of the nascent chain, thereby 
preventing premature chain collapse and preparing the nascent polypeptide for interactions with 
the downstream Hsp70/40 systems (Kaiser, Chang et al. 2006, Kim, Hipp et al. 2013). In eukaryotes, 
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two systems have evolved that play a role similar to that of TF in protein folding: the ribosome-
associated complex that interacts with the Hsp70 Ssb (RAC-Ssb) and the nascent chain-associated 
complex (NAC). The yeast RAC consists of the Hsp70 Ssz1 and its cochaperone, the Hsp40 Zuotin, 
and cooperates with the ribosome-binding Hsp70s, Ssb1 and Ssb2. NAC is a heterodimeric 
complex that is highly conserved from yeast to mammals and is required for intracellular protein 
sorting (del Alamo, Hogan et al. 2011, Preissler and Deuerling 2012, Willmund, Del Alamo et al. 
2013). Newly synthesized proteins that cannot be folded by any of the ribosome-associated 
chaperone systems (more than 30 % of the proteome) are recognized by the cytosolic Hsp70 
system. The C-terminal substrate binding domain of Hsp70 recognizes exposed hydrophobic 
stretches of five to seven amino acids of client proteins (Mayer 2013). Protein folding is then 
achieved by repeated, ATP-dependent cycles of substrate binding and release, thereby 
eliminating aberrant interactions between client residues, and allowing the substrate to explore 
alternative conformations (Sharma, De Los Rios et al. 2010). Hsp70 activity can be modulated by 
a variety of Hsp40 cochaperones that deliver substrates to Hsp70 and stimulate ATP hydrolysis, 
and Hsp110 nucleotide exchange factors that facilitate ADP release and binding of a new 
molecule of ATP (Mayer 2013, Zhuravleva and Gierasch 2015). At the same time, the Hsp70 
system acts as a central hub that directs nascent chains to more specific chaperone systems such 
as the Hsp90 or Hsp60 systems (Hartl and Hayer-Hartl 2002, Calloni, Chen et al. 2012). In 
addition, the hexameric chaperone Prefoldin, which is present in archaea and eukaryotes, 
recognizes nascent polypeptides and facilitates transfer to the chaperonin TRiC/CCT (Hartl and 
Hayer-Hartl 2002). 
 The bacterial GroEL/GroES chaperonin system and its eukaryotic counterpart TRiC/CCT 
are large, cylindrical complexes with lid-shaped structures that allow a single unfolded 
polypeptide chain to undergo repeated, ATP-dependent cycles of folding in the isolated 
environment of their inner cavities (Leitner, Joachimiak et al. 2012, Lopez, Dalton et al. 2015, 
Hayer-Hartl, Bracher et al. 2016). Both bacterial and eukaryotic chaperonins are responsible for 
the folding of approximately 10 % of their respective proteomes, with GroEL mainly targeting 
aggregation-prone substrates of up to 60 kDa in size and TRiC being especially important for the 
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folding of cytoskeleton proteins such as actin and tubulin (Fujiwara, Ishihama et al. 2010, Gupta, 
Haldar et al. 2014, Lopez, Dalton et al. 2015, Hayer-Hartl, Bracher et al. 2016). 
 Besides its role in de novo folding of substrates, the Hsp90 system is responsible for the 
conformational maintenance of a number of clients involved in signaling pathways, for example 
kinases, transcription factors and steroid hormone receptors (Taipale, Krykbaeva et al. 2012, Röhl, 
Rohrberg et al. 2013). Strikingly, Hsp90 is able to recognize exposed hydrophobic patches of client 
proteins independent of their folding state and to stabilize the native state of metastable proteins 
such as the protooncogenic v-Src kinase, thereby explaining why inhibition of this chaperone 
system might be a promising target for cancer therapy (Boczek, Reefschläger et al. 2015, Karagöz 
and Rüdiger 2015). However, the precise mode of substrate recognition and client folding by 
Hsp90, remains largely unknown. 
 
I.3.2 Degradation of proteins 
A prerequisite for cells to maintain proteome integrity is a mechanism for the rapid and efficient 
clearance of aberrantly folded proteins and protein aggregates. Cells have evolved two major 
mechanisms for protein degradation: the ubiquitin proteasome system (UPS) and autophagy. 
Prerequisites for proteasomal degradation by the UPS are ubiquitination of the substrate by an 
E3 ubiquitin ligase, and delivery of the ubiquitinated polypeptide to the proteasome in a non-
aggregated state (Finley 2009). To this end, cells have evolved a canonical pathway for 
ubiquitination that is conserved throughout all kingdoms of life. First, ubiquitin is activated by 
conjugation of its C-terminal carboxyl group to a cysteine residue of the E1 ubiquitin-activating 
enzyme in an ATP-dependent manner. In the second step, the activated ubiquitin is transferred 
to a cysteine residue of the E2 ubiquitin-conjugating enzyme. Finally, the E2-ubiquitin conjugate 
forms a ternary complex with a specific E3 ubiquitin ligase and the client protein, and an 
isopeptide bond is formed between the C-terminal carboxyl group of the ubiquitin moiety and 
the ε-amino group of a lysine residue of the client protein. Client proteins are usually marked for 
proteasomal degradation by conjugation with several ubiquitin molecules in a process called 
polyubiquitination, where the lysine residue K48 of ubiquitin serves as the ε-amino group donor 
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for the next round of ubiquitination (Hershko and Ciechanover 1992). Ubiquitination does not 
only target proteins for proteasomal degradation. Linkage through the lysine K63 of ubiquitin 
has been associated with lysosomal degradation, and modification with a single ubiquitin 
molecule on one or several lysine residues of the client protein may modulate its subcellular 
localization and activity rather than its stability (Polo, Sigismund et al. 2002, Flick, Ouni et al. 2004, 
Barriere, Nemes et al. 2007). Due to the sequential nature of the ubiquitination cascade, organisms 
evolved to possess only one or two E1 and up to 35 E2 enzymes, but a comparatively large set of 
E3 ligases (> 600 in mammals) that allows the ubiquitination system to target a broad array of 
substrate proteins with high specificity (Li, Bengtson et al. 2008). The cochaperone CHIP, which 
is also an E3 ligase, can bind to Hsc70 and Hsp90 and ubiquitinate their clients to target them for 
proteasomal degradation, thereby providing a link between the chaperone and UPS machineries 
(Kettern, Dreiseidler et al. 2010). Protein aggregates are first dissociated in an ATP-dependent 
manner either by the Hsp70 system or the Hsp100 disaggregase in bacteria and fungi, 
ubiquitinated by cytosolic E3 ligases (e.g. Ubr1p in yeast) and then delivered to the proteasome 
in a soluble state for degradation (Prakash and Matouschek 2004, Rampelt, Kirstein-Miles et al. 
2012, Escusa-Toret, Vonk et al. 2013, Mogk, Kummer et al. 2015). Alternatively, misfolded 
substrates might also be transported to the nucleus in a chaperone-bound state, ubiquitinated by 
nuclear E3 ligases (e.g. San1p in yeast), and degraded by nuclear proteasomes (Amm, Sommer et 
al. 2014). Being a key player of the UPS, the 26S proteasome complex is located both in the cytosol 
and the nucleus, making the latter a compartment that is subject to protein quality control. In fact, 
several terminally misfolded proteins were described that are subject to proteasomal degradation 
and require chaperones for delivery to the nucleus (Heck, Cheung et al. 2010, Park, Kukushkin et 
al. 2013). The cellular disaggregase machinery, however, sometimes fails to dissociate protein 
aggregates, e.g. when the aggregate is too large in size or is in the extremely stable amyloid 
conformation. In this case, cells exploit the autophagy machinery to selectively degrade these 
aggregates. The E3 ligase CHIP recognizes and ubiquitinates aggregate structures that are bound 
to Hsp70. Subsequently, the Hsp70 cofactor Bag-3 mediates macroautophagy either via the 
autophagic ubiquitin adaptor p62 or in an ubiquitin-independent manner (Arndt, Dick et al. 2010, 
Gamerdinger, Kaya et al. 2011). Notably, cells promote concentration of aggregates in specific 
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compartments often termed “aggresomes” or “JUNQ” (JUxtaNuclear Quality control 
compartment), presumably to facilitate degradation and to keep aberrant proteins in a nontoxic 
state until degradation occurs (Kopito 2000, Kaganovich, Kopito et al. 2008, Sontag, Vonk et al. 
2014). Finally, Hsp70 can also directly target its misfolded clients for lysosomal degradation by 
using the highly abundant KFERQ peptide motif as a signal sequence, a pathway called 
chaperone-mediated autophagy (CMA) (Arias and Cuervo 2011). 
Besides the canonical UPS pathway for damaged or terminally misfolded proteins, a 
considerable number of newly synthesized nascent polypeptide chains are subject to 
cotranslational ubiquitination. Whereas earlier studies suggested that more than 30 % of newly 
synthesized nascent chains are ubiquitinated, more recent findings questioned the significance of 
ubiquitination at the ribosome for degradation and indicated a much lower number of 1-5 % 
(Schubert, Anton et al. 2000, Vabulas and Hartl 2005, Duttler, Pechmann et al. 2013). This might at 
least in part be due to the fact that translation is much faster than folding and that newly 
synthesized polypeptide chains are unable to fold until a complete domain has emerged from the 
ribosome, making nascent chains vulnerable to cellular quality control systems. However, the 
exact mechanisms and the importance of cotranslational ubiquitination in vivo remain largely 
unknown. Experiments with reporters with N-terminal ubiquitination signals have shown that 
the propensity of newly synthesized polypeptide chains to become ubiquitinated correlates with 
their size (Turner and Varshavsky 2000). Conversely, a mutant variant of actin that is unable to 
fold can only be ubiquitinated after release from the ribosome (Frydman and Hartl 1996). 
Furthermore, not all nascent chains are ubiquitinated to the same extent; instead, a small subset 
consisting of large, aggregation-prone polypeptides with high translation rates and inefficient 
spontaneous folding seems to be the preferential target of cotranslational ubiquitination (Duttler, 
Pechmann et al. 2013). Ribosome-associated chaperones such as NAC may counteract this quality 
control system by shielding newly synthesized nascent chains, thereby protecting them from 
ubiquitination (Duttler, Pechmann et al. 2013). The ribosomal quality control (RQC) pathway, 
which also involves cotranslational ubiquitination of nascent polypeptide chains, represents a 
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crucial pathway for the clearance of aberrant protein species and will be discussed in detail in 
section I.4. 
 
I.3.3 The cellular stress response 
All organisms need to adequately respond to exogenous and endogenous stressors in order to 
protect core biological processes such as DNA repair, protein folding, clearance of misfolded 
proteins and aggregation prevention, and ultimately to preserve proteome integrity. Examples of 
such stressors include elevated temperatures, nutrient starvation or the presence of toxic agents 
such as heavy metals or reactive oxygen species, all posing severe challenges to the proteostasis 
network as they can promote the accumulation of potentially toxic misfolded protein species. 
Cells have evolved several pathways, e.g. the cytosolic heat shock response (HSR) and the 
unfolded protein response (UPR) in organelles such as the endoplasmic reticulum (ER) and 
mitochondria, with the common goal of a rapid and robust upregulation of Hsps to prevent 
further protein damage (Morimoto 2008, Anckar and Sistonen 2011, Walter and Ron 2011, Schulz 
and Haynes 2015). Although Hsps are highly abundant and ubiquitously expressed, their 
concentration is often closely titrated to the requirements of the cell to prevent the accumulation 
of aberrant protein species, one of the hallmarks of proteostasis imbalance. Thus, the cellular 
stress response needs to be tightly regulated in order to rapidly adapt the proteostasis network 
to the particular requirements of the cell. The expression of Hsps is proportional to the intensity 
and duration of the respective stress condition (Gasch, Spellman et al. 2000). 
 Heat shock factor 1 (Hsf1p) is the central hub for activation, attenuation and regulation of 
the cytosolic HSR. Whereas Hsf1p is conserved from yeast to humans, three additional isoforms 
(Hsf2-4p) have evolved in vertebrates that exhibit various functions during development and 
stress and are also involved in longevity (Akerfelt, Morimoto et al. 2010). The overall Hsf1p 
architecture consists of an N-terminal DNA binding domain for binding to heat shock elements 
(HSE) upstream of heat shock genes, followed by hydrophobic heptad repeats (HR-A/B/C) 
responsible for the formation of active Hsf1p homotrimers, and a C-terminal transcription 
activation domain that ultimately leads to the stimulation of the RNA polymerase II complex and 
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subsequent high-level transcription of stress-inducible genes (Anckar and Sistonen 2011, 
Neudegger, Verghese et al. 2016). The conversion from monomeric Hsf1p to its homotrimeric 
form, its accumulation in the nucleus and the subsequent binding to HSEs of heat shock genes 
represent the key steps in Hsf1p activation. A prerequisite for the formation of active Hsf1p 
trimers is the conversion from intramolecular contacts between HR-A/B and HR-C domains to 
solely intermolecular interactions between the HR-A/B domains, resulting in the formation of an 
unusual, triple-stranded coiled coil and the derepression of the transcriptional activation domain 
(Sorger and Nelson 1989). In addition, the sudden appearance of non-native protein species leads 
to sequestration of cytosolic Hsp40, Hsp70 and Hsp90, thereby releasing monomeric Hsf1p from 
its inactive, chaperone-bound state and making it available for trimerization (Shi, Mosser et al. 
1998). After trimerization, Hsf1p activity is modulated mainly by posttranslational modifications 
(PTMs) such as phosphorylation, sumoylation and acetylation, and by inactivation through 
binding to chaperones (Wu 1995, Shi, Mosser et al. 1998). Interestingly, activation of Hsf1p not 
only leads to upregulated transcription of chaperones, but also of genes involved in protein 
degradation, DNA repair, signal transduction and metabolism, with 3 % of all known yeast 
genomic loci showing binding of Hsf1p upon heat stress (Gasch, Spellman et al. 2000, Trinklein, 
Murray et al. 2004). Conversely, studies have shown that especially neurons – presumably owing 
to their postmitotic state – might be partially or even completely HSR-deficient, making this cell 
type especially vulnerable to proteotoxic stress (Mathur, Sistonen et al. 1994, Marcuccilli, Mathur 
et al. 1996). 
 In the ER and mitochondria, a set of gene expression programs termed the UPR ensures 
proteome integrity by responding to insufficient folding capacities in the respective organelle. In 
case of the ER, activation of the UPR leads to an expansion of the ER membrane and the induction 
of ER-resident chaperones (Schuck, Prinz et al. 2009). Since prolonged UPR activation can trigger 
the induction of apoptosis and therefore cell death, it is vital for cells to rapidly and efficiently 
target misfolded proteins for proteasomal degradation, a process called ER-associated 
degradation (ERAD) (Smith, Ploegh et al. 2011, Tabas and Ron 2011). Therefore, cells have evolved 
three pathways in order to detect the accumulation of misfolded proteins in the ER lumen: the 
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ATF6 branch, the PERK branch and the IRE1 branch (Walter and Ron 2011). ATF6 is an ER-
resident transmembrane protein with a large N-terminal cytosolic portion that is delivered to the 
Golgi and subject to limited proteolysis upon UPR induction, resulting in nuclear localization of 
the N-terminal fragment and subsequent induction of UPR target genes such as the ER Hsp70 BiP 
and Hsp90 GRP94. In contrast, the PERK pathway involves oligomerization of the PERK kinase 
and phosphorylation of eIF2α, thereby attenuating translation and reducing protein flux into the 
ER. Additionally, upregulation of the transcription factor ATF4 leads to the induction of several 
UPR target genes, including genes involved in apoptosis. Finally, IRE1 is a bifunctional kinase 
and endoribonuclease that oligomerizes and splices an mRNA coding for the transcription factor 
XBP1, which, in its active form, induces the expression of proteins involved in lipid biosynthesis 
and ERAD. All three branches rely on sensors that reliably and specifically detect non-native 
proteins. However, it remains unclear how misfolded proteins are exactly recognized by the 
respective sensors and how aberrant species can be distinguished from newly synthesized and 
unfolded proteins that have just been translocated to the ER. Whereas earlier work suggested a 
transient interaction of the sensors with ER-resident chaperones that is lost upon accumulation 
of misfolded proteins and allows the sensors to oligomerize, recent work implies more direct 
modes of interaction (Walter and Ron 2011). 
 
I.3.4 Endoplasmic reticulum-associated degradation 
As described in the previous section, cells need to rely on efficient degradation of misfolded 
proteins in the ER to prevent unnecessary cell death by UPR-mediated apoptosis. Since the ER is 
lacking proteasomes, misfolded ER-resident proteins need to be dislocated to the cytosol for 
proteasomal degradation to occur (Claessen, Kundrat et al. 2011). The main factors that determine 
if a protein is subjected to ERAD are its size and hydrophobicity, folding rate, and precise location 
within the ER. This means that proteins that spend an extended amount of time folding might be 
targeted by ERAD and degraded although they would be functional, a kinetic control that 
becomes deleterious in cases where mutations produce proteins with mild folding defects, e.g. 
during cystic fibrosis (Drumm, Wilkinson et al. 1991). 
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 Multiprotein ER transmembrane complexes with core E3 RING finger domain ubiquitin 
ligases are the central hubs of the ERAD machinery (Carvalho, Goder et al. 2006). In yeast, the 
two known ER membrane-associated E3 ligases are Hrd1p and Doa10p, whereas mammals show 
a much higher diversity in ERAD-associated E3 ligases (Gardner, Swarbrick et al. 2000, Swanson, 
Locher et al. 2001). Hrd1p alone is able to ubiquitinate soluble ER substrates, but a plethora of 
adaptor proteins is needed to ensure substrate specificity and to facilitate delivery to the E3 ligase 
complex (Carvalho, Stanley et al. 2010). Adaptor proteins typically consist of one transmembrane 
domain and an ER-luminal tetratricopeptide repeat (TPR) domain for interactions with misfolded 
clients (Gauss, Jarosch et al. 2006). Cytosolic and ER-resident chaperones such as Hsp70 might 
also serve as adaptors by delivering unfolded or partially folded polypeptides to ERAD-
associated E3 ligases (Hosokawa, Wada et al. 2008, Nakatsukasa, Huyer et al. 2008). ERAD activity 
itself largely depends on the activity of the underlying E3 ligases, which is in turn regulated by 
autoubiquitination, oligomerization status, and the levels of adaptor proteins and other ERAD 
components (Gardner, Swarbrick et al. 2000, Carvalho, Stanley et al. 2010). The delivery of 
substrates to E3 ligase complexes is a complex process with various underlying mechanisms and 
pathways, with some of them being exploited by pathogens such as the human cytomegalovirus 
(hCMV) and toxins like ricin or cholera toxin (Lord, Roberts et al. 2006). One possibility for 
regulated delivery is the recognition of small peptide motifs serving as ERAD-associated 
“degrons” or simply the constitutive ubiquitination of substrates (Shearer and Hampton 2005, 
Mbonye, Wada et al. 2006). Proteins in a particularly compact misfolded state or non-native 
oligomers may require dismantling by disulfide isomerases or peptidyl-prolyl isomerases prior 
to dislocation into the cytosol (Ushioda, Hoseki et al. 2008, Bernasconi, Soldà et al. 2010). Besides 
that, the glycosylation status can also play a role since proteins undergo repeated cycles of de- 
and re-glycosylation after the initial cotranslational modification of specific asparagines with 
branched high-mannose glycans. Consequently, these proteins are repeatedly bound by the 
chaperone lectins calnexin (CNX) and calreticulin (CRT) in order to promote folding (Helenius 
and Aebi 2004). Mannosidases progressively deglycosylate these folding intermediates on their 
way to the native state, thereby reducing the chance of entry into further folding cycles, but also 
exposing an α1,6-linked mannose that is necessary for ERAD (Oda, Hosokawa et al. 2003). Finally, 
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ER-resident chaperones such as Hsp70 might directly deliver their unfolded or partially folded 
clients to the E3 ligase complexes (Okuda-Shimizu and Hendershot 2007).  
After ubiquitination, substrates need to be extracted from the ER membrane for 
subsequent proteasomal degradation, an ATP-dependent process driven by the AAA+ ATPase 
activities of Cdc48p or the proteasome lid (Lee, Liu et al. 2004). In the case of glycosylated proteins, 
a cytosolic peptide N-glycanase (PNGase) deglycosylates the substrate prior to proteasomal 
degradation (Hirsch, Blom et al. 2003). Transmembrane proteins with misfolded cytosolic 
domains residing in the ER membrane are recognized and ubiquitinated by Doa10p in yeast, a 
process that involves no adaptor proteins. Substrate recognition might be driven by direct 
interactions between the E3 ligase and hydrophobic patches of misfolded proteins, explaining the 
broad substrate specificity of Doa10p and its ability to ubiquitinate even soluble cytosolic proteins 
(Swanson, Locher et al. 2001, Ravid, Kreft et al. 2006). 
 
I.3.5 The proteostasis network in disease and aging 
In order to be able to respond to multiple conditions of environmental and cellular stresses, the 
proteostasis network shows a high degree of redundancy – approximately 1400 components are 
known in mammals, and only 55 of the 332 chaperones that are expressed in human K562 
leukemia cells are essential (Taipale, Tucker et al. 2014, Wang, Birsoy et al. 2015). However, during 
aging, the proteostasis network capacity declines, thereby facilitating the occurrence of various 
protein misfolding diseases such as type II diabetes, certain types of cancer, and especially 
neurodegenerative diseases (Taylor and Dillin 2011, Labbadia and Morimoto 2015). This 
inevitable collapse is accelerated if the proteostasis network is constantly challenged by 
aggregation-prone proteins, as is the case in certain hereditary types of neurodegenerative 
diseases or single nucleotide polymorphisms (SNPs) that lead to the expression of metastable 
proteins (Ben-Zvi, Miller et al. 2009, Sahni, Yi et al. 2015). The accumulation of aggregates of 
disease-related proteins in turn further perturbates proteome integrity, thereby initiating a 
vicious cycle that ultimately leads to a complete collapse of the proteostasis network and cell 
death. Although hereditary forms of protein misfolding diseases such as Huntington’s disease or 
Introduction 
 
21 
 
ALS pose a serious threat to proteome integrity and are essentially incurable, they have a very 
low prevalence, with the result of aging being the major risk factor for the collapse of the 
proteostasis network. In fact, numerous studies have shown that during evolution, the 
propagation of a healthy and intact germline during early adulthood has evolved to be more 
important for higher organisms than to achieve immortality by long-term maintenance of the 
somatic proteome, a phenomenon that led to the theory of the “disposable soma” (Kirkwood 
1977).  
Nevertheless, multiple components of the proteostasis network including chaperones 
have been identified as targets for small molecules in the last decades, with the common goal of 
modulating the proteostasis network in a way that it can buffer the detrimental effects of 
aggregation-prone proteins and eventually suppress or at least postpone the manifestation of 
protein misfolding and age-related diseases. In theory, both boosting the proteostasis network 
capacity and inhibiting specific components might be effective in achieving this goal (Powers, 
Morimoto et al. 2009, Pratt, Gestwicki et al. 2015). Screening with low molecular weight 
compounds, for example, has led to the identification of potential drugs that activate the heat 
shock response and therefore induce the upregulation of chaperones, and that enhance the 
clearance of misfolded proteins by stimulating proteasome activity (Lee, Lee et al. 2010, Calamini, 
Silva et al. 2012). Conversely, the drug Guanabenz has been shown to attenuate translation, 
thereby reducing the amount of unfolded and potentially aggregation-prone nascent chains that 
the cellular folding machinery has to cope with (Tsaytler, Harding et al. 2011). Finally, the Hsp90 
inhibitor Geldanamycin represents a promising candidate for cancer therapy, as Hsp90 is known 
to be involved in the folding of various proto-oncogenic proteins (Goetz, Toft et al. 2003). 
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I.4 The ribosomal quality control pathway 
 
The reliable and faithful translation of genomic information is absolutely crucial for maintaining 
proteostasis and cell survival. Thus, cells have evolved multiple quality control pathways that 
recognize aberrant mRNAs, their translation products and even defective ribosomes, and target 
them for degradation (LaRiviere, Cole et al. 2006, Van Hoof and Wagner 2011). Defects in the 
translational machinery have been linked to a plethora of pathological conditions including 
neurodegenerative diseases, thereby underlining the importance of translational fidelity (Lee, 
Beebe et al. 2006, Scheper, Van Der Knaap et al. 2007, Ishimura, Nagy et al. 2014). Therefore, the 
recognition and degradation of aberrant mRNAs and their translation products contributes to 
prevent their accumulation and, as a result, proteome damage (Gregersen, Bross et al. 2006, 
Anckar and Sistonen 2011). 
 
I.4.1 Ribosomal stalling 
The phenomenon of ribosomal stalling is defined as a state in which either elongation of the 
nascent chain or translation termination is irreversibly blocked as a result of the ribosome trying 
to translate a faulty mRNA (Shoemaker and Green 2012). Translation of aberrant transcripts leads 
to truncated proteins that are not only partially or completely nonfunctional, but also potentially 
prone to aggregation and thus need to be eliminated rapidly in order to prevent the accumulation 
of toxic aggregates. Strikingly, all surveillance mechanisms targeting defective mRNAs and their 
translation products rely on ribosomal stalling as an activation signal, which is why a defective 
mRNA needs to be translated at least once in order to be recognized as corrupted (Van Hoof and 
Wagner 2011, Shoemaker and Green 2012). 
During the complex and naturally error-prone process of RNA maturation in eukaryotic 
cells, incorrect splicing events or polyadenylation within the open reading frame (ORF) can result 
in the generation of so-called “non-stop (NS) mRNAs”, i.e. truncated transcripts or mRNAs 
lacking an in-frame stop codon (Fig. I.4 (B)) (Frischmeyer, van Hoof et al. 2002, van Hoof, 
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Frischmeyer et al. 2002, Meaux and Van Hoof 2006, Ozsolak, Kapranov et al. 2010). Translation of 
a truncated mRNA leads to ribosomal stalling at the 3’ end of the mRNA, leaving the aminoacyl 
(A) site of the translating ribosome empty and rendering the stalled 80S ribosome inaccessible for 
the canonical translation elongation and termination machineries (Inada 2016). The HAC1 mRNA 
is an example for an endogenous NS-mRNA as it is subject to frequent erroneous splicing in the 
cytosol, resulting in considerable amounts of truncated transcripts (Guydosh and Green 2014). In 
case of mRNA lacking an in-frame stop codon, translation of the 3’ untranslated region (UTR) 
and the poly(A) tail lead to C-terminal extension of the nascent chain and a poly-lysine stretch 
that is added as a result of the poly(A) tail being interpreted as a series of lysine-encoding AAA 
codons. In addition to stalling at the 3’ end of the mRNA, translation of the poly(A) tail itself was 
shown to induce a translational arrest and to cause ribosomal stalling, presumably due to 
electrostatic interactions between the positively charged poly-lysine stretch and the negatively 
charged ribosomal exit channel (Lu and Deutsch 2005, Ito-Harashima, Kuroha et al. 2007, Lu, 
Kobertz et al. 2007). More recent studies, however, could demonstrate that deletion of the 40S 
subunit protein Asc1p (RACK1 in mammals) or the ribosome-associated E3 ubiquitin ligase 
Hel2p (presumably ZNF598 in mammals) strongly enhances read-through of sequences encoding 
polybasic tracts, thereby questioning the relevance of electrostatic interactions in the ribosomal 
exit channel for stalling (Brandman, Stewart-Ornstein et al. 2012, Letzring, Wolf et al. 2013, 
Juszkiewicz and Hegde 2016). Moreover, codon usage was also found to play a role, as an internal 
poly(AAA) stretch induced ribosomal stalling and translational repression much more efficiently 
than a synonymous poly(AAG) stretch in mammals, indicating that the poly(A) tail might 
represent a strong endogenous stalling sequence to repress translation of faulty NS-mRNAs 
(Inada and Aiba 2005, Arthur, Pavlovic-Djuranovic et al. 2015). Interestingly, a recent study found 
that the introduction of defined poly(A) stretches into an ORF can be used to fine tune protein 
expression levels independent of promoter strength, thereby facilitating the generation of 
hypomorphic mutants (Arthur, Chung et al. 2017). Ribosomal stalling can also be induced in the 
absence of polybasic sequences by a lack of suitable and charged aminoacyl-tRNAs, a condition 
that might be the result of amino acid depletion and/or the repeated occurrence of rare codons 
such as the arginine-encoding CGA codon (Fig. I.4 (C)) (Letzring, Dean et al. 2010, Letzring, Wolf 
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et al. 2013, Wolf and Grayhack 2015). In this context, it is important to distinguish between 
ribosomal stalling, which represents a terminal state that is the result of faulty mRNA translation, 
and ribosomal pausing, which might use stalling sequences such as polybasic stretches or rare 
codons to modulate local translation speeds in order to ensure efficient folding or translocation 
of the nascent chain (Pechmann and Frydman 2013, Pechmann, Chartron et al. 2014). Consistently, 
synonymous codon changes have been found to alter various properties of the corresponding 
translation product and can even lead to disease in the case of silent SNPs in patients (Sauna and 
Kimchi-Sarfaty 2011, Zhou, Guo et al. 2013, Buhr, Jha et al. 2016). In addition, mRNAs might also 
show the tendency to form strong secondary structures that block the ribosome during translation 
and prevent further elongation of the nascent chain, thereby also leading to ribosomal stalling 
(Fig. I.4 (D))  (Doma and Parker 2006). 
 
 
Fig. I.4: Types of ribosomal stalling. (A) Canonical transcription usually involves assembly of the 
translationally active 80S ribosome at the initation (AUG) codon, followed by translation of the ORF, 
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dissociation of the ribosome at the stop (UAG) codon and release of the newly synthesized polypeptide 
chain. (B) NS-mRNAs such as truncated transcripts or mRNAs lacking an in-frame stop codon lead to 
ribosomal stalling at the 3’ end of the transcript. (C) Amino acid insufficiency or stalling features such as 
repeats of rare codons within the ORF lead to internal stalling of the ribosome. (D) mRNA secondary 
structures within the ORF can block the ribosome during translation and also induce stalling. 
 
I.4.2 Recognition and dissociation of stalled ribosomes 
Since ribosomal stalling can be the result of translation of different aberrant mRNA species, the 
topology and conformation of stalled ribosomes can vary significantly. A hallmark of ribosomes 
that stall due to translation of a NS-mRNA is the absence of a codon in the ribosomal A-site, 
making it impossible for canonical translation elongation or termination factors to bind since they 
require the presence of a sense or stop codon, respectively. In the case of internal stalling events, 
e.g. as a result of rare codons, the A-site is occupied with a sense codon, but delivery of an 
appropriate aminoacyl-tRNA fails due to tRNA insufficiency. Thus, cells evolved a pathway for 
noncanonical ribosome dissociation that acts specifically on stalled ribosomes and consists of the 
proteins Dom34p (Pelota in mammals), Hbs1p (hHbs1 in mammals) and the canonical ribosome 
dissociation factor Rli1p (ABCE1 in mammals) (Shoemaker, Eyler et al. 2010, Pisareva, Skabkin et 
al. 2011, Brandman and Hegde 2016).  
In short, this pathway involves binding of the Dom34p/Hbs1p-GTP complex at the stalled 
ribosome, followed by GTP hydrolysis and positioning of Dom34p in the ribosomal A-site, 
recruitment of Rli1p, and subsequent dissociation of the ribosome by Rli1p in an ATP-dependent 
manner (Fig.I.5 (b)) (Shoemaker, Eyler et al. 2010, Becker, Armache et al. 2011, Shoemaker and 
Green 2011). Unlike the canonical translation termination machinery, which also uses the AAA+ 
ATPase Rli1p for the dissociation of ribosomes that reached a stop codon, the Dom34p/Hbs1p 
pathway does not depend on the presence of a codon in the A-site, indicating that ribosomes that 
stalled during translation of NS-mRNAs might be the primary target of this complex (Fig. I.5 (a), 
(b)). Strikingly, in vitro experiments with purified stalled ribosomes have shown that the 
Dom34p/Hbs1p complex can recognize and dissociate stalled ribosomes independent of the 
presence or absence of a codon in the A-site, suggesting a role as a general splitting pathway for 
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the rescue of stalled ribosomes (Shoemaker, Eyler et al. 2010, Becker, Armache et al. 2011, Pisareva, 
Skabkin et al. 2011, Shoemaker and Green 2011). Although these findings suggest a role as a 
general ribosome splitting pathway, other mechanisms might exist in vivo for the dissociation of 
stalled ribosomes with an occupied A-site. Dom34p/Hbs1p shows a low affinity for ribosomes in 
the GTP-bound state, indicating that during the time of GTP hydrolysis, Dom34p/Hbs1p might 
compete with the translation elongation and termination machinery or other factors for ribosome 
binding until the irreversible decision to split the ribosome is made (Brandman and Hegde 2016). 
 
Fig. I.5: Canonical translation termination and dissociation of stalled ribosomes. (a) At the end of 
translation under normal conditions, a stop codon in the A site leads to binding of a ternary eRF1-eRF3-
GTP complex. Upon GTP hydrolysis, eRF3 dissociates and eRF1 undergoes conformational changes that 
lead to hydrolysis of the peptidyl-tRNA bond and release of the nascent chain. The AAA+ ATPase Rli1p 
then binds to eRF1 and dissociates the 80S ribosome in an ATP-dependent manner. (b) Upon ribosomal 
stalling (indicated by a star in the ribosomal A site), the ternary Dom34p/Hbs1p-GTP complex, which is 
homologous to the eRF1-eRF3-GTP termination complex, binds close to the A site. Following GTP 
hydrolysis and Hbs1p release, Dom34p provides a binding platform for Rli1p to allow for ribosome 
dissociation without releasing the nascent chain. Figure adapted from (Simms, Thomas et al. 2017). 
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Dom34p is a homolog of the eukaryotic release factor 1 (eRF1), with whom it shares 
structural similarity to a tRNA molecule, thereby allowing it to bind to the ribosomal A-site 
(Chen, Muhlrad et al. 2010). The β3- β4 loops of the N-terminal domain of Dom34p were shown 
to directly interact with the decoding site of the 40S subunit, thereby making the presence of a 
sense or stop codon in the A-site dispensable for binding (Kobayashi, Kikuno et al. 2010). After 
binding of the ternary Dom34p/Hbs1p-GTP complex to the GTPase center close to the A-site of 
the ribosome, positioning of Dom34p in the ribosomal A-site is accomplished upon GTP 
hydrolysis by Hbs1p, a translational GTPase with similarity to eukaryotic elongation factor 1A 
(eEF1A) and eukaryotic release factor 3 (eRF3) (Shoemaker, Eyler et al. 2010, Becker, Armache et 
al. 2011). Dom34p can then recruit the canonical ribosome splitting factor Rli1p, which dissociates 
the ribosome in an ATP-dependent, yet largely unknown mechanism. In addition, binding of 
Dom34p/Hbs1p to the ribosome per se might facilitate dissociation by weakening the codon-
anticodon interactions at the peptidyl (P)-site of the ribosome (Kobayashi, Kikuno et al. 2010). 
Furthermore, the Dom34p/Hbs1p complex was also shown to mediate the release of stalled 
nascent chains that were targeted for the ER or mitochondria into the lumen of the respective 
organelle (Izawa, Tsuboi et al. 2012). 
 
I.4.3 Degradation of aberrant polypeptides 
Following dissociation of the stalled ribosome and release of both the defective mRNA and the 
40S subunit, the cell is faced with a complex consisting of the 60S subunit and a peptidyl-tRNA 
molecule, i.e. the stalled nascent chain that is located in the ribosomal exit channel and linked to 
a tRNA moiety in the ribosomal P-site. This complex represents an aberrant species that requires 
a specific machinery for its recognition and disassembly, as canonical translation termination 
typically results in a released nascent chain and free 60S and 40S subunits. In eukaryotic cells, the 
ribosomal quality control (RQC) pathway is responsible for the degradation of stalled nascent 
chains, its main role being to ubiquitinate the aberrant polypeptide, to extract it from the 60S 
subunit and to deliver it to the proteasome for degradation (Bengtson and Joazeiro 2010, 
Brandman, Stewart-Ornstein et al. 2012, Defenouillere, Yao et al. 2013). Interestingly, 
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ubiquitination of faulty nascent chains occurs independent of the type of stalling and stringently 
requires ribosome dissociation, indicating that the RQC pathway might represent a general 
cotranslational quality control mechanism for the recognition of 60S-peptidyl-tRNA complexes 
and degradation of aberrant polypeptides (Shao, von der Malsburg et al. 2013, Shao and Hegde 
2014). Moreover, failure of the RQC pathway in yeast leads to the formation of SDS-resistant 
cytosolic aggregates that sequester various essential chaperones, thereby leading to proteotoxic 
stress (Choe, Park et al. 2016, Defenouillere, Zhang et al. 2016, Yonashiro, Tahara et al. 2016). 
A mutation in the LISTERIN gene encoding a E3 ubiquitin ligase has been linked to a 
neurodegenerative phenotype in mice, including impairment of rear leg movement, reduced life 
span, and neuronal cell death (Chu, Hong et al. 2009). Deletion of the yeast homolog of Listerin, 
Ltn1p, was identified in a screen as a suppressor of the phenotype caused by a non-stop mutation 
(Wilson, Meaux et al. 2007). This E3 ligase was later found to be involved in the ubiquitination of 
non-stop proteins at the ribosome, indicating a central role in cotranslational protein quality 
control (Bengtson and Joazeiro 2010). In two comprehensive studies in yeast screening for 
activators of Hsf1 and proteins being functionally linked to SKI complex-mediated RNA 
degradation, two genetic interactors of Ltn1p, Rqc1p and Tae2p (now termed Rqc2p), were 
identified that, together with Ltn1p, form a 60S-associated complex that interacts with the AAA+ 
ATPase Cdc48p and its cofactors Npl4p and Ufd1p (Brandman, Stewart-Ornstein et al. 2012, 
Defenouillere, Yao et al. 2013). Whereas the main role of Rqc2p remained unclear, it was found 
that Rqc1p is required for the recruitment of Cdc48p, and that the latter mediates extraction of 
the ubiquitinated nascent polypeptide chain from the 60S subunit and delivery to the proteasome 
in an ATP-dependent manner (Brandman, Stewart-Ornstein et al. 2012, Defenouillere, Yao et al. 
2013, Verma, Oania et al. 2013). However, the exact mechanism of peptidyl-tRNA hydrolysis prior 
to nascent chain extraction still remains unclear, although recent findings suggest that the empty 
ribosomal A-site of the 60S subunit might be involved, e.g. via noncanonical binding of eRF1 
(Shao, Brown et al. 2015, Brandman and Hegde 2016). Rqc2p and its mammalian homolog Nuclear 
Export Mediation Factor (NEMF) were later found to specifically bind to 60S-peptidyl-tRNA 
complexes by recognizing the exposed tRNA moiety in the P-site with its N- and C-terminal lobes 
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and by making interactions between its middle domain and the sarcin-ricin loop (SRL) and the P 
stalk of the 60S subunit (Fig. I.6b, c) (Lyumkis, Oliveira dos Passos et al. 2014, Shao, Brown et al. 
2015, Shen, Park et al. 2015). This extensive network not only allows for specific recognition of 
these aberrant ribosomal species and provides a binding platform for Ltn1, but also prevents 
reassociation with the 40S subunit by occupying a large parts of the subunit interface (Fig. I.6a) 
(Shao, Brown et al. 2015). The N-terminal domain of Ltn1p then interacts with both the middle 
domain of Rqc2p and the 60S subunit, thereby ensuring specificity for stalled 60S-peptidyl-tRNA 
complexes (Fig. I.6b, c) (Shao, Brown et al. 2015). Due to the HEAT repeats in its middle domain 
that confer enhanced flexibility and an elongated shape by forming an extended superhelical 
structure, Ltn1p is able to wrap around the 60S subunit and to position its C-terminal RING 
domain close to the vestibule of the ribosomal exit channel for ubiquitination of the nascent 
polypeptide (Fig. I.6c) (Lyumkis, Doamekpor et al. 2013, Shao, Brown et al. 2015). 
 
 
Fig. I.6: Mechanism and structure of the RQC complex. (a) Following dissociation of the stalled ribosome, 
the cell is faced with an aberrant 60S-peptidyl-tRNA complex. NEMF (Rqc2p in yeast) interacts with both 
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the exposed tRNA moiety and the subunit interface, thereby preventing reassociation with the 40S subunit 
and providing a binding platform for Listerin (Ltn1p in yeast). The N-terminal domain of Listerin then 
interacts with Rqc2p and the 60S subunit, and positions its C-terminal RING finger domain in close 
proximity to the ribosomal exit channel by using its elongated shape to wrap around the 60S subunit. The 
nascent chain is then ubiquitinated in a Listerin-dependent manner, allowing for extraction by VCP 
(Cdc48p in yeast) and proteasomal degradation. (b) + (c) Cryo-EM structure of the mammalian 60S-
peptidyl-tRNA-RQC complex. Teal, NEMF; orange, Listerin; purple, P-site tRNA; gray, 60S subunit. PTC, 
peptidyl transferase center. Figure adapted from (Brandman and Hegde 2016). 
 
 Strikingly, whereas deletion of LTN1 or RQC1 leads to activation of the cytosolic heat 
shock response, deletion of RQC2 alone or in combination with LTN1 or RQC1 resulted in 
suppression of Hsf1p induction, indicating a central role of Rqc2p in activation of the cellular 
stress response (Brandman, Stewart-Ornstein et al. 2012). In a recent study, cryo-EM and mass 
spectrometry analyses of 60S-RQC complexes revealed the presence of tRNAs in ribosomal A-
sites and a C-terminal extension of the stalled nascent chain with alanine and threonine residues, 
respectively (Shen, Park et al. 2015). Elongation of nascent polypeptides with these so-called 
C-terminal alanine and threonine (CAT) tails was shown to be mediated by Rqc2p in a 
noncanonical, 40S- and mRNA-independent manner (Shen, Park et al. 2015). It was suggested that 
specificity for tRNAs carrying alanine and threonine residues might be the result of recognition 
by Rqc2p due to similarities in their anticodon loops (Gerber and Keller 1999). Notably, CAT tails 
seem to be heterogeneous in both length and sequence: extensions of up to 20 amino acids 
consisting of roughly equal amounts of alanine and threonine have been described that seem to 
lack a clear sequence (Shen, Park et al. 2015). A mutant version of Rqc2p was identified that can 
still recognize stalled 60S-peptidyl-tRNA complexes and provides a binding platform for Ltn1p, 
but lacks the ability to generate CAT tails (Shen, Park et al. 2015). Strikingly, suppression of CAT 
tail formation in LTN1 and RQC1 deletion backgrounds not only abolished Hsf1p induction, but 
also prevented the formation of proteotoxic SDS-resistant aggregates (Shen, Park et al. 2015, Choe, 
Park et al. 2016, Yonashiro, Tahara et al. 2016). Thus, it was reasoned that the Rqc2p-dependent 
activation of the heat shock response might either be a direct result of CAT tail recognition by 
Hsf1p or due to CAT tail-mediated aggregation of aberrant nascent chains (Choe, Park et al. 2016, 
Yonashiro, Tahara et al. 2016). Besides that, the precise role of CAT tails remains unclear. It was 
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suggested that a C-terminal extension of the stalled nascent polypeptide might serve as a spacer 
to resolve stalling due to electrostatic interactions between polybasic stretches of the nascent 
chain and the ribosomal exit channel, and to bring these stretches, which are potentially attractive 
targets for Ltn1p-mediated ubiquitination due to their high lysine content, out of the exit tunnel 
(Brandman and Hegde 2016). Another hypothesis is that CAT tails might have a protective role 
by promoting aggregation of aberrant nascent chains, thereby facilitating both sequestration into 
less toxic inclusions that can be targeted for vacuolar degradation and activation of the heat shock 
response in order to restore proteostasis (Yonashiro, Tahara et al. 2016). In fact, it has previously 
been shown that homopolymers of alanine form aggregates, and that activation of the heat shock 
response results in a global attenuation of translation, thereby facilitating degradation of 
potentially aggregation-prone nascent chains and mRNAs that are in the process of translation 
(Forood, Perez-Paya et al. 1995, Shalgi, Hurt et al. 2013, Merret, Nagarajan et al. 2015). 
  
I.4.4 mRNA quality control pathways 
Since aberrant mRNAs might participate in iterative rounds of translation and subsequent 
ribosomal stalling, they pose a considerable threat to the translation machinery and proteostasis 
in general. Thus, cells have evolved several cotranslational quality control pathways that allow 
for selective and rapid degradation of transcripts containing potential stalling sequences such as 
NS-mRNAs or transcripts with strong secondary structure elements or rare codons (Shoemaker 
and Green 2012, Inada 2013).  
In general, eukaryotic cells can degrade mRNAs in two ways: from the 5’ end or the 3’ 
end. In both cases, the typical features of an mRNA, the 5’ cap and the 3’ poly(A) tail, need to be 
removed prior to degradation (Parker 2012). Whereas removal of the 5’ cap structure is mediated 
by the decapping enzymes Dcp1p and Dcp2p, the Pan2p-Pan3p and Ccr4p-Not complexes are 
responsible for deadenylation of the transcript (Parker 2012). Following deadenylation, most 
mRNAs are subject to degradation from their 3’ end by the exosome, a complex consisting of 9 
subunits and the RNase Rrp44p that is present in both the cytosol and the nucleus (Klauer and 
van Hoof 2012). Degradation of mRNAs by the cytosolic exosome complex requires the SKI 
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complex, which consists of a helicase (Ski2p), two copies of a regulatory WD-repeat protein 
(Ski8p) and a scaffold protein (Ski3p), and that facilitates mRNA degradation by binding to the 
exosome complex and threading target mRNAs to the active site of Rrp44p (Klauer and van Hoof 
2012, Schmidt, Kowalinski et al. 2016). The protein Ski7p, which is only present in a subset of 
fungi, mediates contact between the SKI complex and the exosome via its N-terminal domain, 
whereas the C-terminal domain shows structural similarity to translational GTPases like eRF3 
and Hbs1p, but has no detectable GTPase activity due to several mutations in its active site 
(Kowalinski, Schuller et al. 2015). As an alternative to exosome-dependent degradation, mRNAs 
might also be degraded from the 5’ end by the exonuclease Xrn1p after decapping. 
Three major RNA quality control mechanisms have been identified in eukaryotic cells: 
nonsense-mediated decay (NMD), which mediates degradation of transcripts with a premature 
stop codon, non-stop decay (NSD), which targets NS-mRNAs that lead to ribosomal stalling at 
their 3’ end, and no-go decay (NGD), which is responsible for the degradation of transcripts with 
features that result in internal stalling (Losson and Lacroute 1979, Doma and Parker 2006, Klauer 
and van Hoof 2012, Lykke-Andersen and Jensen 2015). The NSD pathway was originally found 
to be involved in the degradation of mRNAs that were subject to erroneous splicing events or 
premature polyadenylation and therefore lack an in-frame stop codon (Frischmeyer, van Hoof et 
al. 2002, van Hoof, Frischmeyer et al. 2002, Ozsolak, Kapranov et al. 2010). Translation of these 
aberrant transcripts leads to stalling of the ribosome at the 3’ end of the mRNA, leaving the 
ribosomal A-site empty. This configuration triggers dissociation of the ribosome by the 
Dom34p/Hbs1p complex and RQC-dependent degradation of the nascent chain (Bengtson and 
Joazeiro 2010, Shoemaker, Eyler et al. 2010, Brandman, Stewart-Ornstein et al. 2012, Lyumkis, 
Oliveira dos Passos et al. 2014). The released mRNA is then degraded from the 3’ end by the 
cytosolic exosome machinery (Fig. I.7 (A)) (Tsuboi, Kuroha et al. 2012). Interestingly, Ski7p seems 
to be essential for degradation of NS-mRNAs, but the exact mechanism of NS-mRNA recognition 
remains unknown (Frischmeyer, van Hoof et al. 2002, van Hoof, Frischmeyer et al. 2002, Meaux 
and Van Hoof 2006). Rescue and dissociation of ribosomes that stalled during translation of 
mRNAs with internal stalling features such as rare codons or secondary structures, however, is 
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more complex as the ribosomal A-site is still occupied with a sense codon, thereby making the 
ribosome an unfavorable target for dissociation by the Dom34p/Hbs1p complex (Doma and 
Parker 2006, Chen, Muhlrad et al. 2010). In this case, stalling leads to cleavage of the mRNA in 
close vicinity and upstream of the stalled ribosome by a yet to be identified endonuclease, 
resulting in the generation of two fragments: a 5’ fragment that resembles a truncated mRNA, 
and a 3’ fragment with the stalled ribosome close to the 5’ end of this fragment (Tsuboi, Kuroha 
et al. 2012, Inada 2016). Whereas the 5’ fragment can be targeted for exosome-mediated 
degradation via the NSD pathway, the 3’ fragment is subject to Xrn1p-dependent degradation 
from the 5’ end (Fig.I.7 (B)). However, the exact mechanism of ribosome dissociation in the latter 
case remains unsolved. 
 
 
Fig. I.7: Mechanisms of NSD and NGD. (A) Translation of NS-mRNA leads to ribosomal stalling at the 3’ 
end of the aberrant transcript. Following dissociation of the stalled ribosome by the Dom34p/Hbs1p 
complex and RQC-dependent degradation of the nascent chain, the NS-mRNA is degraded from the 3’ end 
by the cytosolic SKI complex/exosome machinery. (B) Aberrant transcripts with internal stalling features 
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lead to stalled ribosomes with an occupied A-site, thereby disfavoring Dom34p/Hbs1p-dependent 
dissociation. Ribosomal stalling induces cleavage of the mRNA upstream of the ribosome, generating a 5’ 
fragment that is subject to NSD, and a 3’ fragment, which is degraded from the 5’ end via Xrn1p. Figure 
adapted from (Inada 2016). 
 
I.5 Aim of the study 
 
The intrinsically error-prone process of mRNA maturation in higher eukaryotes can lead to the 
generation of defective transcripts, e.g. truncated mRNAs or transcripts lacking an in-frame stop 
codon. Furthermore, mRNAs can contain stretches of nonoptimal codons or form strong 
secondary structures due to sequence-specific internal base pairing. Translation of these faulty 
transcripts leads to ribosomal stalling, i.e. an irreversible block of the elongation process. 
Truncated polypeptide chains, which are produced during translation of these defective mRNAs, 
pose a serious threat to proteome integrity as they are nonfunctional and typically prone to 
aggregation. Besides that, stalled ribosomes are not recognized and recycled by the canonical 
translation termination machinery, hence they are not available for subsequent rounds of 
translation. Thus, a network of quality control pathways has evolved in all kingdoms of life, its 
main tasks being to recognize and rescue stalled ribosomes and to degrade faulty mRNAs and 
their potentially harmful translation products. Failure of this process has previously been linked 
to pathological conditions, e.g. the development of neurodegenerative disorders. However, the 
mechanisms by which impairment of ribosome-associated RNA and protein quality control leads 
to toxicity remain elusive. 
 The goal of the present study was to dissect the molecular mechanisms of the RQC 
pathway in the yeast Saccharomyces cerevisiae and to find possible explanations for the 
neurodegenerative phenotype observed in RQC-deficient mice. To this end, a set of reporter 
constructs with distinct stalling features was expressed in RQC-deficient yeast to determine the 
critical features that are necessary for aggregation of faulty translation products. Furthermore, a 
mass spectrometric approach was used to determine the interactome of a recombinantly 
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expressed NS-protein. The influence of RQC deficiency on general protein quality control was 
also analyzed in order to reveal the toxicity of endogenous aberrant polypeptides that are the 
result of translation of faulty mRNAs. Since these faulty transcripts are normally subject to rapid 
degradation via one of the mRNA quality control pathways, the role of mRNA surveillance in the 
aggregation of aberrant nascent chains was investigated. Strikingly, cells seem to be constantly 
challenged by aberrant polypeptides, but the reasons for ribosomal stalling under normal 
conditions as well as the identity of endogenous faulty mRNAs and their translation products 
remain unknown. Thus, a mass spectrometric approach was used in order to determine the 
identity of endogenous stalled nascent chains and to possibly identify the features that are 
responsible for the majority of stalling events in vivo. Finally, in vitro aggregation experiments 
with purified proteins resembling translation products of faulty mRNAs were performed in order 
to characterize the aggregation process of aberrant polypeptides. 
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II. Materials & Methods 
 
II.1 Chemicals 
 
Name Vendor 
100 mM dNTP Mix Bioline 
LE Agarose Biozym 
[13C6, 15N2]L-lysine Cambridge Isotope Laboratories 
L-lysine D4 Cambridge Isotope Laboratories 
Bacto Agar Difco 
Bacto Peptone Difco 
Bacto Tryptone Difco 
Bacto Yeast Extract Difco 
Yeast Nitrogen Base without amino acids Difco 
InstantBlue Protein Stain expedeon 
Formic acid Fluka 
L-Serine Fluka 
ECL Western Blotting Detection Reagent GE Healthcare 
Ammonium chloride Merck 
Calcium chloride dihydrate Merck 
D-Sorbitol Merck 
Ethylenediamine tetraacetate disodium salt Merck 
Glycerol anhydrous Merck 
L-Leucine Merck 
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Magnesium acetate tetrahydrate Merck 
Sodium dihydrogen phosphate monohydrate Merck 
Sodium hydroxide Merck 
Sucrose Merck 
Trifluoroacetic acid Merck 
Tris(hydroxymethyl)aminomethane Merck 
CutSmart Buffer (10x) NEB 
1,4-Dithiothreitol Roche 
cOmplete Mini, EDTA-free protease inhibitor cocktail Roche 
Acetonitrile Roth 
Di-potassium hydrogen phosphate trihydrate Roth 
Di-sodium hydrogen phosphate Roth 
Ethanol p.a. Roth 
Glycine Roth 
Guanidine hydrochloride Roth 
Isopropyl β-D-1-thiogalactopyranoside Roth 
Methanol Roth 
Potassium acetate Roth 
Potassium chloride Roth 
Potassium dihydrogen phosphate Roth 
Milk powder Saliter 
Dimethyl sulfoxide Serva 
Sodium dodecyl sulfate Serva 
α-D-Raffinose Serva 
2-Propanol Sigma 
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3-(N-morpholino)propanesulfonic acid Sigma 
Acetic acid Sigma 
Acetone Sigma 
Adenine hemisulfate Sigma 
Ampicillin sodium salt Sigma 
Bis-Tris Sigma 
Bromophenol blue sodium salt Sigma 
Chloramphenicol Sigma 
Cycloheximide Sigma 
D-Galactose Sigma 
D-Glucose Sigma 
Iodoacetamide Sigma 
L-Alanine Sigma 
L-Arginine Sigma 
L-Asparagine Sigma 
L-Aspartic acid sodium salt Sigma 
L-Cysteine hydrochloride monohydrate Sigma 
L-Glutamic acid sodium salt Sigma 
L-Glutamine Sigma 
L-Histidine Sigma 
L-Isoleucine Sigma 
Lithium acetate dihydrate Sigma 
L-Lysine Sigma 
L-Methionine Sigma 
L-Phenylalanine Sigma 
Materials & Methods 
 
39 
 
L-Proline Sigma 
L-Threonine Sigma 
L-Tryptophane Sigma 
L-Tyrosine Sigma 
L-Valine Sigma 
Magnesium chloride hexahydrate Sigma 
Myo-inositol Sigma 
Para-aminobenzoic acid Sigma 
Polyethylene glycol 3,350 Sigma 
Rubidium chloride Sigma 
Sodium azide Sigma 
Sodium deoxycholate Sigma 
Trichloroacetic acid Sigma 
Triton X-100 Sigma 
Tween 20 Sigma 
Uracil Sigma 
Urea Sigma 
β-mercaptoethanol Sigma 
DNA Gel Loading Dye (6x) Thermo Fisher Scientific 
Herring Sperm DNA Solution Thermo Fisher Scientific 
PageRuler Prestained Protein Ladder Thermo Fisher Scientific 
SYBR Safe DNA Gel Stain Thermo Fisher Scientific 
Nonidet P40 USB 
Hydrochloric acid VWR 
Sodium chloride VWR 
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II.2 Enzymes and antibodies 
 
II.2.1 Enzymes 
Name Vendor 
Herculase II Fusion DNA Polymerase Agilent 
PreScission Protease GE Healthcare 
Benzonase Millipore 
AgeI-HF NEB 
BamHI-HF NEB 
EcoRI NEB 
HindIII-HF NEB 
SpeI-HF NEB 
T4 DNA Polymerase NEB 
XbaI NEB 
XhoI NEB 
RNase A Qiagen 
Lysozyme Sigma 
Lysyl Endopeptidase, MS  Grade Wako 
 
II.2.2 Antibodies 
Immunogen Host Vendor Working dilution 
GFP Mouse monoclonal Roche 1:1,000 
Pgk1p Mouse monoclonal Invitrogen 1:1,000 
mCherry Mouse monoclonal Clontech 1:1,000 
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Rpl3p Mouse monoclonal Developmental Studies 
Hybridoma Bank 
1:500 
β-galactosidase Mouse polyclonal Sigma 1:1,000 
Sis1p Rabbit polyclonal cosmobio 1:5,000 
FLAG Rabbit polyclonal Sigma 1:1,000 
Hsp104p Rabbit polyclonal abcam 1:4,000 
Hsp42p Rabbit polyclonal Johannes Buchner lab 1:4,000 
Hsp26p Rabbit polyclonal Johannes Buchner lab 1:4,000 
HA Rat monoclonal Roche 1:1,000 
Ubiquitin Mouse monoclonal Santa Cruz 1:500 
Mouse IgG Goat polyclonal Dako 1:1,000 
Rabbit IgG Goat polyclonal Sigma 1:10,000 
Rat IgG Goat polyclonal Sigma 1:5,000 
 
II.3 Strains 
 
II.3.1 Bacterial strains 
Name Genotype Source 
DH5α F– endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG 
purB20 φ80dlacZΔM15 Δ(lacZYA-argF)U169, hsdR17(rK–
mK+), λ– 
Invitrogen 
Rosetta 2      
(DE3) pLysS 
F– ompT gal dcm lon? hsdSB(rB–mB–) λ(DE3 [lacI lacUV5-
T7p07 ind1 sam7 nin5]) [malB+]K-12(λS) pLysSRARE[T7p20 
ileX argU thrU tyrU glyT thrT argW metT leuW proL 
orip15A](CmR) 
Novagen 
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II.3.2 Yeast strains 
Name Genotype Source 
BY4741 MATα his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 EUROSCARF 
ltn1Δ BY4741 ltn1Δ::KanMX EUROSCARF 
rqc1Δ BY4741 rqc1Δ::KanMX EUROSCARF 
rqc2Δ BY4741 rqc2Δ::KanMX EUROSCARF 
ltn1Δrqc2Δ BY4741 ltn1Δ::KanMX rqc2Δ::LEU2(K. lactis) (Choe, Park et al. 2016) 
rqc1Δrqc2Δ BY4741 rqc1Δ::KanMX rqc2Δ::LEU2(K. lactis) (Choe, Park et al. 2016) 
ltn1Δhel2Δ BY4741 ltn1Δ::KanMX hel2Δ::loxP (Choe, Park et al. 2016) 
ltn1Δski7Δ BY4741 ltn1Δ::KanMX ski7Δ::LEU2(K. lactis) Young-Jun Choe 
ltn1Δski2Δ BY4741 ltn1Δ::KanMX ski2Δ::LEU2(K. lactis) Timm Hassemer 
ltn1Δski3Δ BY4741 ltn1Δ::KanMX ski3Δ::LEU2(K. lactis) Young-Jun Choe 
ltn1Δski8Δ BY4741 ltn1Δ::KanMX ski8Δ::LEU2(K. lactis) Young-Jun Choe 
ltn1Δxrn1Δ BY4741 ltn1Δ::KanMX xrn1Δ::LEU2(K. lactis) Timm Hassemer 
ltn1Δski7Δdom34Δ BY4741 ltn1Δ::KanMX ski7Δ::LEU2(K. lactis) 
dom34Δ::HIS3MX(S. pombe) 
Young-Jun Choe 
ltn1Δski7Δhbs1Δ BY4741 ltn1Δ::KanMX ski7Δ::LEU2(K. lactis) 
hbs1Δ::HIS3MX(S.pombe) 
Young-Jun Choe 
SIS1-GFP BY4741 sis1Δ::SIS1-GFP-HIS3 (Huh, Falvo et al. 2003) 
ltn1Δ SIS1-GFP SIS1-GFP ltn1Δ::HphMX (Choe, Park et al. 2016) 
SIS1-HA BY4741 sis1Δ::SIS1-HA-HphMX (Choe, Park et al. 2016) 
ltn1Δ SIS1-HA SIS1-HA ltn1Δ::KanMX (Choe, Park et al. 2016) 
ltn1Δski7Δ       
SIS1-HA 
SIS1-HA ltn1Δ::KanMX ski7Δ::LEU2(K. lactis) Young-Jun Choe 
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II.4 Plasmids 
 
Vector Source 
pRS413 (Sikorski and Hieter 1989) 
pRS413GAL-∆ss-CPY*-GFP (Park, Kukushkin et al. 2013) 
pRS413GAL-∆ss-CPY*-mCherry (Park, Kukushkin et al. 2013) 
pRS413RQC2-RQC2 (Choe, Park et al. 2016) 
pRS413RQC2-rqc2aaa (Choe, Park et al. 2016) 
pRS415-PHSE-lacz Dennis Thiele lab 
pRS415GAL-HA-SIS1 (Park, Kukushkin et al. 2013) 
pRS416 (Sikorski and Hieter 1989) 
pRS416GAL-2xmyc-Luc (Choe, Park et al. 2016) 
pRS416GAL-2xmyc-NS-Luc (Choe, Park et al. 2016) 
pRS416GAL-GFP-s (Choe, Park et al. 2016) 
pRS416GAL-GFP-s-K12 (Choe, Park et al. 2016) 
pRS416GAL-GFP-s-K20 (Choe, Park et al. 2016) 
pRS416GAL-GFP-s* (Choe, Park et al. 2016) 
pRS416GAL-GFP-s*-K20 (Choe, Park et al. 2016) 
pRS416GAL-GFP-s-mCherry (Choe, Park et al. 2016) 
pRS416GAL-GFP-s-K20-mCherry (Choe, Park et al. 2016) 
pRS416GAL-GFP-s-R3RARE Timm Hassemer 
pRS416GAL-GFP-s-R4RARE-mCherry (Choe, Park et al. 2016) 
pRS416GAL-GFP-s-R20RARE-mCherry (Choe, Park et al. 2016) 
pRS416GAL-GFP-s-R20FREQ-mCherry (Choe, Park et al. 2016) 
pRS416GAL-GFP-s-R20FREQ-R4RARE-mCherry (Choe, Park et al. 2016) 
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pRS416GAL-GFP-s-(AT)6 (Choe, Park et al. 2016) 
pRS416GAL-GFP-s-K20-(AT)6 (Choe, Park et al. 2016) 
pRS416GAL-GFP-s-K20-(GS)6 (Choe, Park et al. 2016) 
pRS416GAL-RQC2-2xFLAG Young-Jun Choe 
pRS416GAL-rqc2aaa-2xFLAG Young-Jun Choe 
pRS316CUP-RNQ1-GFP (Choe, Park et al. 2016) 
YEplac181CUP-His6-ubiquitin (Scazzari, Amm et al. 2015) 
pGEX-6P-1-GFP-s Timm Hassemer 
pGEX-6P-1-GFP-s-K20 Timm Hassemer 
pGEX-6P-1-GFP-s-(AT)10 Timm Hassemer 
pGEX-6P-1-GFP-s-K20-(AT)10 Timm Hassemer 
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II.5 Media and buffers 
 
II.5.1 Media 
Medium Composition Comment 
LB 1 % (w/v) tryptone 
0.5 % (w/v) yeast extract 
170 mM NaCl 
 
Standard medium for 
bacterial growth 
SOB 2 % (w/v) tryptone 
0.5 % (w/v) yeast extract 
10 mM NaCl 
2.5 mM KCl 
10 mM MgCl2 (add after autoclaving) 
10 mM MgSO4 (add after autoclaving) 
 
Improved bacterial 
growth medium for 
preparation of 
chemocompetent cells 
TB 1.2 % (w/v) tryptone 
2.4 % (w/v) yeast extract 
0.5 % (v/v) glycerol 
90 mM K-phosphate pH 7.5 (add after autoclaving) 
 
Rich bacterical growth 
medium for expression 
and purification of 
recombinant proteins 
YPD 2 % (w/v) peptone 
1 % (w/v) yeast extract 
2 % (w/v) glucose (add after autoclaving) 
 
 
Standard medium for 
yeast growth 
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SC 0.67 % (w/v) yeast nitrogen base w/o amino acids 
0.2 % (w/v) amino acid dropout mix 
 
Defined medium for 
yeast growth and 
expression of 
recombinant proteins 
 
 If required (add after autoclaving): 
55.3 mg/L adenine 
22.4 mg/L uracil 
219 mg/L leucine 
62.85 mg/L histidine 
180.26 mg/L lysine 
82 mg/L tryptophane 
 
 
Supplements added as 
required by presence or 
absence of auxotrophic 
markers 
 
 2 % (w/v) glucose 
or 
2 % (w/v) raffinose 
or 
2 % (w/v) raffinose 
3 % (w/v) galactose 
 
Repression of PGAL1 
 
Derepression of PGAL1 
 
Induction of PGAL1 
Amino acid 
dropout 
mix 
5 g of each of the following L-amino acids: alanine, 
arginine, asparagine, aspartic acid, cysteine, 
glutamine, glutamic acid, glycine, isoleucine, 
methionine, phenylalanine, proline, serine, 
threonine, tryptophane, tyrosine 
5 g myo-inositol 
0.5 g p-aminobenzoic acid 
Grind to homogeneity in 
a mortar and store at 
room temperature 
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II.5.2 Buffers 
Buffer Composition 
Yeast Alkaline Lysis Buffer 
(freshly prepared) 
1.85  M   NaOH 
1  M   β-mercaptoethanol 
 
Yeast IP Lysis Buffer 25  mM   Tris-HCl pH 7.4 
150  mM   NaCl 
1  mM   EDTA 
5  % (v/v)  Glycerol 
cOmplete protease inhibitor (freshly added) 
 
Yeast IP Wash Buffer 25  mM   Tris-HCl pH 7.4 
150  mM   NaCl 
1  mM   EDTA 
5  % (v/v)  Glycerol 
0.5  % (v/v)  NP40 
 
Yeast Sucrose Gradient Lysis Buffer 10  mM   Tris-HCl pH 7.5 
100  mM   NaCl 
30  mM   MgCl2 
1  mM   DTT (freshly added) 
100  µg/ml   CHX (freshly added) 
cOmplete protease inhibitor (freshly added) 
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7 % Sucrose Gradient Solution 40  mM   Tris-acetate pH 7.0 
50  mM   NH4Cl 
12  mM   MgCl2 
7  % (w/v)  Sucrose 
1  mM   DTT (freshly added) 
100  µg/ml   CHX (freshly added) 
 
47 % Sucrose Gradient Solution 40  mM   Tris-acetate pH 7.0 
50  mM   NH4Cl 
12  mM   MgCl2 
47  % (w/v)  Sucrose 
1  mM   DTT (freshly added) 
100  µg/ml   CHX (freshly added) 
 
HU Buffer 200  mM   Tris-HCl pH 6.8 
8  M   Urea 
5  % (w/v)  SDS 
1  mM   EDTA 
100  mM   DTT (freshly added) 
0.01  % (w/v)  Bromophenol blue 
 
Materials & Methods 
 
49 
 
MOPS-SDS Running Buffer for SDS-PAGE 50  mM   Tris-base 
50  mM   MOPS 
0.1  % (w/v)  SDS  
1  mM   EDTA 
 
Towbin Transfer Buffer 50  mM   Tris-base 
192  mM   Glycine 
0.1  % (w/v)  SDS 
20  % (v/v)  Methanol 
 
5x SDD-AGE Sample Buffer 250  mM   Tris-HCl pH 6.8  
10  % (w/v)  SDS  
50  % (v/v)  Glycerol  
0.5  % (w/v)  Bromophenol blue 
 
SDD-AGE Running Buffer 40  mM   Tris-base 
20  mM   Acetic acid 
1  mM   EDTA 
0.1  % (w/v)  SDS 
 
SDD-AGE Transfer Buffer 50  mM   Tris-HCl pH 7.5 
150  mM   NaCl 
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PBS-T 25  mM   Na-phosphate pH 7.4 
150  mM   NaCl 
0.05  % (v/v)  Tween 20 
 
Blocking Buffer 25  mM   Na-phosphate pH 7.4 
150  mM   NaCl 
0.05  % (v/v)  Tween 20 
5  % (w/v)  Milk powder 
 
Stripping Buffer 62.5  mM   Tris-HCl pH 6.8 
100  mM   β-mercaptoethanol 
2  % (w/v) SDS 
 
TAE 40  mM   Tris-base 
20  mM   Acetic acid 
1  mM   EDTA 
 
TfB I 30  mM   K-acetate pH 7.5 
100  mM   RbCl2 
50  mM   MnCl2 
10  mM   CaCl2 
15  % (v/v)  Glycerol 
 
Materials & Methods 
 
51 
 
TfB II 10  mM   MOPS-NaOH pH 6.8 
10  mM   RbCl2 
75  mM   CaCl2 
15  % (v/v)  Glycerol 
 
TE Buffer 10  mM   Tris-HCl pH 7.5 
1  mM   EDTA 
 
TEL Buffer 10  mM   Tris-HCl pH 7.5 
1  mM   EDTA 
100  mM   Lithium acetate 
 
PLATE Solution 10  mM   Tris-HCl pH 7.5 
1  mM   EDTA 
100  mM   Lithium acetate 
40  % (w/v)  PEG 3,350 
 
Yeast DNA Isolation Buffer 10  mM   Tris-HCl pH 8.0 
100  mM   NaCl 
1  mM   EDTA 
1  % (w/v)  SDS 
2  % (v/v)  Triton X-100 
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Bacterial Lysis Buffer 50  mM   Na-phosphate pH 8.0 
100  mM  NaCl 
10  % (v/v)  Glycerol 
1  mM  DTT (freshly added) 
2  mg/mL  Lysozyme                       
   (freshly added) 
5  U/mL   Benzonase                     
   (freshly added) 
1  % (w/v)  Triton X-100 
cOmplete protease inhibitor (freshly added) 
 
Bacterial Wash Buffer 1 50  mM   Na-phosphate pH 8.0 
1  M  NaCl 
10  % (v/v)  Glycerol 
1  mM  DTT (freshly added) 
1  % (w/v) Triton X-100 
 
Bacterial Wash Buffer 2 50  mM   Na-phosphate pH 8.0 
100  mM   NaCl 
10  % (v/v)  Glycerol 
1 mM   DTT (freshly added) 
1  % (w/v)  Triton X-100 
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Bacterial Elution Buffer 50  mM   Na-phosphate pH 8.0 
100  mM   NaCl 
10  % (v/v)  Glycerol 
1  mM   DTT (freshly added) 
1  % (w/v)  Triton X-100 
20  mM   Reduced glutathione                       
   (freshly added) 
 
Dialysis Buffer 20  mM   Tris-HCl pH 8.0 
150  mM  KCl 
100  µM   EDTA 
10  % (v/v)  Glycerol 
100  µM   DTT (freshly added) 
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II.6 Materials and instruments 
 
II.6.1 Kits and consumables 
Name Vendor 
β-Galactosidase Assay Kit Agilent 
Pierce Coomassie Plus (Bradford) Protein Assay Kit Invitrogen 
Pierce BCA Protein Assay Kit Invitrogen 
µMACS GFP/HA Isolation Kit Miltenyi Biotec 
Q5 Site-Directed Mutagenesis Kit NEB 
Wizard SV Gel and PCR Clean-up System Promega 
QIAprep Spin Miniprep Kit Qiagen 
Rapid DNA Ligation Kit Roche 
Pierce High pH Reversed-Phase Peptide Fractionation Kit Thermo Fisher Scientific 
 
II.6.2 Instruments 
Name Vendor 
51708TS Fridge AEG 
Sonorex RK100 ultrasonic bath Bandelin 
Allegra X-15R Centrifuge + SX4750 rotor Beckman Coulter 
Avanti J-25I Centrifuge + JA-14 rotor Beckman Coulter 
J6-MI Centrifuge + JS 4.2 rotor Beckman Coulter 
Optima L-90K Ultracentrifuge + SW41 rotor Beckman Coulter 
Optima MAX-XP Ultracentrifuge + TLA 120.2 rotor Beckman Coulter 
Gradient Master Biocomp 
PGF ip Piston Gradient Fractionator Biocomp 
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T3 Thermocycler Biometra 
(Wide) Mini-Sub Cell GT Cell DNA electrophoresis system Bio-Rad 
ChemiDoc XRS Imaging system Bio-Rad 
Econo UV Monitor Bio-Rad 
Mini Trans-Blot Cell Bio-Rad 
PowerPac 300 power supply Bio-Rad 
PipetAid XP Drummond Scientific 
Sky Line Shaker DRS-12 Elmi 
BioSpectrometer kinetic eppendorf 
Centrifuge 5424/5415 R eppendorf 
Research (2.5/10/20/100/200/1000 µL) and                                            
Research Plus multi-channel  (10 µL) pipettes 
eppendorf 
Thermomixer comfort eppendorf 
biostep ViewPix 700 Gel Scanner Epson 
LAS-3000 Imaging System Fujifilm 
FC203B Fraction Collector Gilson 
LaminAir HA2448GS sterile hood Heraeus 
Genie Blotter Idea Scientific 
RCT basic magnetic stirrer IKA 
Fireboy Integra 
SafeImager 2.0 Invitrogen 
Type B Waterbath LAUDA 
Wavedom Microwave LG Electronics 
Premium NoFrost Freezer Liebherr 
AB265-5/FACT precision scale Mettler Toldeo 
M200L ice machine Microcubes 
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Reference A+ Milli-Q Water Dispenser Millipore 
Magnetic rack Miltenyi Biotec 
Sonicator Ultrasonic Processor XL Misonix 
FastPrep-24 bead beater MP Biomedicals 
innova 40 incubator shaker series New Brunswick Scientific 
U570 Ultra-Low Temperature High Efficiency Freezer New Brunswick Scientific 
MC6 Centrifuge Sarstedt 
CP3202 P scale Sartorius 
Vortex Genie 2 Scientific Industries 
Rotator SB3 Stuart 
See-saw rocker SSL4 Stuart 
EASY-nLC 1000 nano liquid chromatography system Thermo Fisher Scientific 
NanoDrop One Spectrophotometer Thermo Fisher Scientific 
Q-Exactive orbitrap mass spectrometer Thermo Fisher Scientific 
Savant SPD-121P SpeedVac Concentrator Thermo Fisher Scientific 
XCell SureLock Mini-Cell Electrophoresis System Thermo Fisher Scientific 
Lourmat Quantum Imaging System Vilber 
inoLab pH meter WTW Series 
Axiovert 200M Inverted Fluorescence Microscope 
 
Zeiss 
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II.7 Molecular biology 
 
II.7.1 DNA quantification 
Concentration and purity of DNA samples were measured by UV spectroscopy at a wavelength 
of 260 nm under the assumption that one absorption unit corresponds to 50 ng/µL dsDNA. 
Nuclease-free water or elution buffer (Qiagen) served as a reference. The A260/A280 ratio was also 
measured to check for protein contaminants in the sample, where a value of 1.85 or higher 
indicated negligible contamination. 
 
II.7.2 Agarose gel electrophoresis 
1.2 % (w/v) agarose gels were prepared by melting agarose in TAE buffer until the agarose was 
completely dissolved. SYBR Safe DNA gel stain was added at a final dilution of 1:10,000 to 
visualize DNA bands. For analytical agarose gels, 5 µL of DNA sample were mixed with 1 µL 6x 
DNA loading dye and 5 µL were loaded on the gel. For preparative agarose gels, the whole PCR 
or restriction digest mixture (typically 50 µL) was mixed with 10 µL 6x DNA loading dye and the 
whole sample was loaded on the gel. Gel electrophoresis was performed at a constant voltage of 
110 V in TAE buffer until the lower dye front had migrated approximately 60 % towards the 
bottom end of the gel. 
 
II.7.3 DNA sequencing 
DNA sequencing was performed by eurofins Genomics (Ebersberg, Germany). Premixed samples 
containing 1 µg purified plasmid DNA and 20 pmol of the respective primer in a total volume of 
17 µL were prepared and submitted for sequencing. 
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II.7.4 Purification of DNA fragments and plasmid DNA 
For purification of linear dsDNA fragments from PCR amplifications or out of excised agarose 
gel bands, the Wizard SV Gel and PCR Clean-Up Kit was used according to the manufacturer’s 
instructions. 
For purification of plasmid DNA, 5 mL LB medium supplied with 100 µg/mL Ampicillin 
were inoculated with E. coli DH5α cells harboring the respective plasmid and the culture was 
grown overnight at 37 °C with shaking. The next morning, cells were harvested by centrifugation 
at 4,000 x g for 10 minutes and plasmid DNA was isolated using the QIAprep Spin Miniprep Kit 
according to the manufacturer’s instructions. 
 
II.7.5 Polymerase chain reaction 
PCR was used for the amplification of defined DNA fragments. To this end, the Herculase II 
Fusion DNA Polymerase was used according to the manufacturer’s instructions for all PCR-based 
applications. A comprehensive list of primers can be found in section VI. Typically, a PCR 
reaction consisted of 30 repetitive cycles of denaturation, primer annealing and elongation. The 
annealing temperature was calculated by subtracting 5 °C from the primer melting temperature, 
which was in turn calculated using Thermo Fisher Scientific’s “Multiple Primer Analyzer” online 
tool. Primers were designed with melting temperatures in between 52 – 58 °C and with a 
maximum difference of 3 °C. 
 
II.7.6 Restriction digest and DNA ligation 
For enzymatic digestion of plasmid DNA or PCR fragments, typically 5 µg of purified plasmid 
DNA or PCR product were used. The DNA was incubated with 10 U of the respective restriction 
enzyme(s) in 1X CutSmart buffer in a total reaction volume of 50 µL at 37 °C for 2 hours. After 
digestion, the reaction was subjected to agarose gel electrophoresis, the corresponding band was 
cut out and the DNA fragment was isolated by using the Wizard SV Gel and PCR Clean-Up Kit. 
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For DNA ligation, the Rapid DNA ligation kit was used according to the manufacturer’s 
instructions with minor modifications. Briefly, 50 ng of vector DNA was mixed with insert DNA 
at a molar ratio of 1:5 in a total volume of 10 µL. An equal amount of 2X ligation buffer and 1 µL 
of DNA ligase were added and the reaction was incubated at room temperature for 15 minutes. 
2 µL of the ligation reaction were transformed into chemocompetent E. coli DH5α cells. 
 
II.7.7 Sequence- and ligation-independent cloning 
For the construction of bacterial expression vectors, the method of sequence- and ligation-
independent cloning was used, which exploits the exonucleolytic activity of T4 DNA Polymerase 
in the absence of dNTPs (Li and Elledge 2007).To this end, the gene of interest was amplified by 
PCR using primers with 20 bp homology to the regions flanking the insertion site in the target 
bacterial expression vector. Meanwhile, the target vector was digested with a conventional 
restriction enzyme cutting at the insertion site. After purification of both linearized vector and 
insert DNA, 1 µg of each fragment was treated with 0.5 U T4 DNA polymerase at 22 °C for 30 
minutes in a total reaction volume of 20 µL. The reaction was stopped by adding dCTP to a final 
concentration of 1 mM. 100 ng of vector and the respective amount of insert DNA were mixed in 
a molar ratio of 1:2 in 1X ligation buffer and incubated at 37 °C for 30 minutes in a total reaction 
volume of 10 µL. 5 µL of the ligation reaction were transformed into chemocompetent E. coli 
DH5α cells. 
 
II.7.8 Site-directed mutagenesis 
To introduce mutations or to delete or substitute specific regions within a construct, the Q5 site-
directed mutagenesis kit was used according to the manufacturer’s instructions. Briefly, 
appropriate primers were designed using the “NEBaseChanger” online tool and a PCR was 
performed using the respective template DNA and the Q5 High Fidelity Polymerase Master Mix. 
Then, digestion of methylated template DNA, 5’-phosphorylation, and ligation of the amplified 
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DNA fragment were carried out in a single step using the provided KLD reagent. The reaction 
was then transformed into chemocompetent E. coli DH5α cells. 
 
II.7.9 Preparation and transformation of chemocompetent E. coli cells 
Chemocompetent E. coli DH5α and SURE cells were prepared using the RbCl method (Hanahan 
1983). Briefly, cells were grown to mid-log phase (OD600 ≈ 0.5) in SOB medium, chilled on ice for 
15 minutes and then harvested by centrifugation at 4,000 x g for 15 minutes at 4 °C. The cell pellet 
was resuspended in 16 mL TfB 1 buffer, chilled on ice for 15 minutes and centrifuged again at 
4,000 x g for 15 minutes at 4 °C. Cells were resuspended in 4 mL TfB 2 buffer, chilled on ice for 15 
minutes and 100 µL aliquots were prepared on dry ice in prechilled Eppendorf tubes. Cells were 
immediately frozen at -80 °C until further use. 
For transformation, aliquots of competent cells were thawed on ice. Approximately 100 
ng of plasmid DNA or 2 µL of ligation reaction were added and the cell suspension was gently 
mixed with the pipette tip. Cells were incubated on ice for 20 minutes, followed by a heat shock 
at 42 °C in a waterbath for exactly 45 seconds and incubation on ice for 2 minutes. 300 µL LB 
medium were added to the cell suspension, the mixture was incubated at 37 °C for 45 minutes 
and then plated on LB agar plates containing the appropriate antibiotic. 
 
II.7.10 Preparation and transformation of chemocompetent S. cerevisiae cells 
Chemocompetent S. cerevisiae cells were prepared freshly at the day of transformation using the 
LiOAc/single-stranded carrier DNA/PEG method (Gietz and Woods 2002). Briefly, yeast cells 
were grown to mid-log phase (OD600 ≈ 0.8) in YPD medium at 30 °C with shaking and 2.5 OD600 
of cells were harvested per transformation reaction by centrifugation at 4,000 x g for 5 minutes. 
Cells were washed once with 1 mL of TE buffer and then resuspended in 100 µL of TEL buffer. 
In the meantime, single stranded Herring Sperm DNA was boiled at 95 °C for 10 minutes and 
immediately put on ice. 5 µL of the denatured Herring Sperm DNA and 1 – 5 µg of plasmid DNA 
or PCR product were added to the yeast cell suspension. Next, 700 µL of PLATE solution were 
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added and the sample was thoroughly mixed by vortexing. Samples were then incubated at 30 
°C for 1 hour, followed by a heat shock at 42 °C for 20 minutes in waterbaths, respectively. Cells 
were pelleted by centrifugation at 16,000 x g for 2 minutes, the supernatant was discarded and 
the cell pellet was resuspended in 100 µL nuclease-free water. Cells were plated on appropriate 
selective medium agar plates and incubated at 30 °C for 2 – 3 days. 
 
II.7.11 Construction of mutant S. cerevisiae strains 
For the generation of mutant yeast knockout strains that were not available through the 
EUROSCARF yeast deletion library, a method was used that is based on the integration of PCR-
amplified selective marker cassettes into the yeast genome by homologous recombination 
(Baudin, Ozier-Kalogeropoulos et al. 1993). To this end, the appropriate marker cassette was 
amplified by PCR using a plasmid carrying the respective marker as a template. By using 
respective primers, the final PCR product also carried short flanking sequences of 45 bp that were 
homologous to the flanking regions of the gene that was to be deleted. After purification, the PCR 
product was transformed into chemocompetent yeast cells and the transformed cells were plated 
on agar plates with the appropriate selective medium. After 4 - 5 days of incubation, several big 
colonies were picked, genomic DNA was isolated and the correct integration of the marker 
cassette was verified by PCR using primers that were specific for the flanking regions of the 
deleted gene and for the marker cassette. 
 
II.7.12 Isolation of genomic DNA from S. cerevisiae 
For isolation of genomic DNA from yeast cells, 10 mL YPD medium were inoculated with BY4741 
cells and grown to saturation at 30 °C with shaking. Cells were harvested by centrifugation at 
4,000 x g for 10 minutes and washed once with water. Cells were then resuspended in 300 µL 
yeast DNA isolation buffer. 300 µL of a mixture of phenol, chloroform and isoamyl alcohol 
(25:24:1) and 300 µL glass beads were added and cells were lysed using a bead beater (3 cycles of 
60 seconds each on intensity level 6.5 with 60 seconds incubation on ice between two cycles). 
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200 µL TE buffer were added and the sample was vortexed for 15 seconds, followed by 
centrifugation at 16,000 x g for 5 minutes. The top aqueous layer was transferred to a new tube 
and 1 mL ethanol p.a. was added to the sample. After thorough mixing by inversion, the sample 
was incubated at -20 °C for 30 minutes and then centrifuged at 16,000 x g for 10 minutes. The 
supernatant was discarded and the pellet resuspended in 400 µL TE with 75 ng/ µL RNase A, 
followed by incubation at 37 °C for 15 minutes to degrade RNA contaminants. DNA was 
precipitated by adding 10 µL 3 M sodium acetate pH 5.2 and 1 mL ethanol p.a. and mixing the 
sample by inverting the tube several times. After centrifugation at 16,000 x g for 10 minutes, the 
supernatant was discarded, the pellet was air dried, washed once with 70 % (v/v) ethanol, air 
dried again and resuspended in 50 µL TE buffer. 
 
II.8 Expression and purification of proteins 
 
II.8.1 Expression of proteins in E. coli 
Recombinant GST fusion proteins were expressed in E. coli Rosetta 2 (DE3) pLysS cells by 
induction of the lac operon. These cells are harboring an additional plasmid coding for several 
tRNAs that are rarely used in bacteria, which makes them suitable for the expression of 
eukaryotic proteins. 
For each construct, 1 L of TB medium supplied with 100 µg/mL Ampicillin and 34 µg/mL 
Chloramphenicol was inoculated with cells from an overnight culture to an optical density of 
OD600 ≈ 0.02. Cultures were incubated at 37 °C with shaking until an optical density of OD600 ≈ 0.7 
was reached. Protein expression was induced by the addition of IPTG to a final concentration of 
0.5 mM, the incubation temperature was shifted to 30 °C and cultures were kept shaking for 3 
more hours. Cells were then harvested by centrifugation at 4,000 x g for 15 minutes at 4 °C and 
cell pellets were stored at -80 °C. 
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II.8.2 Purification of proteins expressed in E. coli 
Cells were resuspended in 25 mL bacterial lysis buffer, incubated for 30 minutes at 4 °C on a 
rotator, and lysed by sonication (10 % amplitude, 5 cycles of 2.5 minutes and intervals of 30 
seconds). The resulting lysate was cleared by centrifugation at 30,000 x g for 30 minutes at 4 °C 
and the supernatant was incubated with 2.5 mL of preequilibrated glutathione-agarose beads for 
30 minutes at 4 °C on a rotator. The slurry was filled into disposable gravity flow columns and 
the agarose beads were washed 4 times with 20 mL bacterial wash buffer 1, followed by a washing 
step with 10 mL of bacterial wash buffer 2. GST fusion proteins were then eluted with 20 mL of 
bacterial elution buffer. 2 mL fractions were collected and analyzed by SDS-PAGE. Fractions 
containing detectable amounts of the GST fusion proteins were pooled and dialyzed overnight in 
2 L dialysis buffer per construct at 4 °C. The next day, the buffer was replaced with 2 L of fresh 
dialysis buffer, samples were dialyzed for 8 more hours, the buffer was again replaced and the 
samples again dialyzed overnight. The next day, the protein concentration of the purified GST 
fusion proteins was determined using the Pierce BCA Protein Assay Kit according to the 
manufacturer’s instructions. Samples were diluted to a concentration of 2 µM, aliquots of 100 µL 
were prepared, flash-frozen in liquid nitrogen and stored at -80 °C. 
 
II.8.3 Expression of proteins in S. cerevisiae 
Proteins were overexpressed in S. cerevisiae under control of the regulatable GAL1 promoter, 
which allows for tight repression or strong induction of protein expression depending on the 
presence or absence of glucose or galactose in the growth medium, respectively. Typically, a fresh 
colony was picked from a plate, resuspended in 3 mL of the respective dropout medium 
containing 2 % (w/v) glucose and the culture was grown to saturation overnight at 30 °C with 
shaking. The next day, 20-50 µL of the culture were used to inoculate 3 mL of dropout medium 
supplied with 2 % (w/v) raffinose, and the culture was again grown to saturation. Finally, 
50-100 mL of dropout medium containing 2 % (w/v) raffinose and 3 % (w/v) galactose were 
inoculated with cells from the raffinose culture to produce an initial optical density of OD600 ≈ 0.02 
and to induce protein expression. Cultures were then incubated at 30 °C with shaking for 
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approximately 16-18 hours until cells reached mid-log phase, which corresponds to an optical 
density of ≈ 0.8. Cells were harvested by centrifugation at 4,000 x g for 10 minutes at 4 °C, cell 
pellets were washed once with 1 mL of cold 30 mM NaN3, flash-frozen in liquid nitrogen and 
stored at -80 °C until lysis. 
 For SILAC experiments, 30 mL of dropout medium containing 2 % (w/v) raffinose and 
either light, medium or heavy lysine were inoculated with cells from a raffinose culture that was 
grown to saturation to produce an initial optical density of OD600 ≈ 0.02. Cultures were then 
incubated at 30 °C with shaking for approximately 16-18 hours until cells reached an optical 
density of ≈ 0.8. 15 OD600 of cells were harvested by gentle centrifugation at 1,000 x g for 10 
minutes, resuspended in 60 mL of fresh dropout medium, and incubated at 30 °C with shaking 
for 90 minutes to allow for recovery. Overexpression of Rqc2p under control of the GAL1 
promoter was then induced by the addition of galactose to a final concentration of 3 % (w/v), 
cultures were incubated for 3 more hours at 30 °C with shaking, and cells were harvested as 
described above. 
 
II.9 Protein analytics 
 
II.9.1 Preparation of yeast lysates 
Yeast lysates were prepared by disrupting the yeast cell wall and membranous structures with 
glass beads. Typically, approximately 500 µL of 0.5 mm acid washed glass beads and 500 µL of 
the respective yeast lysis buffer were added to a frozen yeast cell pellet. Cells were then disrupted 
using a FastPrep-24 bead beater with a CoolPrep adaptor (3 cycles of 60 seconds with intensity 
6.5, 60 seconds incubation on ice between each cycle). Unbroken cells, glass beads and cellular 
debris were removed by centrifugation at 400 x g for 5 minutes and 4 °C. The supernatant was 
then transferred into a new tube and centrifuged twice at 2,000 x g for 5 minutes at 4 °C to yield 
the final lysate. 
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II.9.2 Protein quantification 
To determine the total protein concentration of a precleared lysate or of purified GST fusion 
proteins, the Pierce Coomassie Plus (Bradford) Assay Kit or the Pierce BCA Protein Assay Kit 
were used according to the manufacturer’s instructions, respectively. A dilution series of BSA in 
the respective buffer was used to generate a calibration curve. Typically, 30 µL of a 1:100 dilution 
of lysate were mixed with 1 mL of the Bradford reagent and samples were incubated for 10 
minutes at room temperature before measuring the absorbance at 595 nm. In case of the BCA 
protein assay kit, 50 µL of the purified protein sample were mixed with 1 mL of the BCA reagent 
and samples were incubated for 30 minutes at 37 °C before measuring the absorbance at 562 nm. 
 
II.9.3 Trichloroacetic acid precipitation 
In order to concentrate proteins from a dilute solution for subsequent SDS-PAGE analysis, a TCA 
precipitation was performed. Briefly, protein samples were incubated on ice for 15 minutes after 
addition of sodium deoxycholate to a final concentration of 0.02 % (w/v). Subsequently, TCA was 
added to a final concentration of 10 % (v/v) and samples were further incubated on ice for 60 
minutes. Precipitated proteins were then sedimented by centrifugation at 16,000 x g for 30 
minutes at 4 °C. The supernatant was discarded, the pellet was washed once with 1 mL of -20 °C 
acetone and the sample was again centrifuged at 16,000 x g for 5 minutes at 4 °C. The supernatant 
was aspirated, the pellet was air dried and dissolved in HU buffer by incubation at 70 °C for 10 
minutes with shaking. 
 
II.9.4 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
To separate proteins based on their molecular weight, NuPAGE 4-12 % Bis-Tris gradient gels with 
1X MOPS-SDS running buffer were used. Typically, 30 µg protein sample were loaded and 
electrophoresis was performed at a constant voltage of 180 V until the dye front reached the 
bottom of the gel. 
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II.9.5 Semidenaturing-detergent agarose gel electrophoresis 
In order to resolve SDS-resistant high molecular weight aggregates that might get trapped in the 
wells of a polyacrylamide gel, the SDD-AGE method was used with minor modifications 
(Kryndushkin, Alexandrov et al. 2003). Briefly, a 1.5 % (w/v/) agarose gel was prepared with 1X 
SDD-AGE running buffer. Samples were prepared by mixing lysates with 5X SDD-AGE sample 
buffer and subsequent incubation of the samples for 10 minutes at room temperature. Typically, 
30 µg protein sample were loaded and electrophoresis was performed for 3 hours at a constant 
voltage of 75 V at 4 °C and with prechilled 1X SDD-AGE running buffer. 
 
II.9.6 Transfer of proteins onto nitrocellulose membranes 
After SDS-PAGE, proteins were transferred onto nitrocellulose membranes for subsequent 
detection via immunoblotting. Transfer was performed at a constant voltage of 70 V for 60 
minutes with a cooling pack to prevent overheating. Proteins resolved by SDD-AGE were 
transferred at a constant voltage of 7 V overnight at 4 °C. 
 
II.9.7 Western blotting 
Membranes were first blocked by incubation in blocking buffer for 45 minutes at room 
temperature to prevent unspecific binding of primary or secondary antibodies. Membranes were 
then incubated in blocking buffer containing the primary antibody for 60 minutes at room 
temperature or overnight at 4 °C using the working dilutions described in section II.2.2. 
Membranes were then washed twice with PBS-T for 15 minutes and subsequently incubated in 
blocking buffer containing the respective secondary antibody for 60 minutes at room 
temperature. Membranes were then washed once with blocking buffer and twice with PBS-T for 
10 minutes each and developed using the ECL Western Blotting detection reagent and the LAS-
3000 imaging system. 
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II.9.8 Mass spectrometry analysis of protein samples 
 
II.9.8.1 Isotopic labeling of proteins 
For isotopic labeling of proteins for subsequent SILAC analysis, cells were grown as described in 
section II.7.3 in the respective dropout medium supplied with either normal L-lysine, 
[4,4,5,5-D4]L-lysine or [13C6,15N2]L-lysine at a final concentration of 150 µg/mL. Typically, the 
control was labeled with normal, light (L) L-lysine, [4,4,5,5-D4]L-lysine served as medium (M) 
lysine and produced a mass shift of 4 Da, and [13C6, 15N2]L-lysine served as heavy (H) lysine, 
generating a mass shift of 8 Da. During each experiment, 10 µg of each labeled lysate were kept 
aside, processed as described in section II.8.13.3 without mixing, and separately analyzed to check 
for efficient incorporation of the labeled amino acids. 
 
II.9.8.2 In-gel digestion 
Following immunoprecipitation of genomically tagged Sis1-HA, eluates containing light-, 
medium- and heavy-labeled proteins were mixed 1:1:1 and 100 µL of the mixture were resolved 
by SDS-PAGE. Gels were stained in 0.1 % (w/v) Coomassie R250, 10 % (v/v) acetic acid for 20 
minutes, fixed in 30 % (v/v) methanol, 10 % (v/v) acetic acid for 30 minutes and then destained in 
8.5 % (v/v) acetic acid. The region between the sample well and the 170 kDa marker band 
containing SDS-resistant aggregates was cut out with a clean scalpel blade, transferred to Protein 
LoBind tubes and cut into cubes of 1 mm side length. Reduction, alkylation and digestion of 
proteins in the gel pieces was carried out as described in (Shevchenko, Wilm et al. 1996). After 
extraction, peptides were dried in a vacuum concentrator, dissolved in 100 µL 0.1 % (v/v) 
trifluoroacetic acid and subjected to desalting using Bond Elut OMIX C18 pipette tips according 
to the manufacturer’s instructions. Peptides were eluted in 100 µL 0.1 % (v/v) trifluoroacetic acid, 
70 % (v/v) acetonitrile, dried in a vacuum concentrator and stored at -20 °C until analysis. 
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II.9.8.3 Filter-aided sample preparation 
For total protein analysis, protein lysates labeled with light, medium or heavy L-lysine were 
reduced and denatured by adding DTT and SDS to final concentrations of 1 mM and 2 % (w/v), 
respectively. Samples were then boiled for 5 minutes at 95 °C and mixed 1:1:1. Protein reduction, 
alkylation and digestion was then carried out in Vivacon 10 kDa ultrafiltration devices as 
described in (Wisniewski, Zielinska et al. 2011). Peptides were dried in a vacuum concentrator 
after extraction, dissolved in 300 µL 0.1 % (v/v) trifluoroacetic acid, and fractionated using the 
Pierce High pH Reversed-Phase Peptide Fractionation Kit to reduce sample complexity. After 
fractionation, peptides were again dried in a vacuum concentrator and stored at -20 °C until 
analysis. 
 
II.9.8.4 LC-MS/MS analysis of peptides 
All peptides were analyzed using an EASY-nLC 1000 nano liquid chromatography system with 
a home-made 25 cm silica reversed-phase capillary column packed with 1.9 µm ReproSil-Pur C18-
AQ coupled to a Q-Exactive orbitrap mass spectrometer. To this end, peptides were dissolved in 
6 µL of 5 % (v/v) formic acid, sonicated for 5 minutes and loaded on the column by using a nLC 
autosampler at a flow rate of 0.5 µL/min. Peptides were separated by a stepwise 120-minute 
gradient of 0-95 % between 0.2 % (v/v) formic acid in H2O and 0.2 % (v/v) formic acid in 
acetonitrile at a flow rate of 0.25 µL/min. MS/MS analysis was performed with standard settings 
using cycles of 1 high resolution (70,000 full width at half maximum (FWHM) setting) MS scan 
followed by MS/MS scans of the 10 most intense ions with charge states of +2 or higher at a 
resolution setting of 17,500 FWHM. Protein identification and SILAC based quantitation was 
performed with MaxQuant (version 1.3.0.5) using default settings. The UNIPROT S. cerevisiae 
database (version 2013-12-05) was used for protein identification. MaxQuant uses a decoy version 
of the specified UNIPROT database to adjust the false discovery rates for proteins and peptides 
to below 1%. Proteins that were enriched ≥ 2-fold in at least two out of three independent 
experiments were defined as interactors. 
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II.10 Functional in vivo and in vitro assays 
 
II.10.1 Protein expression analysis 
For determination of the steady-state level of a protein, yeast lysates were prepared in yeast IP 
lysis buffer and normalized to a total protein concentration of 20 mg/mL. 5 µL of lysate were 
mixed with 45 µL HU buffer, samples were incubated for 10 minutes at 70 °C and 15 µL resolved 
by SDS-PAGE. After transfer of proteins onto a membrane, proteins of interest were detected by 
immunoblotting. Immunoblotting against Pgk1p served as a loading control. Band intensities 
were quantified densitometrically with correction for background and loading control signals. 
 
II.10.2 Immunoprecipitation 
For immunoprecipitation of reporter constructs or tagged proteins from crude lysates, the 
epitope-tagged protein isolation kit was used according to the manufacturer’s instructions with 
minor modifications. Yeast lysates were prepared in yeast IP lysis buffer, 100 µg total protein 
were mixed with HU buffer to a final volume of 50 µL, and DTT was added to a final 
concentration of 100 mM. Samples were incubated for 10 minutes at 70 °C with shaking, and kept 
aside as an input control. Lysis buffer was added to 2 mg total protein to a final volume of 950 µL, 
and NP40 was added to a final concentration of 0.5 % (v/v). 50 µL of the respective microbeads 
were added, and samples were incubated for 60-90 minutes at 4 °C on a rotator. The sample was 
subsequently loaded on a µMACS column equilibrated with 200 µL yeast IP wash buffer, 
followed by washing the column 4 times with 200 µL yeast IP lysis buffer and once with 100 µL 
25 mM Tris-HCl pH 7.4. Bound proteins were eluted by first applying 20 µL of preheated HU 
buffer without DTT, waiting for 5 minutes and then applying 50 µL of preheated HU buffer 
without DTT while collecting the eluate in a fresh tube. DTT was added to the eluate to a final 
concentration of 100 mM, the sample was incubated for 5 more minutes at 70 °C with shaking 
and 10 µL were resolved by SDS-PAGE. 
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II.10.3 Protein stability analysis 
To test the half-life of a reporter protein in living yeast cells, a cycloheximide chase assay was 
performed. Yeast cells were grown to mid-log phase, 10 OD600 of cells were centrifuged at 
4,000 x g for 5 minutes at room temperature and resuspended in 2 mL of fresh dropout medium 
containing 2 % (w/v) Raffinose, 3 % (w/v) Galactose and 500 µg/mL cycloheximide. 400 µL of the 
culture were immediately taken and mixed with 500 µL ice-cold 30 mM NaN3 and incubated on 
ice for 5 minutes. The cells were then pelleted by centrifugation at 16,000 x g for 2 minutes at 
room temperature, the supernatant was aspirated and the cells flash-frozen in liquid nitrogen. 
The culture was meanwhile incubated at 30 °C with shaking and further samples of 400 µL each 
were taken at the indicated timepoints. Cell pellets were resuspended in 1 mL distilled H2O and 
150 µL yeast alkaline lysis buffer and lysed by incubation on ice for 15 minutes with vigorous 
vortexing for 30 seconds every 5 minutes. The resulting lysates were then subjected to TCA 
precipitation. The protein pellet was dissolved in 100 µL HU buffer and 15 µL were resolved by 
SDS-PAGE. Band intensities were quantified densitometrically. 
 
II.10.4 Sucrose density gradient centrifugation 
To analyze the sedimentation behavior of a protein in a sucrose density gradient, cells were 
grown to mid-log phase in the respective dropout medium. Cycloheximide was added to a final 
concentration of 100 µg/mL, cultures were incubated for 15 more minutes at 30 °C with shaking 
and then harvested. Lysates were prepared in yeast sucrose gradient lysis buffer and an amount 
of lysate corresponding to 40 OD260 was carefully layered upon a precooled 7-47% sucrose density 
gradient that had previously been prepared using a Biocomp Gradient Master. Sucrose gradients 
were centrifuged at 40,000 x rpm (corresponding to an average of 200,000 x g) for 2 hours at 4 °C 
without braking down the rotor after the run. Gradients were then fractionated into 13 fractions 
while recording the UV trace at a wavelength of 260 nm using a Biocomp Piston Gradient 
Fractionator, and 500 µL of every fraction was diluted with an equal volume of distilled H2O. 
Subsequently, proteins were TCA precipitated, the protein pellet was dissolved in 50 µL HU 
buffer and 15 µL of every sample was resolved by SDS-PAGE. 
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II.10.5 β-Galactosidase assay 
To determine the influence of protein overexpression on the cellular heat shock response, a β-
Galactosidase assay was performed according to the manufacturer’s instructions with minor 
modifications. Briefly, 400 µg of yeast lysate were mixed with 900 µL of the supplied buffer and 
brought to a volume of 1 mL with sterile, distilled H2O. 200 µL of ONPG solution were added 
and samples were incubated at 37 °C in a waterbath until all samples developed a clear yellow 
color. Reactions were stopped by adding 500 µL of stop solution and the exact time of incubation 
was recorded. Subsequently, the absorbance at a wavelength of 420 nm was measured and used 
to calculate the specific β-Galactosidase activity in each sample, which in turn was a direct 
measure of the cellular heat shock response. 
 
II.10.6 Yeast growth assay 
To reveal cytotoxic effects induced by overexpression of proteins, growth assays were performed. 
Yeast cells were grown to an optical density of ≈ 0.5 in the respective dropout medium containing 
2 % (w/v) Raffinose. An amount of cells corresponding to 0.1 OD600 were taken and fresh Raffinose 
medium was added to a final volume of 1 mL. Five serial 1:5 dilutions of this culture were 
prepared in sterile, distilled H2O, 4 µL of every dilution were spotted on the respective dropout 
medium agar plates containing either 2 % (w/v) Glucose or 2 % (w/v) Raffinose and 3 % (w/v) 
Galactose, and plates were incubated for 2-3 days at 30 °C or 37 °C. 
  
II.10.7 Live cell fluorescence microscopy 
To visualize inclusion bodies in living cells, a Zeiss Axiovert 200M inverted fluorescence 
microscope was used. Yeast cells were grown to mid-log phase in the respective dropout 
medium, 2 µL were spotted on a glass microscope slide and covered with a cover slide without 
trapping any air bubbles in between. A drop of immersion oil was put on the cover slide, the 
sample was mounted on the microscope and images were acquired. 
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II.10.8 In vitro aggregation of purified GST fusion proteins 
To evaluate the aggregation propensity of purified fusion proteins after removal of the highly 
soluble Glutathion-(S)-Transferase (GST) domain, 3.75 µL of dialysis buffer or 7.5 U of PreScission 
protease were added to 150 µL of 1.5 µM purified protein and the samples were incubated for 
16 hours at 30 °C with shaking at 300 rpm. The next day, samples were mixed with an equal 
volume of 4 % (w/v) SDS, 100 mM DTT and boiled for 5 minutes at 95 °C. Sample volumes 
corresponding to 5-75 pmol of purified protein were applied into the wells of a slot blot apparatus 
with a 0.2 µm cellulose acetate membrane that has been equilibrated in 0.1 % (w/v) SDS. All wells 
were washed 3 times with 200 µL 0.1 % (w/v) SDS and the membrane was processed as described 
in section II.8.7 for immunodetection. 
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III. Results 
 
III.1 Properties of non-stop proteins 
 
In order to determine the consequences of RQC impairment on the aggregation state of NS-
proteins, two RQC model substrates were designed by deletion of the canonical stop codon as 
well as all in-frame stop codons in the 3’ UTR: non-stop green fluorescent protein (NS-GFP) and 
non-stop firefly luciferase (NS-Luc). These NS-proteins and their respective wild-type (WT) 
counterparts (GFP and Luc) were expressed in WT-yeast and in yeast lacking Ltn1p. Both NS-
GFP and NS-Luc were barely detectable in WT yeast cells, indicating that NS-proteins are subject 
to rapid degradation (Fig. III.1a, c). In contrast, NS-GFP and NS-Luc strongly accumulated in the 
absence of Ltn1p and formed SDS-resistant high molecular weight species that were detectable 
as smears at the upper part of the gel (Fig. III.1a, c). In addition, NS-GFP also formed visible 
inclusions when expressed in ltn1∆ cells, indicating that considerable amounts of at least partially 
folded NS-protein accumulate in the cytosol upon impairment of the RQC pathway (Fig. III.1b). 
To rule out the possibility that the observed high molecular weight species represent a 
ubiquitinated or otherwise posttranslationally modified form of NS-proteins, NS-GFP was 
treated with formic acid after immunoprecipitation in order to specifically dissolve aggregates 
without harming covalently linked modifiers such as ubiquitin. Indeed, the smear observed with 
NS-GFP disappeared after formic acid treatment, indicating that the high molecular weight 
species does not represent a ubiquitinated form of NS-GFP (Fig. III.2a). This hypothesis was 
further supported by the fact that polyubiquitinated NS-Luc was detected in a different region of 
the gel and only in WT cells, consistent with Ltn1p being the major E3 ligase responsible for 
ubiquitination of NS-proteins in yeast (Fig. III.2b). 
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Fig. III.1: NS-proteins form SDS-resistant aggregates and visible inclusions upon deletion of LTN1. (a) 
NS-GFP or GFP were expressed in WT and ltn1∆ cells, immunoprecipitated, and detected by 
immunoblotting against GFP. Pgk1p served as a loading control. EV = empty vector. (b) Cells expressing 
NS-GFP or GFP were analyzed by fluorescence microscopy, and cells containing visible fluorescent 
inclusions were counted and expressed as a fraction of total (standard deviation from 3 independent 
experiments). Nuclei were stained with Hoechst 33342. Exposure time was adjusted for ltn1∆ cells 
expressing GFP to prevent overexposure. Scale bar, 5 µm. (c) Myc-tagged Luc or NS-Luc were expressed 
in WT and ltn1∆ cells, immunoprecipitated, and detected by immunoblotting against Luc. Pgk1p served as 
a loading control. EV = empty vector. Figure modified from (Choe, Park et al. 2016). 
 
Since cells fail to efficiently ubiquitinate NS-proteins when RQC is defective, and given 
that extraction of the faulty nascent chain by Cdc48p relies on ubiquitination, we reasoned that a 
substantial fraction of NS-proteins might still be bound to the ribosome while aggregating in the 
absence of Ltn1p. Surprisingly, sucrose density gradient centrifugation revealed that, despite 
inefficient ubiquitylation, NS-GFP is still released from the ribosome (Fig. III.3). Furthermore, the 
SDS-resistant high molecular weight species is substantially smaller in size than ribosomes, 
indicating that the observed smear represents SDS-resistant oligomers that coexist with visible 
inclusions (Fig. III.1b, Fig. III.3). 
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Fig. III.2: High molecular weight species of NS-proteins do not represent ubiquitinated protein. (a) NS-
GFP expressed in ltn1∆ cells was immunoprecipitated and subjected to formic acid treatment. Pgk1p served 
as a loading control. (b) NS-Luc or Luc were immunoprecipitated from WT or ltn1∆ cells and detected by 
immunoblotting against Luc or Ubiquitin. Pgk1p served as a loading control. EV = empty vector. Figure 
modified from (Choe, Park et al. 2016). 
 
To rule out that inclusion body formation in ltn1∆ cells is dependent on the RNQ prion 
status of the cell, Rnq1 was expressed in ltn1∆ cells in the [RNQ+] state or in an isogenic strain that 
has been cured from this state by growth on medium supplied with 3 mM guanidinium chloride. 
Notably, the ability of Rnq1p to form inclusions is abolished in ltn1∆ cells with the [rnq-] state, 
proving that deletion of LTN1 per se does not lead to the formation of visible inclusions (Fig. 
III.4a). Moreover, formation of SDS-resistant high molecular weight species of NS-GFP is 
independent of the prion state of ltn1∆ cells, thereby showing that NS-GFP aggregation does not 
rely on the presence of preexisting inclusions (Fig. III.4b). 
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Fig. III.3: NS-proteins are efficiently released from the ribosome in the absence of Ltn1p. NS-GFP was 
expressed in ltn1∆ cells and clarified lysate was subjected to sucrose density gradient centrifugation. After 
centrifugation, the gradient was fractionated while continuously monitoring UV absorbance at 254 nm, and 
equal amounts of every fraction were analyzed by immunoblotting against GFP. Rpl3p served as a marker 
for the 60S subunit, 80S ribosomes and polysomes. The top part of the blot was overexposed to visualize 
SDS-resistant aggregates. Figure modified from (Choe, Park et al. 2016). 
 
Taken together, the results show that artificial NS-proteins are not ubiquitinated in the 
absence of Ltn1p, but are still efficiently released from the ribosome. Furthermore, NS-proteins 
form both SDS-resistant aggregates and visible inclusions in ltn1∆ cells, thereby proving that 
efficient degradation of the reporter constructs indeed relies on a functional RQC. 
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Fig. III.4: Aggregation of NS-GFP in ltn1∆ cells is independent of the RNQ prion status. (a) Rnq1p-GFP 
was expressed in ltn1∆ cells with the [RNQ+] or the [rnq-] phenotype. Scale bar, 5 µm. (b) NS-GFP was 
immunoprecipitated from ltn1∆ cells with the [RNQ+] or the [rnq-] phenotype and detected by 
immunoblotting against GFP. Figure modified from (Choe, Park et al. 2016). 
 
III.2 Aggregation of polybasic proteins 
 
Since translation of the poly(A) tail of a NS-mRNA leads to C-terminal extension of the nascent 
chain with a polylysine tract, reporter constructs with C-terminal polylysine sequences were 
generated in order to investigate the role of polybasic sequences in ribosomal stalling and nascent 
chain aggregation. Since poly(A) tails are of variable length (median of 27 nt in yeast, 
corresponding to 9 lysines), polylysine tracts consisting of either 12 or 20 lysines were added 
(Subtelny, Eichhorn et al. 2014). In addition, two alternative spacer sequences of 134 or 53 amino 
acids length were placed between the GFP moiety and the polybasic tract in order to ensure that 
the N-terminal GFP domain can completely leave the ribosomal exit channel and fold into its 
native structure before ribosomal stalling occurs. Surprisingly, a clear correlation between the 
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length of the polylysine stretch and aggregation propensity of the respective construct was 
observable: whereas expression of GFP-s-K12 resulted in 11 % of all cells carrying an inclusion, 
more than every second cell was showing visible aggregates upon expression of the construct 
coding for 20 lysines (Fig. III.5). This is consistent with the finding that expression of NS-GFP, 
which presumably contains a C-terminal extension of roughly 10 lysines, in ltn1∆ cells leads to 
visible inclusions in approximately 17 % of all cells (Fig. III.1b). Moreover, aggregation did not 
depend on the sequence of the spacer used and did not occur when GFP was fused to either of 
the spacer sequences, indicating that aggregation is indeed mediated by the polybasic tract (Fig. 
III.5). Interestingly, even expression of the reporter construct coding for 20 lysines did not lead to 
the formation of inclusions in WT cells, suggesting that inclusion formation is not mediated 
directly by the polylysine tract, but instead via an indirect effect such as ribosomal stalling, which 
would trigger rapid degradation of the reporter construct in cells with a functional RQC system 
(Fig. III.5). 
 
 
Fig. III.5: Effect of polybasic sequences on aggregation. GFP fusion constructs containing a spacer derived 
from the naturally unstructured, but aggregation-resistant M domain of Sup35p (s) or from the disordered 
region of Hsp82p (s*) and a polylysine tract of the indicated length were expressed in WT and ltn1∆ cells 
(Krishnan and Lindquist 2005). Cells containing visible inclusions were counted and expressed as a fraction 
of total (standard deviation from 3 independent experiments). Scale bar, 5 µm. Figure modified from (Choe, 
Park et al. 2016). 
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Since translation of a polylysine-encoding stretch per se may induce ribosomal stalling, it 
remained unclear whether the aggregation of NS-proteins and polylysine-encoding reporter 
constructs was a result of ribosomal stalling or the accumulation of nascent chains with polybasic 
tracts. To resolve this issue, a new series of reporter constructs with internal polyarginine 
stretches were employed that can be used to modulate ribosomal stalling via frequent (AGA) or 
rare (CGA) arginine codons (Fig. III.6a). If aggregation is simply a result of the physical properties 
of a protein containing a polybasic tract, then expression of GFP-s-R20FREQ-mCh (construct #4) in 
ltn1∆ cells should lead to the formation of visible inclusions in a large number of cells, comparable 
to the result observed with the GFP-s-K20 construct (Fig. III.5). Surprisingly, GFP-s-R20FREQ-mCh 
was efficiently translated even in ltn1∆ cells, as judged by the presence of a strong band 
corresponding to the full-length protein, mCherry fluorescence and the absence of visible 
inclusions in the cell (Fig. III.6b, c). Furthermore, no SDS-resistant high molecular weight species 
were detectable upon immunoblotting, indicating that a polybasic tract alone is also not sufficient 
to induce the formation of oligomeric species (Fig. III.6b). Conversely, expression of constructs 
coding for 4 or 20 rare arginine codons (constructs #3 and #5, respectively) in ltn1∆ cells resulted 
in the formation of SDS-resistant high molecular weight species and only small or even 
undetectable amounts of full-length protein, indicating that ribosomal stalling is already induced 
by a repeat of 4 rare arginine codons and leads to the formation of SDS-insoluble aggregates upon 
RQC deficiency (Fig. III.6b). Strikingly, even expression of GFP-s-R20RARE-mCh, which is 
supposed to strongly induce ribosomal stalling, did not lead to the formation of visible inclusions 
in ltn1∆ cells, proving that ribosomal stalling per se is also not sufficient to induce the formation 
of visible aggregates (Fig. III.6c). Upon expression of a fusion construct coding for a non-stalling 
polybasic tract followed by a stalling motif (construct #6) in ltn1∆ cells, however, visible 
inclusions in approximately 23 % of all cells could be observed, demonstrating that the formation 
of visible aggregates requires both a polybasic sequence and ribosomal stalling (Fig. III.6c). 
Moreover, almost no high molecular weight smear could be detected by immunoblotting upon 
expression of GFP-s-R20FREQ-R4RARE-mCh in ltn1∆ cells, thereby providing further evidence that 
SDS-resistant species might resemble oligomeric aggregates that are distinct from observable 
inclusions (Fig. III.6b). Consistent with this hypothesis, analysis of ltn1∆ cell extracts by SDD-
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AGE revealed that GFP-s-R20FREQ-R4RARE-mCh formed aggregates substantially larger in size than 
the ones observed upon expression of GFP-s-R4RARE-mCh or GFP-s-R20RARE-mCh (Fig. III.6d). 
 
 
Fig. III.6: Modulation of aggregation propensity of polybasic constructs by codon usage. (a) GFP fusion 
constructs containing a spacer and a C-terminal mCherry domain were generated. Where indicated, 
stretches of frequent (AGA) or rare (CGA) codons coding for arginine were inserted upstream of the 
mCherry domain. (b) Fusion constructs shown in (a) were expressed in WT and ltn1∆ cells, 
immunoprecipitated and detected by immunoblotting. Arrow, full-length product. Asterisk, stalled 
truncation products and proteolytic fragments. (c) ltn1∆ cells expressing the indicated constructs were 
analyzed for GFP and mCherry fluorescence. Scale bar, 5 µm. (d) Extracts of ltn1∆ cells expressing the 
indicated constructs were prepared, resolved by SDD-AGE and subjected to immunoblotting. Only 25% of 
lysate from cells expressing construct 1 were applied to prevent overloading. Figure modified from (Choe, 
Park et al. 2016). 
 
 In summary, these findings provide evidence that ribosomal stalling per se is already 
sufficient to induce the formation of SDS-resistant oligomeric species in the absence of Ltn1p. The 
ability to form visible inclusions, however, requires the additional presence of a polybasic tract. 
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III.3 The role of Rqc2p in the aggregation of stalled nascent chains 
 
Whereas Rqc1p is thought to be involved in the Cdc48p-mediated extraction of the ubiquitinated 
nascent chain, Rqc2 was shown to bind to 60S-peptidyl-tRNA complexes (Defenouillere, Yao et 
al. 2013, Lyumkis, Oliveira dos Passos et al. 2014). Consistent with Rqc1p and Rqc2p being key 
players of the RQC pathway, deletion of the respective genes resulted in accumulation of NS-GFP 
to a similar extent as observed in ltn1∆ cells (Fig. III.7a). Deletion of RQC1, but not of RQC2, led 
to the formation of SDS-resistant aggregates and visible inclusions (Fig. III.7a, b). Additional 
deletion of RQC2 in cells lacking Ltn1p or Rqc1p abolished formation of both SDS-resistant 
aggregates and visible inclusions, despite even higher steady-state levels of NS-GFP than in any 
of the single deletion mutants (Fig. III.7a, b). Suppression of inclusion body formation in all 
strains lacking RQC2 was accompanied by accumulation of significant amounts of NS-GFP in the 
nucleus (Fig. III.7b). 
 
 
Fig. III.7: Role of RQC components on the formation of SDS-resistant aggregates and visible inclusions. 
(a) NS-GFP was expressed in WT or RQC mutant strains, immunoprecipitated, and detected via 
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immunoblotting. Pgk1p served as a loading control. (b) RQC mutant cells expressing NS-GFP were 
analyzed by fluorescence microscopy. Hoechst 33342 was used for nuclear staining. Scale bar, 5 µm. Figure 
modified from (Choe, Park et al. 2016). 
 
Since it has previously been shown that Rqc2p plays a role upstream of Rqc1p and Ltn1p 
by providing a binding platform for the latter, it was reasoned that deletion of RQC2 leads to 
inefficient recognition of 60S-peptidyl-tRNA complexes and only small amounts of free stalled 
nascent chains. Surprisingly, the vast majority of NS-GFP was efficiently released from the 
ribosome, thereby demonstrating that suppression of aggregation in an RQC2 deletion 
background is not due to the nascent chain being protected by the ribosome (Fig. III.8). 
 
 
Fig. III.8: NS-proteins are efficiently released from the ribosome in the absence of Rqc2p. NS-GFP was 
expressed in rqc2∆ cells and clarified lysate was subjected to sucrose density gradient centrifugation. After 
centrifugation, the gradient was fractionated, and equal amounts of every fraction were analyzed by 
immunoblotting against GFP. Rpl3p served as a marker for the 60S subunit, 80S ribosomes and polysomes. 
Figure modified from (Choe, Park et al. 2016). 
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In order to exclude the possibility that deletion of RQC2 leads to an impairment in 
depositing aggregation-prone proteins in intracellular inclusions, the ability of the prion protein 
Rnq1p to form aggregates was tested in rqc2∆ and ltn1∆rqc2∆ cells. Analysis by fluorescence 
microscopy revealed that Rnq1p forms visible inclusions in the absence of Rqc2p, thereby 
showing that the general ability to form aggregate deposits is not affected (Fig. III.9). 
 
 
Fig. III.9: Suppression of nascent chain aggregation upon deletion of RQC2 is not due to a general defect 
in aggregate deposition. Rnq1p-GFP was expressed in WT cells with the [RNQ+] or [rnq-] phenotype as 
well as in rqc2∆ or ltn1∆rqc2∆ cells. Scale bar, 5 µm. Figure modified from (Choe, Park et al. 2016). 
 
 It has recently been shown that Rqc2p is able to mediate a template-free C-terminal 
extension of the nascent chain with alanine and threonine residues, thereby generating so-called 
CAT tails (Shen, Park et al. 2015). Since these CAT tails might confer the ability to form aggregates 
due to their mildly hydrophobic nature, it was suggested that aggregation of stalled nascent 
chains in the absence of Ltn1p might be dependent on these CAT tails. Western blot analysis 
revealed the presence of a faint smear above the truncated protein that disappears upon deletion 
of RQC2, suggesting that these stalled nascent chains might be subject to a C-terminal extension 
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mediated by Rqc2p (Fig. III.10a). Indeed, the absence of the observed smear in ltn1∆rqc2∆ cells 
expressing GFP-s-R20FREQ-R4RARE-mCh was accompanied by efficient suppression of inclusion 
body formation, indicating that CAT tails might play a role in aggregation of stalled nascent 
chains (Fig. III.10b). 
 
 
Fig. III.10: C-terminal extension and aggregation of stalled nascent chains is dependent on Rqc2p. (a) 
Extracts of ltn1∆ or ltn1∆rqc2∆ cells expressing the indicated constructs were prepared and subjected to 
immunoblotting against GFP. Pgk1p served as a loading control. (b) ltn1∆ or ltn1∆rqc2∆ cells expressing 
GFP-s-R20FREQ-R4RARE-mCh were analyzed by fluorescence microscopy. Scale bar, 5 µm. Figure modified 
from (Choe, Park et al. 2016). 
 
A recent study identified three key residues (D9, D98, and R99) in the N-terminal domain 
of Rqc2p that might be involved in the recognition of tRNA molecules, which bind to the A-site 
of the 60S-peptidyl-tRNA complex in order to deliver alanine and threonine residues for CAT tail 
extension (Shen, Park et al. 2015). Mutation of these residues to alanine gave rise to a variant that 
is deficient in CAT tail synthesis, but is still able to bind to 60S-peptidyl-tRNA complexes and to 
provide a binding platform for Ltn1p (Shen, Park et al. 2015). In order to evaluate whether the 
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aggregation of stalled nascent chains is mediated by the ability of Rqc2p to synthesize CAT tails, 
a stalling reporter construct and either WT Rqc2p or the CAT tail-deficient mutant rqc2aaa were 
coexpressed in rqc2∆ or ltn1∆rqc2∆ cells, respectively. Indeed, overexpression of WT Rqc2p, but 
not of rqc2aaa, restored the ability to form aggregates as shown by the presence of SDS-resistant 
high molecular weight species of NS-GFP and visible inclusions of GFP-s-K20, respectively 
(Fig. III.11a, b). Interestingly, overexpression of either of the Rrqc2p variants led to reduced levels 
of NS-GFP in the rqc2∆ background, indicating that prevention of reassociation of the 60S-
peptidyl-tRNA complex with the 40S subunit by Rqc2p might represent a rate-limiting step in the 
degradation pathway of NS-proteins (Fig. III.11a). 
 
 
Fig. III.11: Aggregation of NS-GFP and GFP-s-K20 is CAT tail-dependent. (a) NS-GFP was 
immunoprecipitated from WT, rqc2∆ or ltn1∆rqc2∆ cells expressing either WT RQC2 or the CAT tail-
deficient rqc2aaa mutant, and subjected to immunoblotting against GFP. (b) ltn1∆rqc2∆ cells expressing GFP-
s-K20 and either WT RQC2 or the CAT tail-deficient rqc2aaa mutant were analyzed by fluorescence 
microscopy. Scale bar, 5 µm. Figure modified from (Choe, Park et al. 2016). 
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To provide further evidence that nascent chain aggregation is mediated by Rqc2p-
dependent addition of CAT tails, a set of reporter constructs with polybasic tracts and artificial 
C-terminal extensions consisting of alternating alanine and threonine or glycine and serine 
residues was established (Fig. III.12a). ltn1∆hel2∆ was used as a host strain since it has previously 
been shown that deletion of HEL2, which codes for a ribosome-associated E3 ligase, markedly 
enhances read-through efficiency for polybasic and other stalling sequences (Brandman, Stewart-
Ornstein et al. 2012). Indeed, expression of a reporter construct containing an internal sequence 
coding for 20 consecutive lysines was efficiently translated in this strain as judged by the 
appearance of a strong band corresponding to full-length protein (Fig. III.12b). Interestingly, 
expression of neither GFP-s-K20 nor GFP-s-(AT)6 resulted in the formation of visible inclusions, 
indicating that a polybasic tract or a CAT tail alone is not sufficient for nascent chain aggregation 
(Fig. III.12a). Conversely, expression of GFP-s-K20-(AT)6 led to large amounts of cells carrying 
visible aggregates, whereas expression of GFP-s-K20-(GS)6 only weakly induced inclusion body 
formation (Fig. III12a). 
Taken together, our results show that the ability of stalled nascent chains to form SDS-
resistant aggregates and visible inclusions is dependent on the Rqc2p-mediated addition of CAT 
tails. Moreover, the absence of visible inclusions of GFP-s-K20 in ltn1∆hel2∆ cells provides 
additional evidence that both a polybasic tract and ribosomal stalling are required for the 
formation of enhanced aggregates. Visible inclusions reappeared after addition of an encoded 
CAT tail, indicating that these C-terminal extensions are usually added as a result of ribosomal 
stalling. 
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Fig. III.12: Formation of visible inclusions is dependent on CAT tails and polybasic tracts. (a) ltn1∆hel2∆ 
cells expressing the indicated reporter constructs were analyzed by fluorescence microscopy. Scale bar, 5 
µm. (b) Extracts were prepared from ltn1∆ or ltn1∆hel2∆ cells expressing the indicated reporter constructs, 
and subjected to immunoblotting against GFP. Arrow, full-length product. Figure modified from (Choe, 
Park et al. 2016). 
 
 
 
 
 
 
Results 
 
88 
 
III.4 Non-stop protein aggregates sequester chaperones 
 
Since the formation of visible inclusions and SDS-resistant aggregates has previously been 
associated with the sequestration of various cytosolic factors such as molecular chaperones, we 
reasoned that NS-GFP might also form aberrant interactions with components of the proteostasis 
network upon aggregation in the absence of Ltn1p (Olzscha, Schermann et al. 2011, Park, 
Kukushkin et al. 2013). To this end, a quantitative proteomics approach was used to determine 
the interactome of NS-GFP in ltn1∆ cells, with the interactomes of NS-GFP in WT cells and GFP 
in ltn1∆ cells serving as background controls, respectively (Fig. III.13). Interestingly, the Hsp40, 
Sis1p, an essential cochaperone of Hsp70 that has previously been shown to be sequestered by 
amyloid-forming polyQ proteins and artificial β-sheet polypeptides, was found to be a very 
strong interactor of NS-GFP (Fig. III.13) (Olzscha, Schermann et al. 2011, Park, Kukushkin et al. 
2013). Besides Sis1p, a plethora of other molecular chaperones were identified as NS-GFP 
interactors, including the small Hsps, Hsp42 and Hsp26, the amyloid-targeting cochaperone 
Sgt2p, the Hsp90 cochaperones Cns1 and Sti1, and several Hsp70s and Hsp90s (Fig. III.13). 
Consistent with these results, Sis1p was found to physically interact with both visible inclusions 
and SDS-insoluble aggregates of NS-GFP in ltn1∆ cells (Fig. III.14a, b). 
Interestingly, deletion of RQC2 in WT, ltn1∆ or rqc1∆ cells suppressed Sis1p interaction 
with NS-GFP, indicating that Rqc2p-mediated aggregation of stalled nascent chains is a 
prerequisite for Sis1p sequestration. Indeed, Sis1p coaggregation with NS-GFP was reconstituted 
by expression of wildtype Rqc2p, but not of the CAT tail-deficient rqc2aaa mutant, in ltn1∆rqc2∆ 
cells, indicating that Sis1p sequestration is dependent on CAT tail-mediated aggregation (Fig. 
III.15). 
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Fig. III.13: Interactome of NS-GFP in ltn1∆ cells. Molecular chaperones identified as interactors of NS-
GFP in the absence of Ltn1p. Black bars, fold enrichment over GFP in ltn1∆ cells. Grey bars, fold enrichment 
over NS-GFP in WT cells. Figure modified from (Choe, Park et al. 2016). 
 
 
Fig. III.14: Sis1p and NS-GFP interact in ltn1∆ cells. (a) ltn1∆ cells with SIS1-mCh integrated at the SIS1 
locus expressing NS-GFP were analyzed by fluorescence microscopy. Scale bar, 5 µm. (b) NS-GFP was 
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expressed in WT or RQC mutant strains, immunoprecipitated, and Sis1p was detected via immunoblotting. 
Pgk1p served as a loading control. Figure modified from (Choe, Park et al. 2016). 
 
To test whether the ability of NS-GFP aggregates to sequester Sis1p is specific for NS-
proteins or rather a generic feature of stalled polypeptides, GFP-s-R4RARE-mCh, which induces 
ribosomal stalling but lacks a polybasic sequence, was expressed in WT, ltn1∆ and ltn1∆rqc2∆ 
cells. Again, a strong interaction between Sis1p and this construct was observed in ltn1∆, but not 
in ltn1∆rqc2∆ cells, indicating that sequestration of Sis1p indeed relies on aggregation of stalled 
nascent chains and is independent of the type of stalling (Fig. III.16). 
 
 
Fig. III.15: Interaction of Sis1p with NS-GFP is CAT tail-dependent. (a) NS-GFP was immunoprecipitated 
from ltn1∆rqc2∆ cells expressing either wildtype RQC2 or the CAT tail-deficient rqc2aaa mutant, and 
subjected to immunoblotting against GFP and Sis1p, respectively. Figure modified from (Choe, Park et al. 
2016). 
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Fig. III.16: Sis1p interacts with stalled nascent chains in the absence of Ltn1p. (a) GFP-s-mCh or GFP-s-
R4RARE-mCh were expressed in WT, ltn1∆ and ltn1∆rqc2∆ cells, immunoprecipitated, and subjected to 
immunodetection for GFP and Sis1p, respectively. Arrowhead, stalled truncation product; asterisks, 
proteolytic fragments; dashed box, CAT tails. Figure modified from (Choe, Park et al. 2016). 
 
Since the RQC pathway is highly conserved from yeast to mammals, we assumed that 
cells are constantly challenged by stalled nascent chains that must be efficiently recognized and 
degraded to maintain proteome integrity. Consistent with this notion, Sis1p was found to form 
high molecular weight, SDS-resistant aggregates in ltn1∆ and rqc1∆ cells, even without expression 
of a stalling reporter construct (Fig. III.17a, b). Again, deletion of RQC2 completely abolished 
Sis1p aggregation, indicating that aggregation of endogenous stalled nascent chains and thus 
aggregation of Sis1p is CAT tail-dependent (Fig. III.17a, b). Furthermore, the fraction of cells 
carrying visible Sis1p-positive inclusions was markedly enhanced in the absence of Ltn1p, 
suggesting that endogenous stalled polypeptides can form both SDS-resistant oligomers and 
visible inclusions (Fig. III.17c). 
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Fig. III.17: Sis1p forms SDS-resistant aggregates and visible inclusions in ltn1∆ cells. (a) Cell extracts of 
WT, ltn1∆ and ltn1∆rqc2∆ cells were prepared, resolved by Blue Native-PAGE, and subjected to 
immunodetection for Sis1p. Pgk1p served as a loading control. HMW, high molecular weight species. (b) 
Cell extracts of a WT and the indicated RQC mutant strains were prepared and resolved by SDD-AGE. 
Sis1p was detected by immunoblotting. Rpl3p served as a loading control. (c) Fluorescence microscopy of 
WT and ltn1∆ cells carrying the SIS1-GFP allele at the chromosomal SIS1 locus. Cells containing visible 
fluorescent inclusions were counted and expressed as a fraction of total (standard deviation from 3 
independent experiments). Scale bar, 5 µm. Figure modified from (Choe, Park et al. 2016). 
 
 In summary, it was shown that stalled nascent polypeptides such as NS-proteins or 
nascent chains with internal stalling sequences interact with various cellular components, 
especially molecular chaperones. The Hsp40 Sis1p was found to be recruited to both SDS-resistant 
aggregates and visible inclusions of NS-GFP, and also interacted with a stalling reporter lacking 
a polybasic stretch. Similar to aggregation of stalled nascent polypeptides, coaggregation with 
Sis1p was dependent on Rqc2p-mediated CAT tail synthesis. Moreover, Sis1p forms both SDS-
resistant aggregates and visible inclusions in ltn1∆ cells even in the absence of a stalling reporter, 
indicating that cells accumulate considerable amounts of endogenous stalled nascent chains upon 
failure of the RQC pathway. 
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III.5 Impairment of ribosomal quality control induces proteotoxic stress 
 
Since Sis1p sequestration by amyloid aggregates has been shown to perturb the proteostasis 
network by interfering with nuclear transport of polypeptides targeted for proteasomal 
degradation, it was assumed that deletion of LTN1 might result in proteostasis stress as well 
(Park, Kukushkin et al. 2013). The terminally misfolded reporter protein cytosolic 
carboxypeptidase Y (CPY*), whose transport to the nucleus for degradation is known to depend 
on Sis1p, was fused to mCherry (CmCh*) and expressed in WT, ltn1∆ and ltn1∆rqc2∆ cells. 
Alternatively, CPY* fused to GFP (CG*) was expressed in ltn1∆ cells with or without additional 
overexpression of HA-Sis1p. After global translation shutdown by addition of cycloheximide, 
both CmCh* and CG* were rapidly degraded in WT cells, but strongly accumulated in ltn1∆ cells, 
indicating a general failure of cytosolic protein quality control upon impairment of the RQC 
pathway (Fig. III.18a, b). Furthermore, degradation of both reporters was restored by additional 
deletion of RQC2 or overexpression of Sis1p, consistent with depletion of Sis1p due to 
coaggregation with endogenous stalled nascent chains in an Rqc2p-dependent manner (Fig. 
III.18a, b).  
 To rule out the possibility that deletion of the E3 ligase LTN1 leads to lower levels of 
ubiquitination of CPY* and thus to delayed degradation, the ubiquitination status of CmCh* was 
compared in WT and ltn1∆ cells. As expected for a ribosome-associated E3 ligase such as Ltn1p, 
which is mainly responsible for the ubiquitination of stalled nascent chains, deletion of LTN1 did 
not affect ubiquitination of CmCh* (Fig. III.19). 
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Fig. III.18: Degradation of a terminally misfolded reporter is markedly delayed in ltn1∆ cells. (a) CmCh* 
was expressed in WT, ltn1∆ and ltn1∆rqc2∆ cells, and degradation was followed by cycloheximide chase. 
CmCh* levels were detected via immunoblotting against CPY and quantified by densitometry. Pgk1p 
served as a loading control. Error bars represent standard deviation from three independent experiments. 
(b) CG* was expressed in ltn1∆ with or without additional overexpression of HA-Sis1p, and degradation 
was followed by cycloheximide chase. CG* levels were detected via immunoblotting against GFP and 
quantified by densitometry. Pgk1p served as a loading control. Expression of HA-Sis1p was confirmed by 
immunoblotting against the HA tag. Error bars represent standard deviation from three independent 
experiments.  Figure modified from (Choe, Park et al. 2016). 
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Fig. III.19: Terminally misfolded proteins are efficiently ubiquitinated in ltn1∆ cells. (a) CmCh* was 
coexpressed with or without His6-tagged ubiquitin in WT and ltn1∆ cells. His6-ubiquitinated proteins were 
immunoprecipitated and CmCh* was detected via immunoblotting for CPY. Figure modified from (Choe, 
Park et al. 2016). 
 
Although considerable amounts of Sis1p are sequestrated by aggregates of endogenous 
stalled nascent chains, deletion of LTN1 or RQC1 alone did not lead to a measurable growth defect 
(Fig. III.20a). However, the presence of low amounts of Hygromycin B, an antibiotic that reduces 
translational fidelity and thus leads to enhanced production of non-stop proteins, was highly 
toxic for cells lacking functional Ltn1p or Rqc1p, and strongly increased the amount of visible 
Sis1p-positive foci in ltn1∆ cells (Fig. III.20a, b). Again, this phenotype was rescued by additional 
deletion of RQC2, indicating that the growth defect was caused by aggregation of stalled nascent 
chains (Fig. III.20a). 
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Fig. III.20: RQC-deficient cells are hypersensible to translational stress. (a) WT and RQC mutant strains 
were grown to mid-log phase in YPD medium, serial dilutions were spotted onto YPD plates with or 
without Hygromycin B (HygB), and plates were incubated for 2-3 days at 37 °C. (b) WT or ltn1∆ cells 
carrying the SIS1-GFP allele at the chromosomal SIS1 locus were grown in YPD medium with or without 
HygB and analyzed by fluorescence microscopy. Scale bar, 5 µm. Figure modified from (Choe, Park et al. 
2016). 
 
Taken together, these results implicate that RQC impairment per se, although leading to a 
general defect in protein quality control, does not exert a cytotoxic effect on cells. Upon additional 
proteostasis stress such as the presence of Hygromycin B in combination with mild heat stress, 
however, a defect in the RQC pathway causes a strong defect in cell growth. 
 
III.6 In vitro aspects of CAT tail- and polybasic stretch-dependent 
aggregation 
 
In order to elucidate the mechanisms of CAT tail- and polybasic stretch-induced aggregation, 
studies were performed in vitro with purified proteins containing encoded polylysine tracts and 
CAT tails (Fig. III.21a). Constructs were N-terminally fused to the highly soluble glutathione-S-
transferase (GST) domain for purification and to prevent aggregation, a strategy that has 
previously been used for in vitro aggregation studies with polyQ proteins (Muchowski, Schaffar 
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et al. 2000, Haacke, Broadley et al. 2006, Haacke, Hartl et al. 2007). In addition, a PreScission 
protease cleavage site was inserted between the GST and GFP domains to allow for proteolytic 
removal of the GST domain (Fig. III.21a). Aggregation was then induced by incubation with 
PreScission Protease for 16 hours at 30 °C, which led to efficient cleavage of the GST tag (Fig. 
III.21b). The faint band corresponding to cleaved GFP-s-K20-(AT)10 indicates that only a small 
fraction of this construct remains SDS-soluble after proteolytic removal of the GST moiety, 
presumably because the aggregates formed by this construct are too large to migrate into the gel 
and thus are retained in the well, where they escape Coomassie staining (Fig. III.21b). 
 
 
Fig. III.21: GST fusion proteins are efficiently cleaved by PreScission Protease in vitro. (a) GFP-spacer 
constructs with or without a polylysine stretch and an encoded CAT tail were N-terminally fused to a 
cleavable GST domain and purified from E. coli. Arrowhead, PreScission Protease cleavage site. (b) 
Constructs indicated in (a) were subjected to incubation for 16 hours at 30 °C with buffer or PreScission 
Protease, and analyzed by SDS-PAGE. 
 
Following proteolytic removal of the GST moiety, a filter retardation assay was used to 
detect SDS-resistant aggregates. Consistent with previous results obtained in vivo, both a 
polybasic stretch and a CAT tail are required for efficient formation of SDS-resistant aggregates 
in vitro (Fig. III.22). Interestingly, a polylysine tract alone was sufficient to induce mild 
aggregation, but the presence of a CAT tail per se did not induce the formation of SDS-resistant 
aggregates large enough to be retained by the filter (pore size 0.2 µm) (Fig. III.22). These results 
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indicate that the aggregation process is mainly driven by stretches of polybasic residues, probably 
by the formation of amyloid-like β-sheet fibrils. CAT tails could support this process by 
facilitating the formation of SDS-soluble, prefibrillar oligomers due to their mildly hydrophobic 
nature. 
 
 
Fig. III.22: Both a polybasic stretch and a CAT tail are required for efficient aggregation in vitro. Purified 
constructs were incubated with buffer or PreScission protease, and indicated amounts were analyzed by a 
filter retardation assay. SDS-resistant aggregates were detected by immunoblotting against GFP. 
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III.7 Proteotoxicity of stalled nascent chains is suppressed by the limited 
capacity of Rqc2p to synthesize CAT tails 
 
The aggregation of stalled nascent chains has been shown to be dependent on the Rqc2p-
mediated addition of CAT tails; however, failure of ribosomal quality control and the 
accumulation of aberrant polypeptides per se did not exert a general proteotoxic effect. We 
reasoned that overexpression of a stalling reporter construct might exceed the capacity of the 
RQC pathway, resulting in a significant amount of nascent chains escaping CAT tail addition, 
rendering them less aggregation-prone than their CAT-tailed counterparts. The toxicity of 
aberrant polypeptides carrying CAT tails could therefore be limited by the availability of Rqc2p 
under physiological conditions. 
To test whether overexpression of a reporter construct containing an internal stalling 
sequence exceeds the capacity of endogenous Rqc2p to add CAT tails, FLAG-tagged Rqc2p or the 
CAT tail-defective mutant rqc2aaa were additionally overexpressed in WT and ltn1∆ cells. Indeed, 
overexpression of wildtype Rqc2p and a stalling reporter resulted in a strong growth defect in 
ltn1∆ cells, whereas overexpression of mutant rqc2aaa did not exert a toxic effect (Fig. III.23a). 
Conversely, overexpression of Rqc2p in WT cells did not lead to a measurable growth defect, 
consistent with efficient degradation of stalled nascent polypeptides (Fig. III.23a). Interestingly, 
toxicity of the stalled reporter construct in the presence of excess amounts of Rqc2p was 
dependent on the presence of a stalling sequence, but not on its length (Fig. III.23b). 
Since the Rqc2p-dependent addition of CAT tails was shown to be necessary for 
aggregation of stalled nascent chains, it seemed possible that overexpression of Rqc2p would lead 
to strongly enhanced aggregation of stalling reporter constructs. Indeed, overexpression of 
wildtype Rqc2p, but not of mutant rqc2aaa, resulted in strong aggregation of GFP-s-R20RARE-mCh 
in ltn1∆ cells, as judged by the appearance of SDS-resistant aggregates and visible inclusions 
(Fig. III.24a, b). In contrast, overexpression of wildtype Rqc2p in WT cells had no effect on the 
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aggregation behavior of GFP-s-R20RARE-mCh, consistent with these cells showing no measurable 
growth defect (Fig. III.23a and III.24a, b). 
 
 
Fig. III.23: Rqc2p becomes the limiting factor upon overexpression of stalling reporter constructs. (a) WT 
and ltn1∆ cells expressing GFP-s-R20RARE-mCh and either empty vector (EV), WT Rqc2p or mutant 
rqc2aaa under control of the GAL1 promoter were grown to mid-log phase in Raffinose medium, and serial 
dilutions were spotted onto dropout plates supplied with Glucose (- Induction) or Raffinose and Galactose 
(+ Induction). Plates were incubated for 2-3 days at 30 °C. (b) ltn1∆ cells expressing wildtype Rqc2p and 
either empty vector (EV) or one of the indicated reporter constructs were grown to mid-log phase in 
Raffinose medium and processed as described in (a). Data obtained in collaboration with Dr. Young-Jun 
Choe. 
 
In summary, these results suggest that upon overexpression of stalled nascent chains in 
the absence of LTN1, only a fraction of aberrant translation products are elongated with CAT tails 
due to the low abundance of endogenous Rqc2p. Upon additional overexpression of Rqc2p, 
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however, the majority of aberrant polypeptides receives CAT tails, which results in strongly 
enhanced aggregation and proteotoxicity. 
 
 
Fig. III.24: Overexpression of RQC2, but not of rqc2aaa, leads to enhanced formation of SDS-resistant 
aggregates and visible inclusions in ltn1∆ cells. (a) Cell extracts were prepared from WT, ltn1∆, and 
ltn1∆rqc2∆ cells expressing GFP-s-R20RARE-mCh and either empty vector (EV), WT Rqc2p or mutant rqc2aaa 
and subjected to immunoblotting against GFP. Expression of Rqc2p variants was confirmed by 
immunoblotting against the FLAG epitope. Pgk1p served as a loading control. (b) ltn1∆ cells expressing 
GFP-s-R20RARE-mCh and either empty vector (EV), WT Rqc2p or mutant rqc2aaa were analyzed by 
fluorescence microscopy. Scale bar, 5 µm. Data obtained in collaboration with Dr. Young-Jun Choe. 
 
III.8 Stalling mRNAs are preferentially degraded via the SKI complex-
exosome pathway 
 
Ribosomal stalling has been shown to induce endonucleolytic cleavage of the aberrant transcript 
by a yet unknown endonuclease, giving rise to two mRNA fragments that can be degraded from 
the 5’ or the 3’ end by Xrn1p or the cytosolic SKI complex-exosome pathway, respectively (Doma 
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and Parker 2006, Van Hoof and Wagner 2011, Shoemaker and Green 2012). Previous studies have 
shown that the adaptor protein Ski7p, which mediates contact between the SKI complex and the 
cytosolic exosome, plays a role in NSD (Frischmeyer, van Hoof et al. 2002, van Hoof, Frischmeyer 
et al. 2002). Overexpression of Rqc2p and the stalling reporter GFP-s-R3RARE resulted in a strong 
growth defect in cells lacking LTN1 and the SKI complex helicase SKI2, but not in cells lacking 
the exonuclease XRN1 (Fig. III.25). This suggests that aberrant recombinant transcripts are 
preferentially degraded via the cytosolic SKI complex-exosome pathway, and that failure of this 
branch of mRNA surveillance leads to accumulation of faulty transcripts and thus to repeated 
rounds of translation and production of toxic aberrant polypeptides. This was further supported 
by the notion that overexpression of Rqc2p alone was already sufficient to cause a strong growth 
defect in ltn1∆ski2∆ cells, indicating that endogenous aberrant mRNAs are also preferentially 
degraded from their 3’ end and accumulate to toxic levels upon failure of the SKI complex-
exosome pathway (Fig. III.25). 
 
 
Fig. III.25: Both recombinant and endogenous faulty mRNAs are preferentially degraded via the 
cytosolic SKI complex-exosome pathway. Indicated strains expressing Rqc2p and either an empty vector 
control or GFP-s-R3RARE were grown to mid-log phase in Raffinose medium, and serial dilutions were 
spotted onto dropout plates supplied with Glucose (- Induction) or Raffinose and Galactose (+ Induction). 
Plates were incubated for 2-3 days at 30 °C. Data obtained in collaboration with Dr. Young-Jun Choe. 
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 To further confirm that the growth defect observed in ltn1∆ski2∆ cells was caused by 
impairment of the SKI complex-exosome machinery and not due to a SKI complex-independent 
effect caused by deletion of SKI2, mutant strains lacking each of the components of the SKI 
complex, i.e. Ski3p, Ski7p and Ski8p, were generated. As expected, all strains showed a strong 
growth defect upon overexpression of Rqc2p, accompanied by an enhanced formation of SDS-
resistant, Sis1p-positive aggregates (Fig. III.26a, b). Protein aggregation is a concentration-
dependent process, and thus larger Sis1p aggregates reflect more abundant stalled chains in 
ltn1∆ski7∆ and ltn1∆ski2∆ cells (Fig. III. 26b). Conversely, overexpression of Rqc2p in ltn1∆xrn1∆ 
cells did not cause a measurable growth defect and even resulted in slightly reduced levels of 
Sis1p aggregation when compared to ltn1∆ cells (Fig. III.26a, b). It is notable that the level of 
overexpressed Rqc2p is lower in ltn1∆ski7∆ and ltn1∆ski2∆ cells, indicating that there was a 
negative selection pressure due to a strong toxicity of Rqc2p in these cells (Fig. III.26b). 
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Fig. III.26: Overexpression of Rqc2p causes toxic aggregation of Sis1p in cells lacking a functional RQC 
and exosome pathway. (a) Rqc2p was expressed in the indicated strains, cells were grown to mid-log phase 
in Raffinose medium, and serial dilutions were spotted onto dropout plates supplied with Glucose 
(- Induction) or Raffinose and Galactose (+ Induction). Plates were incubated for 2-3 days at 30 °C. Data 
obtained in collaboration with Dr. Young-Jun Choe. (b) Cell extracts were prepared from the indicated 
strains expressing Rqc2p and resolved by SDD-AGE and SDS-PAGE, followed by immunoblotting against 
Sis1p. Expression of Rqc2p was confirmed by immunoblotting against the FLAG epitope. Pgk1p served as 
a loading control. 
  
 RQC assembly (and thus elongation of stalled nascent chains with CAT tails) requires 
dissociation of the stalled ribosome by the Dom34p/Hbs1p machinery. Therefore, deletion of 
DOM34 and HBS1 was expected to reduce the amount of RQC substrates, thereby reducing both 
cytotoxicity and aggregation of Sis1p. Indeed, deletion of either of the genes in an ltn1∆ski7∆ 
background efficiently suppressed the growth defect and reduced the amount of Sis1p-positive 
aggregates caused by Rqc2p overexpression (Fig. III.27a, b). 
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Fig. III.27: Inhibition of dissociation of stalled ribosomes efficiently suppresses toxic effects caused by 
Rqc2p overexpression. (a) Rqc2p was expressed in the indicated strains, cells were grown to mid-log phase 
in Raffinose medium, and serial dilutions were spotted onto dropout plates supplied with Glucose 
(- Induction) or Raffinose and Galactose (+ Induction). Plates were incubated for 2-3 days at 30 °C. Data 
obtained in collaboration with Dr. Young-Jun Choe. (b) Cell extracts were prepared from the indicated 
strains expressing Rqc2p and resolved by SDD-AGE and SDS-PAGE, followed by immunoblotting against 
Sis1p. Expression of Rqc2p was confirmed by immunoblotting against the FLAG epitope. Pgk1p served as 
a loading control.  
 
 Taken together, simultaneous impairment of RNA and ribosomal protein quality control 
results in massive accumulation of aberrant polypeptides due to repeated rounds of translation 
of faulty transcripts. However, due to the limited capacity of the RQC pathway, most stalled 
nascent chains escape CAT tail elongation and remain soluble, thereby preventing sequestration 
of essential chaperones like Sis1p to a toxic level. Overexpression of Rqc2p, however, leads to 
efficient CAT tail addition and thus strong aggregation of endogenous stalled polypeptides 
 
III.9 Overexpression of Rqc2p triggers the cytosolic heat shock response 
 
Initial studies on the RQC complex suggested a role of Rqc2p in triggering the Hsf1p-mediated 
heat shock response in the absence of LTN1 (Brandman, Stewart-Ornstein et al. 2012). Given that 
the aggregation of aberrant polypeptides depends on Rqc2p-mediated CAT tail elongation and 
that accumulation of misfolded polypeptides per se can induce the cytosolic heat shock response, 
it seemed plausible that Hsf1p signaling could be mediated – directly or indirectly – by CAT tails. 
 To test this, wildtype or mutant Rqc2p variants were expressed in WT or ltn1∆ cells, and 
steady-state levels of heat shock-inducible chaperones such as Hsp104p, Sis1p, Hsp42p and 
Hsp26p were determined (Fig. III.28a). As expected, overexpression of wildtype Rqc2p in ltn1∆ 
cells resulted in an up to two-fold upregulation of these chaperones, whereas expression of the 
CAT tail-defective mutant rqc2aaa barely affected their steady-state levels (Fig. III.28a). 
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Interestingly, deletion of LTN1 alone induced a slight upregulation of all chaperones, indicating 
that endogenous Rqc2p is already sufficient to elicit a mild heat shock response (Fig. III.28a). To 
further prove that the upregulation of the aforementioned chaperones is indeed a result of Hsf1p 
activation, β-galactosidase (lacZ) was expressed as a reporter under control of a heat shock-
inducible promoter. Coexpression of this reporter with WT Rqc2p in ltn1∆ cells resulted in a two-
fold increase in steady-state level and a 1.5-fold increase in activity of β-galactosidase, whereas 
expression of the rqc2aaa mutant did not affect β-galactosidase levels or activity (Fig. III.28b, c). 
Again, deletion of LTN1 alone was already sufficient to cause a slight increase in β-galactosidase 
levels and activity (Fig. III.28b, c). These results indicate that Rqc2p, via its ability to synthesize 
CAT tails, activates Hsf1p and thus triggers the upregulation of heat shock-inducible chaperones.  
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Fig. III.28: Rqc2p activates the cytosolic heat shock response in the absence of LTN1. (a) Cell extracts 
were prepared from WT and ltn1∆ cells expressing either empty vector (EV), wildtype Rqc2p, or mutant 
rqc2aaa,  and subjected to immunoblotting using the indicated antibodies. Expression of Rqc2p variants was 
confirmed by immunoblotting against the FLAG tag. Pgk1p served as a loading control. Band intensities 
were quantified by densitometry. (b) Cell extracts were prepared from WT and ltn1∆ cells expressing β-
Galactosidase (lacZ) under control of a heat shock-inducible promoter and either empty vector (EV), 
wildtype Rqc2p, or mutant rqc2aaa , and subjected to immunoblotting against β-Galactosidase. Expression 
of Rqc2p variants was confirmed by immunoblotting against the FLAG epitope. Pgk1p served as a loading 
control. Band intensities were quantified by densitometry. (c) The same cell extracts as used in (b) were 
assayed for β-Galactosidase activity. Error bars represent standard deviation from three independent 
experiments. 
 
III.10 Identification of endogenous stalled nascent chains 
 
In order to identify potential endogenous stalled nascent chains, we used a stable isotopic labeling 
with amino acids in cell culture (SILAC)-based mass spectrometry approach. To this end, we first 
exploited the tendency of Sis1p to coaggregate with aberrant polypeptides in order to isolate SDS-
resistant aggregates by immunoprecipitation. ltn1∆ cells harboring an empty vector were used as 
a background control and labeled with light (L) lysine. In contrast, ltn1∆ cells or ltn1∆ski7∆ cells 
overexpressing Rqc2p were labeled with medium (M) or heavy (H) lysine, respectively. 
Following immunoprecipitation of genomically tagged HA-Sis1p, LC-MS/MS analysis showed 
that 188 proteins were reproducibly enriched in SDS-resistant aggregates isolated from ltn1∆ski7∆ 
cells overexpressing Rqc2p when compared to aggregates isolated from ltn1∆ cells harboring an 
empty vector (Fig. III.29). Essentially all proteins that were enriched based on their M/L and H/M 
SILAC ratios were also identified in the H/L dataset, suggesting a synergistic effect of quantitative 
CAT tail elongation and impairment of RNA quality control on the accumulation and aggregation 
of stalled nascent chains (Fig. III.29). The list of 188 proteins identified in this experiment should 
thus contain potential endogenous stalled polypeptides. 
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Fig. III.29: Venn diagram of proteins enriched in SDS-resistant aggregates after immunoprecipitation 
of genomically tagged HA-Sis1p. SILAC ratios were calculated by comparing peak intensities between 
proteins labeled with medium and light lysine (M/L, blue circle), heavy and medium lysine (H/M, green 
circle), or heavy and light lysine (H/L, red circle). Numbers indicate the amount of proteins that were 
enriched 2-fold or higher in at least two out of three independent experiments. 
 
 Earlier work identified four genes that produce truncated transcripts, possibly due to the 
existence of cryptic polyadenylation signals within the ORF: CBP1, SIR3, AEP2, and RNA14 
(Sparks and Dieckmann 1998). Furthermore, 127 of the 826 yeast genes deposited in the PACdb 
database were predicted to contain at least one internal polyadenylation signal that could also 
give rise to alternative 3’ processing and thus truncated transcripts (Brockman, Singh et al. 2005). 
Of those, 8 proteins were also identified by mass spectrometry to be significantly enriched in SDS-
resistant aggregates, suggesting that these proteins could indeed represent stalled polypeptides 
that arise from translation of aberrant transcripts (Tab. III.1). Although RQC2 was predicted to 
contain a polyadenylation signal within its coding sequence, the massive enrichment of the 
corresponding protein in SDS-resistant aggregates is probably an artifact due to overexpression 
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of recombinant Rqc2p. Furthermore, due to its size of approximately 120 kDa, a fraction of Rqc2p 
might have been accidentally copurified during isolation of SDS-resistant aggregates from the 
gel. Immunoblotting for Rqc2p failed to detect any SDS-resistant species comigrating with 
aggregates of stalled nascent chains (data not shown). 
 
Tab. III.1 List of potential endogenous stalled nascent chains. The number of predicted internal 
polyadenylation sites was obtained from the PACdb database (Brockman, Singh et al. 2005). 
Gene  
Name 
Number of predicted int. 
polyadenylation sites 
H/L  
Ratio 
Description 
RQC2 1 29.82 Translation-associated element 2 
BAP2 1 7.24 Leu/Val/Ile amino-acid permease 
AEP2 ? 4.67 ATPase expression protein 2, mitochondrial 
ATP1 2 4.35 ATP synthase subunit alpha, mitochondrial 
PGK1 2 4.35 Phosphoglycerate kinase 
RNA14 ? 4.20 mRNA 3-end-processing protein RNA14 
SAH1 1 3.87 Adenosylhomocysteinase 
CPR6 1 3.19 Peptidyl-prolyl cis-trans isomerase CPR6 
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IV. Discussion 
 
This study presents evidence that yeast cells with defective ribosome quality control (RQC) 
produce aberrant polypeptides from mRNAs that stall during translation. Stalling can be induced 
by stretches encoding polybasic sequences, the presence of multiple rare codons, or the absence 
of an in-frame stop codon. Translation of these faulty messages leads to an irreversible block of 
translation elongation or termination known as ribosomal stalling, and to synthesis of aberrant 
polypeptides, which are mostly non-functional and can pose a serious threat to proteome 
integrity due to their propensity to form aggregates and to sequester various key proteostasis 
factors. In healthy cells, stalled ribosomes are efficiently recognized and aberrant nascent chains 
targeted for proteasomal degradation by the RQC system. Failure of this pathway, however, 
results in accumulation of these nascent chains in SDS-resistant aggregates. 
 Besides binding at the subunit interface of the stalled 60S-peptidyl-tRNA complex and 
recruiting Ltn1p, Rqc2p was recently shown to mediate the template-independent elongation of 
stalled nascent chains with alanine and threonine residues (so-called CAT tails) (Shen, Park et al. 
2015). During the course of this study, it was shown that aggregation of stalled aberrant 
polypeptides depends on the presence of these CAT tails, in a manner comparable to aggregation 
caused by the polyalanine repeats of certain disease proteins (Forood, Perez-Paya et al. 1995, 
Amiel, Trochet et al. 2004). In line with previous studies on polyQ and artificial β-sheet proteins, 
the aggregated nascent chains sequester various cellular proteostasis factors such as the essential 
Hsp40 chaperone Sis1p, thereby interfering with general protein quality control and leading to 
proteotoxic stress (Olzscha, Schermann et al. 2011, Park, Kukushkin et al. 2013). Interestingly, the 
additional impairment of exosome-mediated RNA quality control resulted in massive 
accumulation of aberrant polypeptides and a strong growth defect, but only when Rqc2p was 
overexpressed. This provides evidence that, under normal conditions, the potentially toxic nature 
of CAT tails is suppressed by the low abundance of endogenous Rqc2p and thus its limited 
capacity to quantitatively elongate stalled nascent chains. 
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IV.1 Failure of RQC leads to the formation of SDS-resistant aggregates 
  
During translation of a truncated transcript, ribosomes stall at the 3’ end of the mRNA 
due to the absence of a codon in the ribosomal A-site (Fig. IV.1, upper panel). Following 
dissociation of the stalled ribosome by the Dom34p/Hbs1p complex and mRNA decay, the RQC 
complex engages the stalled 60S-peptidyl-tRNA complex and mediates CAT tail elongation of the 
stalled nascent chain via its component Rqc2p (Fig. IV.1, upper panel). When the RQC system is 
compromised, as in the absence of Ltn1p, nascent chains are released from the ribosome in a 
nonubiquitinated form, and CAT tails mediate the formation of SDS-resistant oligomeric 
aggregates that sequester various chaperones, including the Hsp40 Sis1p, which in turn results 
in proteotoxic stress (Fig. IV.1, upper panel). Translation of mRNAs lacking an in-frame stop 
codon, however, leads to elongation of the nascent chain with a polylysine stretch due to the 
poly(A) tail being interpreted as part of the ORF (Fig. IV.1, bottom panel). Following ribosome 
dissociation, CAT tail elongation, and release of the nascent chain, the formation of SDS-resistant 
oligomeric aggregates is again mediated by the hydrophobic nature of CAT tails (Fig. IV.1, 
bottom panel). Formation of visible inclusions may then be mediated by the polybasic tracts of 
NS-proteins, consistent with earlier observations of polylysine being able to form amyloid-like β-
sheet fibrils at high pH (Fig. IV.1, bottom panel) (Fandrich and Dobson 2002). At physiological 
pH, negatively charged molecules such as polyphosphate or nucleic acids could aid in 
overcoming charge repulsion effects (Gray, Wholey et al. 2014). Again, NS-protein aggregates 
sequester various proteostasis factors, but the exact role of CAT tails in this process remains to be 
elucidated (Fig. IV.1, bottom panel). Similar to polyalanine repeats in certain disease proteins, the 
ability of polybasic sequences to form toxic aggregates has been described, e.g. in the case of Gly-
Arg or Pro-Arg dipeptide repeats in mutant C9orf72 genes associated with amyotrophic lateral 
sclerosis and frontotemporal dementia (Mori, Weng et al. 2013, Zu, Liu et al. 2013). Despite the 
absence of a clear growth defect upon RQC impairment, the aggregation of stalled nascent chains 
interferes with general protein quality control pathways and has the potential to cause chronic 
proteotoxic stress by inducing a vicious cycle of upregulation and depletion of essential 
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proteostasis factors (Hipp, Park et al. 2014, Roth, Hutt et al. 2014). Strikingly, failure of the RQC 
system is highly toxic and results in a severe growth defect when cells are exposed to additional 
proteostasis stress, such as elevated temperatures, expression of misfolding proteins, or drugs 
that decrease translational fidelity. Since aging also represents a challenge to the proteostasis 
network, it is tempting to speculate that aggregation of stalled polypeptides contributes to the 
neurodegenerative phenotype observed in Listerin-deficient mice (Chu, Hong et al. 2009). 
 
 
Fig. IV.1: Mechanism of aggregate formation upon failure of RQC. Translation of aberrant mRNAs leads 
to ribosomal stalling in the 3’ region of the transcript. Following ribosome dissociation and RQC assembly 
at the 60S-peptidyl-tRNA complex, Rqc2p mediates elongation of the stalled nascent polypeptide with CAT 
tails. Release of the modified nascent chain in a nonubiquitinated state (i.e. in the absence of Ltn1p) results 
in CAT tail-mediated aggregation and the formation of SDS-resistant oligomers that sequester key 
proteostasis players such as the Hsp40 Sis1p. In case of NS-mRNAs, stalled polypeptides carry an 
additional polylysine tract as a result of translation of the poly(A) tail. Following CAT tail-dependent 
oligomerization, polybasic stretches might aid in the formation of visible inclusions due to their ability to 
fold into highly stable amyloid-like β-sheet fibrils. E, P, A, ribosomal E-/P-/A-sites. Figure modified from 
(Choe, Park et al. 2016). 
    E  P  A 
    E  P  A 
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IV.2 The biological role of CAT tail addition 
 
Given that the aggregation of aberrant nascent chains leads to proteotoxic stress, an 
important question concerns the biological role of CAT tails. Under normal conditions, 
ubiquitination of stalled polypeptides by Ltn1p would result in their rapid degradation by the 
proteasome, thereby preventing CAT tail-mediated aggregation. One possible function of CAT 
tails could be that of a spacer peptide, which serves to push the C-terminal part of the stalled 
nascent chain out of the ribosomal exit channel. This in turn could facilitate ubiquitination of 
lysine residues in the nascent chain by Ltn1p, especially in case of non-stop proteins which 
contain a C-terminal polylysine tract due to translation of the poly(A) tail of the aberrant 
transcript (Brandman and Hegde 2016). Furthermore, the addition of CAT tails might serve in 
overcoming electrostatic interactions between polybasic stretches of non-stop proteins and the 
negatively charged ribosomal exit channel, thus facilitating Cdc48p-dependent extraction of the 
stalled nascent chain. Another hypothesis is that the ability of Rqc2p to elicit an Hsf1p-dependent 
heat shock response (HSR) is mediated by CAT tails, which would be consistent with the rqc2aaa 
mutant not being able to induce upregulation of various molecular chaperones when ribosome 
stalling occurs (Shen, Park et al. 2015, Brandman and Hegde 2016). However, it remains to be 
determined whether activation of the HSR by CAT tails is mediated via a direct effect or rather 
indirectly, e.g. by enabling aberrant polypeptides to form aggregates that in turn cause mild 
proteotoxic stress and thus induce upregulation of heat shock proteins. It also remains unclear 
how many alanine and threonine residues are normally incorporated during the course of CAT 
tail elongation, and if the corresponding aminoacyl-tRNAs are recruited in a random or ordered 
manner. An initial study describing CAT tails characterized C-terminal elongations of up to 19 
residues consisting of roughly equal amounts of alanine and threonine, but CAT tails of a much 
larger size and varying sequence could be possible (Shen, Park et al. 2015). Furthermore, the exact 
mechanism and the kinetics of CAT tail elongation by Rqc2p as well as its processivity still remain 
elusive. Since quantitative elongation of stalled nascent polypeptides with CAT tails seems to be 
limited by the abundance of endogenous Rqc2p, it would be interesting to determine whether 
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Rqc2p overexpression results in longer CAT tails or in unspecific recognition of ribosomes, e.g. 
ribosomes that undergo only transient translational pausing. 
 
IV.3 Cooperation of RNA and protein quality control pathways at the 
ribosome 
 
During the course of this study, it could be shown that simultaneous disruption of 
exosome-dependent RNA quality control and the RQC pathway leads to massive accumulation 
of stalled nascent chains, probably due to repeated translation of faulty transcripts. This 
accumulation however, proved to be highly toxic only in the context of Rqc2p overexpression, 
indicating that endogenous Rqc2p is insufficient to mediate quantitative elongation of aberrant 
polypeptides with CAT tails. This is not surprising, considering that ribosomes (≈ 200,000 
molecules per cell) outnumber the components of the RQC system by a factor of up to 1,000 
(Warner 1999, Ghaemmaghami, Huh et al. 2003). Surprisingly, mRNAs causing ribosomes to stall 
seem to be preferentially degraded via the SKI complex-exosome pathway, whereas abrogation 
of Xrn1p-dependent mRNA decay did not exhibit a toxic effect. In general, all transcripts should 
be degradable by both Xrn1p and the exosome after decapping or deadenylation, respectively. 
However, the process of deadenylation might be preferred over decapping in the case of faulty 
mRNAs, thereby favoring degradation of these transcripts from the 3’ end via the SKI complex-
exosome system. Interestingly, the adaptor protein Ski7p, which is only present in a subset of 
fungi, was also shown to be necessary for the degradation of aberrant mRNAs in earlier studies 
(Frischmeyer, van Hoof et al. 2002, van Hoof, Frischmeyer et al. 2002). Consistent with this work, 
deletion of SKI7 resulted in a phenotype that was similar, albeit less pronounced, to the one 
observed upon direct deletion of SKI complex components. The human homolog of Ski7p has just 
recently been identified as a splice variant of human Hbs1p, but it remains to be determined 
whether this factor is also involved in the degradation of aberrant transcripts in humans 
(Kowalinski, Kogel et al. 2016). Future studies could also focus on the identification of the 
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endonuclease that mediates cleavage of aberrant mRNAs in the vicinity of stalled ribosomes and 
triggers the NGD pathway. 
 
IV.4 Identification of endogenous stalled nascent chains 
 
Recent studies have provided detailed insights into the molecular mechanisms of the RQC 
pathway and its structural basis using recombinant transcripts containing stalling features (Shao, 
Brown et al. 2015, Choe, Park et al. 2016, Yonashiro, Tahara et al. 2016). However, the identity of 
endogenous stalled nascent chains as well as the frequency of stalling events and the reasons for 
ribosomal stalling under normal conditions are still unknown. Recent work suggests that less 
than 5 % of all nascent chains in a cell are subject to cotranslational ubiquitination, suggesting 
that the amount of polypeptides that is getting ubiquitinated by Ltn1p as a result of ribosomal 
stalling is even lower (Duttler, Pechmann et al. 2013). This is consistent with ribosomes 
outnumbering RQC complexes by a factor of 100-1,000 in a yeast cell (Warner 1999, 
Ghaemmaghami, Huh et al. 2003). Since every transcript can potentially be subject to erroneous 
RNA maturation, endonucleolytic cleavage or spontaneous mutations, transcription of virtually 
any gene could potentially result in an aberrant mRNA. However, mRNA maturation processes 
such as polyadenylation are not always 100% specific and rely on conserved sequence motifs 
within the pre-mRNA. Thus, premature addition of a poly(A) tail can also occur due to 
recognition of a cryptic polyadenylation site within the coding sequence of a gene, resulting in 
generation of a non-stop mRNA. Whereas initial in silico studies showed that up to 0.8 % of yeast 
ORFs contain a cryptic poly(A) signal that could lead to premature polyadenylation, later work 
suggested an even higher number (Frischmeyer, van Hoof et al. 2002, Brockman, Singh et al. 2005).  
Translation of these truncated messages could possibly result in ribosomal stalling, and a defect 
in exosome-mediated mRNA quality control together with Rqc2p overexpression should result 
in strong aggregation of the respective aberrant translation products. Indeed, a SILAC-based 
approach led to the identification of 7 genes that not only showed strong enrichment in SDS-
Discussion 
 
116 
 
resistant aggregates isolated from ltn1∆ski7∆ cells overexpressing Rqc2p, but were also predicted 
to have at least one cryptic polyadenylation signal within their coding sequence. The 7 genes 
corresponding to these proteins are thus promising candidates for production of stalled nascent 
chains. However, as premature polyadenylation would only result in the production of NS-
mRNAs, these candidates might only represent a subset of all endogenous aberrant polypeptides. 
The prediction of internal stalling features, such as stretches containing rare codons, or having a 
tendency to form secondary structures, is challenging. Furthermore, random events that would 
lead to generation of truncated mRNAs, e.g. unspecific endonucleolytic cleavage or errors during 
splicing, are impossible to predict. Therefore, the major causes for ribosomal stalling still remain 
elusive. Future studies should try to combine in silico and in vivo approaches to identify the 
reasons for ribosomal stalling under physiologic conditions. 
 In summary, the work presented here describes the mechanism of aggregation for 
stalled nascent polypeptides and the reasons for proteotoxicity upon RQC impairment. It could 
also be shown that RNA and protein quality control pathways tightly cooperate at the ribosome 
in order to protect cells from the deleterious effects of aberrant polypeptides. Furthermore, this 
study provides first evidence for the identification of endogenous stalled nascent chains, and also 
suggests a model for the formation of SDS-resistant aggregates in vitro. These findings provide 
novel insights into the mechanisms of protein quality control in eukaryotic cells and could 
possibly aid in understanding the role of protein aggregation in neurodegenerative diseases.
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VI. Appendix 
 
Tab. VI.1: Interactors of Sis-HA. Interactors sorted according to their enrichment in SDS-resistant 
aggregates from high to low values (M/L ratio corresponding to Sis1-HA in ltn1∆ cells overexpressing 
Rqc2p compared to Sis1-HA in ltn1∆ cells harboring an empty vector; H/M ratio corresponding to Sis1-HA 
in ltn1∆ski7∆ cells overexpressing Rqc2p compared to Sis1-HA in ltn1∆ cells overexpressing Rqc2p; H/L 
ratio corresponding to Sis1-HA in ltn1∆ski7∆ cells overexpressing Rqc2p compared to Sis1-HA in ltn1∆ cells 
harboring an empty vector). Ratios represent the median of three independent experiments. Listed are 
proteins that were enriched 2-fold or more in at least 2 out of 3 independent experiments. MW, molecular 
weight; -/-, SILAC ratio not determined. Potential endogenous stalled polypeptides are highlighted in blue. 
Protein 
ID 
Gene 
Name 
Description 
MW 
(kDa) 
M/L 
Ratio 
H/M 
Ratio 
H/L 
Ratio 
Q12532 RQC2 Translation-associated element 2 119,1 28,32 -/- 29,82 
Q12127; 
Q7LHD1 
CCW12 Covalently-linked cell wall protein 12 13,1 10,42 2,68 24,73 
P48510 DSK2 Ubiquitin domain-containing protein 
DSK2 
39,3 6,95 2,33 17,13 
P40956 GTS1 Protein GTS1 44,4 5,21 3,07 16,34 
Q07442 BDF2 Bromodomain-containing factor 2 72,5 -/- 12,64 16,01 
P32478 HSP150 Cell wall mannoprotein HSP150 41,1 6,68 2,18 15,59 
P40529 AGE2 
ADP-ribosylation factor GTPase-
activating protein effector protein 2 
32,6 6,69 -/- 13,04 
P38011 ASC1 
Guanine nucleotide-binding protein 
subunit beta-like protein 
34,8 3,49 4,17 12,65 
Q12118 SGT2 
Small glutamine-rich tetratricopeptide 
repeat-containing protein 2 
37,2 6,22 2,06 12,07 
P22202; 
P09435 
SSA4; 
SSA3 
Heat shock protein SSA4; 
Heat shock protein SSA3 
69,7 3,90 2,35 11,55 
Q04964 SML1 
Ribonucleotide reductase inhibitor 
protein SML1 
11,8 5,36 -/- 11,34 
O14467 MBF1 Multiprotein-bridging factor 1 16,4 4,19 2,69 11,01 
Q07655 WHI4 Protein WHI4 70,7 2,79 3,12 9,67 
P36102 PAN3 
PAB-dependent poly(A)-specific 
ribonuclease subunit PAN3 
76,5 5,12 2,51 8,92 
P07213 TOM70 
Mitochondrial import receptor subunit 
TOM70 
70,1 2,36 3,13 8,69 
Q08925 MRN1 RNA-binding protein MRN1 68,7 -/- 5,08 8,68 
P38225 FAT1 
Very long-chain fatty acid transport 
protein 
77,1 -/- 4,86 8,50 
P09436 ILS1 Isoleucine--tRNA ligase, cytoplasmic 123,0 -/- 4,50 8,41 
P32618 YEL043W Uncharacterized protein YEL043W 106,1 3,76 2,93 8,28 
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P32909 SMY2 Protein SMY2 81,4 4,64 2,77 7,95 
P06169; 
P26263; 
P16467 
PDC1 Pyruvate decarboxylase isozyme 1 61,5 2,16 3,73 7,67 
P00359; 
P00358 
TDH3; 
TDH2 
Glyceraldehyde-3-phosphate 
dehydrogenase 3; 
Glyceraldehyde-3-phosphate 
dehydrogenase 2 
35,7 2,90 2,72 7,46 
P38084 BAP2 Leu/Val/Ile amino-acid permease 67,8 -/- 4,15 7,24 
P19358 SAM2 S-adenosylmethionine synthase 2 42,3 4,04 -/- 7,12 
P40185 MMF1 Protein MMF1, mitochondrial 15,9 2,83 -/- 7,08 
P09950 HEM1 
5-aminolevulinate synthase, 
mitochondrial 
59,4 2,05 3,14 7,03 
P07246 ADH3 Alcohol dehydrogenase 3, mitochondrial 40,4 -/- 3,91 7,01 
P35191 MDJ1 DnaJ homolog 1, mitochondrial 55,6 -/- 3,32 6,95 
P41338 ERG10 Acetyl-CoA acetyltransferase 41,7 3,11 -/- 6,94 
P05694 MET6 
5-methyltetrahydropteroyltriglutamate--
homocysteine methyltransferase 
85,9 -/- 3,81 6,92 
P35997; 
P38711 
RPS27A; 
RPS27B 
40S ribosomal protein S27-A; 
40S ribosomal protein S27-B 
8,9 2,80 2,46 6,88 
P19414; 
P39533 
ACO1 Aconitate hydratase, mitochondrial 85,4 -/- 3,81 6,83 
P21954; 
P53982 
IDP1 
Isocitrate dehydrogenase [NADP], 
mitochondrial 
48,2 -/- 4,78 6,66 
P14540 FBA1 Fructose-bisphosphate aldolase 39,6 2,21 2,39 6,65 
Q07959 IZH3 ADIPOR-like receptor IZH3 62,6 2,61 2,58 6,48 
P48527 MSY1 Tyrosine--tRNA ligase, mitochondrial 55,3 -/- 4,72 6,43 
P13663 HOM2 Aspartate-semialdehyde dehydrogenase 39,5 -/- -/- 6,40 
P54115 ALD6 
Magnesium-activated aldehyde 
dehydrogenase, cytosolic 
54,4 2,41 2,46 6,29 
P25560 RER1 Protein RER1 22,3 -/- 5,79 6,25 
P35197 GCS1 
ADP-ribosylation factor GTPase-
activating protein GCS1 
39,3 -/- 2,83 6,16 
P23254 TKL1 Transketolase 1 73,8 3,52 -/- 6,04 
P04387 GAL80 
Galactose/lactose metabolism regulatory 
protein GAL80 
48,3 -/- 4,40 5,93 
P14907 NSP1 Nucleoporin NSP1 86,5 3,91 -/- 5,92 
Q08280 BSC6 Bypass of stop codon protein 6 55,1 -/- 3,57 5,88 
P00830 ATP2 
ATP synthase subunit beta, 
mitochondrial 
54,8 -/- 2,59 5,85 
P34761 WHI3 Protein WHI3 71,3 2,81 2,80 5,80 
P32476 ERG1 Squalene monooxygenase 55,1 -/- 3,55 5,70 
P07257 QCR2 
Cytochrome b-c1 complex subunit 2, 
mitochondrial 
40,5 -/- 3,60 5,57 
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P15019 TAL1 Transaldolase 37,0 2,48 2,23 5,43 
P40516 SEE1 N-lysine methyltransferase SEE1 28,7 2,90 -/- 5,42 
P43616 DUG1 Cys-Gly metallodipeptidase DUG1 52,9 -/- 3,30 5,37 
P37292 SHM1 
Serine hydroxymethyltransferase, 
mitochondrial 
53,7 -/- 3,30 5,31 
P40341 YTA12 
Mitochondrial respiratory chain 
complexes assembly protein YTA12 
93,3 -/- 2,90 5,29 
P08417 FUM1 Fumarate hydratase, mitochondrial 53,2 -/- 3,40 5,26 
P33307 CSE1 Importin alpha re-exporter 109,4 -/- -/- 5,25 
P40047 ALD5 
Aldehyde dehydrogenase 5, 
mitochondrial 
56,7 -/- 3,68 5,22 
P32767 KAP122 Importin beta-like protein KAP122 123,5 -/- -/- 5,14 
P12709 PGI1 Glucose-6-phosphate isomerase 61,3 2,55 2,56 5,14 
P40531 GVP36 Protein GVP36 36,7 2,23 2,24 5,10 
P00942 TPI1 Triosephosphate isomerase 26,8 2,03 2,24 4,97 
P39743 RVS167 
Reduced viability upon starvation 
protein 167 
52,8 3,98 -/- 4,95 
P41940 PSA1 Mannose-1-phosphate guanyltransferase 39,6 2,06 -/- 4,90 
P00924 ENO1 Enolase 1 46,8 2,76 -/- 4,85 
P54885 PRO2 Gamma-glutamyl phosphate reductase 49,7 2,25 2,04 4,83 
P07245 ADE3 
C-1-tetrahydrofolate synthase, 
cytoplasmic; 
Methylenetetrahydrofolate 
dehydrogenase; 
Methenyltetrahydrofolate 
cyclohydrolase; 
Formyltetrahydrofolate synthetase 
102,2 -/- -/- 4,75 
P38879 EGD2 
Nascent polypeptide-associated 
complex subunit alpha 
18,7 2,32 2,23 4,68 
P22136 AEP2 
ATPase expression protein 2, 
mitochondrial 
67,5 -/- 4,36 4,67 
Q05016 YMR226C 
Uncharacterized oxidoreductase 
YMR226C 
29,2 2,64 -/- 4,63 
P07262; 
P39708 
GDH1; 
GDH3 
NADP-specific glutamate 
dehydrogenase 1; 
NADP-specific glutamate 
dehydrogenase 2 
49,6 4,17 -/- 4,62 
P05626 ATP4 ATP synthase subunit 4, mitochondrial 26,9 -/- -/- 4,57 
P25039 MEF1 Elongation factor G, mitochondrial 84,6 -/- 2,94 4,51 
P32582 CYS4 Cystathionine beta-synthase 56,0 2,82 2,01 4,51 
Q03648 YMR209C Uncharacterized protein YMR209C 52,2 2,78 -/- 4,47 
P06168 ILV5 
Ketol-acid reductoisomerase, 
mitochondrial 
44,4 -/- 2,60 4,47 
P25340 ERG4 Delta(24(24(1)))-sterol reductase 56,0 -/- -/- 4,42 
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P07256 COR1 
Cytochrome b-c1 complex subunit 1, 
mitochondrial 
50,2 -/- 2,38 4,39 
P40850 MKT1 Protein MKT1 94,5 2,63 2,59 4,39 
P07251 ATP1 
ATP synthase subunit alpha, 
mitochondrial 
58,6 -/- 2,12 4,35 
P00560 PGK1 Phosphoglycerate kinase 44,7 2,54 2,28 4,35 
P09440 MIS1 
C-1-tetrahydrofolate synthase, 
mitochondrial; 
Methylenetetrahydrofolate 
dehydrogenase; 
Methenyltetrahydrofolate 
cyclohydrolase; 
Formyltetrahydrofolate synthetase 
106,2 -/- 2,61 4,31 
P32454 APE2 Aminopeptidase 2, mitochondrial 107,8 -/- 2,21 4,29 
Q04894 ADH6 
NADP-dependent alcohol 
dehydrogenase 6 
39,6 2,22 -/- 4,28 
P25298 RNA14 mRNA 3-end-processing protein RNA14 80,0 2,42 -/- 4,20 
P14065 GCY1 Protein GCY 35,1 3,21 -/- 4,14 
P07284 SES1 Serine--tRNA ligase, cytoplasmic 53,3 2,77 -/- 4,14 
P16387 PDA1 
Pyruvate dehydrogenase E1 component 
subunit alpha, mitochondrial 
46,3 -/- 3,15 4,02 
P38260 FES1 Hsp70 nucleotide exchange factor FES1 32,6 2,41 -/- 3,98 
P38720; 
P53319 
GND1 
6-phosphogluconate dehydrogenase, 
decarboxylating 1 
53,5 2,29 -/- 3,98 
P38986 ASP1 L-asparaginase 1 41,4 -/- -/- 3,95 
P36060 MCR1 
NADH-cytochrome b5 reductase 2; 
NADH-cytochrome b5 reductase p34 
form; 
NADH-cytochrome b5 reductase p32 
form 
34,1 3,32 -/- 3,93 
P32485 HOG1 Mitogen-activated protein kinase HOG1 48,9 3,02 -/- 3,91 
P39954 SAH1 Adenosylhomocysteinase 49,1 2,41 -/- 3,87 
P00925 ENO2 Enolase 2 46,9 2,31 -/- 3,83 
P38323 MCX1 
Mitochondrial clpX-like chaperone 
MCX1 
57,9 -/- -/- 3,82 
P25294 SIS1 Protein SIS1 37,6 2,52 -/- 3,78 
Q3E842 
YMR122
W-A 
Uncharacterized endoplasmic reticulum 
membrane protein YMR122W-A 
8,0 -/- -/- 3,77 
P48837 NUP57 Nucleoporin NUP57 57,5 -/- -/- 3,70 
P11986 INO1 Inositol-3-phosphate synthase 59,6 -/- 2,62 3,67 
P05317 RPP0 60S acidic ribosomal protein P0 33,7 -/- -/- 3,66 
P31116 HOM6 Homoserine dehydrogenase 38,5 2,47 -/- 3,66 
P32487 LYP1 Lysine-specific permease 68,1 -/- -/- 3,62 
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P25379 CHA1 
Catabolic L-serine/threonine 
dehydratase; 
L-serine dehydratase; 
L-threonine dehydratase 
39,3 -/- -/- 3,61 
P34227 PRX1 Mitochondrial peroxiredoxin PRX1 29,5 -/- 2,83 3,57 
P48589 RPS12 40S ribosomal protein S12 15,5 -/- -/- 3,54 
Q12166 LEU9 
2-isopropylmalate synthase 2, 
mitochondrial 
67,2 -/- 4,06 3,52 
P00950 GPM1 Phosphoglycerate mutase 1 27,6 -/- -/- 3,52 
P32316 ACH1 Acetyl-CoA hydrolase 58,7 -/- 2,56 3,51 
P08067 RIP1 
Cytochrome b-c1 complex subunit 
Rieske, mitochondrial 
23,4 -/- -/- 3,48 
P02992 TUF1 Elongation factor Tu, mitochondrial 48,0 -/- 2,48 3,46 
P46951 YPP1 Cargo-transport protein YPP1 95,4 -/- -/- 3,39 
Q02642 EGD1 
Nascent polypeptide-associated 
complex subunit beta-1 
17,0 -/- -/- 3,38 
P53598 LSC1 
Succinyl-CoA ligase [ADP-forming] 
subunit alpha, mitochondrial 
35,0 -/- -/- 3,37 
Q06010 STE23 A-factor-processing enzyme 117,6 -/- -/- 3,32 
P12695 LAT1 
Dihydrolipoyllysine-residue 
acetyltransferase component 
of pyruvate dehydrogenase complex, 
mitochondrial 
51,8 -/- 2,20 3,31 
P00817 IPP1 Inorganic pyrophosphatase 32,3 -/- -/- 3,29 
P54838 DAK1 Dihydroxyacetone kinase 1 62,2 2,59 -/- 3,28 
P40474 QDR2 Quinidine resistance protein 2 59,6 -/- 2,32 3,26 
P15625 FRS2 
Phenylalanine--tRNA ligase alpha 
subunit 
57,5 2,21 -/- 3,23 
P02400 RPP2B 60S acidic ribosomal protein P2-beta 11,1 2,22 -/- 3,21 
P38077 ATP3 
ATP synthase subunit gamma, 
mitochondrial 
34,4 -/- 2,17 3,20 
Q12230 LSP1 
Sphingolipid long chain base-responsive 
protein LSP1 
38,1 -/- -/- 3,20 
P00331 ADH2 Alcohol dehydrogenase 2 36,7 -/- 2,09 3,20 
P14905 CBS2 
Cytochrome B translational activator 
protein CBS2 
44,6 -/- -/- 3,19 
P53691 CPR6 
Peptidyl-prolyl cis-trans isomerase 
CPR6 
42,1 2,09 -/- 3,19 
P13045 GAL3 Protein GAL3 58,1 2,20 -/- 3,14 
P38196 FUI1 Uridine permease 72,2 -/- 2,44 3,12 
Q02805 ROD1 Protein ROD1 92,3 2,83 -/- 3,11 
P31383 TPD3 
Protein phosphatase PP2A regulatory 
subunit A 
70,9 -/- -/- 3,06 
P32263 PRO3 Pyrroline-5-carboxylate reductase 30,1 -/- 2,13 3,03 
P38625 GUA1 GMP synthase [glutamine-hydrolyzing] 58,5 2,25 -/- 3,02 
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P26321 RPL5 60S ribosomal protein L5 33,7 -/- -/- 2,99 
P48353 HLJ1 Protein HLJ1 25,0 -/- 2,53 2,93 
P18900 COQ1 
Hexaprenyl pyrophosphate synthase, 
mitochondrial 
52,6 -/- -/- 2,92 
P0CS90; 
P39987 
SSC1 Heat shock protein SSC1, mitochondrial 70,6 -/- -/- 2,91 
Q12480 AIM45 
Probable electron transfer flavoprotein 
subunit alpha, mitochondrial 
36,8 -/- -/- 2,86 
Q05050 EIS1 Eisosome protein 1 93,3 2,36 -/- 2,85 
P42943 CCT7 T-complex protein 1 subunit eta 59,7 -/- -/- 2,85 
P08018 PBS2 MAP kinase kinase PBS2 72,7 2,46 -/- 2,84 
Q05468 RQC1 Uncharacterized protein YDR333C 83,4 -/- -/- 2,83 
P17505 MDH1 Malate dehydrogenase, mitochondrial 35,7 -/- 2,16 2,82 
P15424 MSS116 
ATP-dependent RNA helicase MSS116, 
mitochondrial 
76,3 -/- 2,06 2,80 
P43603; 
P32793 
LSB3 LAS seventeen-binding protein 3 49,3 2,64 -/- 2,75 
Q12349 ATP14 ATP synthase subunit H, mitochondrial 14,1 3,09 -/- 2,70 
P37291 SHM2 
Serine hydroxymethyltransferase, 
cytosolic 
52,2 -/- -/- 2,69 
P00958 MES1 Methionine--tRNA ligase, cytoplasmic 85,7 -/- -/- 2,66 
P09624 LPD1 
Dihydrolipoyl dehydrogenase, 
mitochondrial 
54,0 -/- -/- 2,63 
P40851 AXL1 Putative protease AXL1 138,3 2,22 -/- 2,62 
P53252 PIL1 
Sphingolipid long chain base-responsive 
protein PIL1 
38,3 2,01 -/- 2,58 
Q12402 YOP1 Protein YOP1 20,3 -/- -/- 2,58 
P39936 TIF4632 
Eukaryotic initiation factor 4F subunit 
p130 
103,9 -/- 2,03 2,56 
P06787 CMD1 Calmodulin 16,1 -/- -/- 2,56 
P39079 CCT6 T-complex protein 1 subunit zeta 59,9 -/- 2,02 2,55 
P0CX53; 
P0CX54 
RPL12A; 
RPL12B 
60S ribosomal protein L12-A; 
60S ribosomal protein L12-B 
17,8 -/- -/- 2,54 
P00330 ADH1 Alcohol dehydrogenase 1 36,8 -/- -/- 2,51 
P38085 TAT1 
Valine/tyrosine/tryptophan amino-acid 
permease 1 
68,8 -/- -/- 2,50 
P15705 STI1 Heat shock protein STI1 66,3 -/- -/- 2,44 
P47143 ADO1 Adenosine kinase 36,4 -/- -/- 2,42 
P06101 CDC37 Hsp90 co-chaperone Cdc37 58,4 2,27 -/- 2,41 
P33418 LOS1 Exportin-T 126,8 -/- -/- 2,41 
P32457 CDC3 Cell division control protein 3 60,1 -/- -/- 2,41 
P32353 ERG3 C-5 sterol desaturase 42,7 -/- -/- 2,40 
P53278 YGR130C Uncharacterized protein YGR130C 92,7 2,06 -/- 2,39 
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P14922 CYC8 
General transcriptional corepressor 
CYC8 
107,2 2,19 -/- 2,36 
P22203 VMA4 V-type proton ATPase subunit E 26,5 -/- -/- 2,36 
P29311 BMH1 Protein BMH1 30,1 -/- -/- 2,35 
P00890; 
P08679 
CIT1 Citrate synthase, mitochondrial 53,4 2,21 -/- 2,35 
P23248 RPS1B 40S ribosomal protein S1-B 28,8 -/- -/- 2,35 
P04807 HXK2 Hexokinase-2 53,9 -/- -/- 2,34 
P05319 RPP2A 60S acidic ribosomal protein P2-alpha 10,7 -/- -/- 2,31 
P40215 NDE1 
External NADH-ubiquinone 
oxidoreductase 1, mitochondrial 
62,8 -/- -/- 2,31 
P04147 PAB1 
Polyadenylate-binding protein, 
cytoplasmic and nuclear 
64,3 -/- -/- 2,29 
P19882 HSP60 Heat shock protein 60, mitochondrial 60,8 -/- -/- 2,27 
P09457 ATP5 ATP synthase subunit 5, mitochondrial 22,8 -/- 2,17 2,26 
P39968 VAC8 Vacuolar protein 8 63,2 -/- -/- 2,26 
Q04947 RTN1 Reticulon-like protein 1 32,9 -/- -/- 2,20 
Q12449 AHA1 Hsp90 co-chaperone AHA1 39,4 -/- -/- 2,18 
P02829 HSP82 
ATP-dependent molecular chaperone 
HSP82 
81,4 -/- -/- 2,18 
P38217 KAP104 Importin subunit beta-2 103,7 -/- -/- 2,17 
P53276 UTP8 
U3 small nucleolar RNA-associated 
protein 8 
80,2 -/- -/- 2,16 
Q02773 RPM2 
Ribonuclease P protein component, 
mitochondrial 
139,4 -/- -/- 2,15 
P00549 CDC19 Pyruvate kinase 1 54,5 -/- -/- 2,14 
P23301; 
P19211 
HYP2 
Eukaryotic translation initiation factor 
5A-1 
17,1 -/- -/- 2,13 
P10592 SSA2 Heat shock protein SSA2 69,5 -/- -/- 2,11 
Q08179 MDM38 
Mitochondrial distribution and 
morphology protein 38 
65,0 -/- 2,16 2,10 
P53303 ZPR1 Zinc finger protein ZPR1 55,1 -/- -/- 2,09 
P04397 GAL10 
Bifunctional protein GAL10;UDP-
glucose 4-epimerase; 
Aldose 1-epimerase 
78,2 2,08 -/- 2,06 
P19659 GAL11 
Mediator of RNA polymerase II 
transcription subunit 15 
120,3 2,34 -/- 2,04 
Q12329 HSP42 Heat shock protein 42 42,8 -/- -/- 2,00 
P08524 ERG20 Farnesyl pyrophosphate synthase 40,5 2,43 -/- -/- 
P27472; 
P23337 
GSY2 Glycogen [starch] synthase isoform 2 80,1 2,00 -/- -/- 
 
